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Abstract 
Social anxiety disorder (SAD) and substance use disorders co-occur at a high rate 
in clinical and epidemiological samples. Despite the high comorbidity between 
these diagnoses, and the poorer outcomes that characterise this clinical 
population, few studies have examined the potential mechanisms underlying the 
co-occurrence of SAD and substance misuse (i.e., hazardous substance use, where 
diagnosis may or may not be specified). Drawing on previous research, the focus 
of this thesis was to examine whether a personality profile characterised by 
elevated impulsivity may underlie the co-occurrence of social anxiety and 
substance misuse. In particular, this thesis employed a two-facet conceptualisation 
of impulsivity, which is consistent with the findings of several factor analytic 
studies examining the multidimensional nature of impulsivity. Within the clinical 
literature these two facets have been termed rash impulsiveness (i.e., rash 
behaviour with lack of forethought for future consequences) and reward 
sensitivity (i.e., sensitivity to rewarding stimuli). In order to investigate the utility 
of a two-facet conceptualisation of impulsivity in understanding the relationship 
between social anxiety and substance misuse, two cross-sectional studies were 
conducted. Study one was conducted in a community sample (n = 351) using self-
report measures. Consistent with hypotheses, the findings of a latent class analysis 
indicated that two qualitatively distinct social anxiety subgroups could be 
identified. Specifically, the first social anxiety subgroup was characterised by 
prototypical SAD symptomatology (i.e., behavioural inhibition and risk-
avoidance), whereas the second social anxiety subgroup was characterised by 
elevated rash impulsiveness, reward sensitivity, risk-taking and co-occurring 
substance misuse. Study two was conducted using self-report methodology in a 
 
 
 
xiv 
clinical sample (n = 74) of individuals suffering from social anxiety 
symptomatology who were seeking treatment for their substance use disorder. 
The data did not support hypotheses that rash impulsiveness and reward 
sensitivity would moderate the relationship between social anxiety symptoms and 
substance misuse. Post-hoc analyses demonstrated that rash impulsiveness 
moderated the relationship between social anxiety symptoms and substance 
misuse in a community sample. It was argued that sample or qualitative 
differences between individuals in clinical and community samples may explain 
the differences between findings. Overall, this thesis demonstrates that a subset of 
socially anxious individuals are characterised by an impulsive personality profile, 
which may underlie the co-occurrence of social anxiety and substance misuse. It 
was postulated that for a subset of individuals with social anxiety symptoms, a 
personality style characterised by elevated reward sensitivity may represent a risk 
factor for the onset of substance misuse, whereas elevated rash impulsiveness 
may underlie the exacerbation and maintenance of substance misuse. Assessment, 
prevention and treatment implications were discussed. It was concluded that the 
two-facet conceptualisation of impulsivity warrants further investigation in 
research examining the co-occurrence of social anxiety and substance misuse.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
Synopsis 
The high prevalence of social anxiety disorder (SAD) among individuals 
seeking treatment for substance use disorders has been well documented (Bakken, 
Landheim, & Vaglum, 2005; Staiger, Ricciardelli, McCabe, Young, & Cross, 
2008). According to Australian data, approximately 40% of individuals presenting 
for treatment of their substance use disorder also suffer from SAD (Staiger et al., 
2008). Notably, evidence suggests that individuals with subthreshold symptoms 
of SAD are more likely to develop a co-occurring substance use disorder than 
individuals who meet diagnostic criteria for SAD (Crum & Pratt, 2001; 
Merikangas, Avenevoli, Acharyya, Zhang, & Angst, 2002; Robinson, Sareen, 
Cox, & Bolton, 2011). In spite of this finding, individuals who do not meet 
diagnostic criteria for SAD are often excluded from comorbidity research (e.g., 
Buckner, Timpano, Zvolensky, Sachs-Ericsson, & Schmidt, 2008; Driessen et al., 
2001). For this reason, the studies reported in this thesis will specifically include 
individuals with subthreshold SAD symptomatology.  
Whilst SAD tends to precede the onset of comorbid conditions (Kessler et 
al., 2005), it is clear that SAD alone does not predict the onset of substance use 
disorders, as only a proportion of SAD sufferers develop co-occurring substance 
use diagnoses (Buckner et al., 2012; Lecrubier et al., 2000; Ruscio et al., 2008). 
Hence, it seems that a subset of SAD sufferers are at greater risk of developing 
this specific comorbidity. Given the co-occurrence of SAD and substance misuse 
(i.e., hazardous substance use, where diagnosis may or may not be specified) 
compromises treatment efficacy for either disorder (Randall, Thomas, & Thevos, 
2001), and is associated with increased symptom severity and poorer clinical 
outcomes (Bakken et al., 2005), it is important to examine the mechanisms that 
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may underlie the relationship between these disorders. Such research may inform 
the development of preventative and treatment interventions that target the 
mechanisms involved in the onset and maintenance of co-occurring SAD and 
substance misuse. 
 A small series of empirical studies investigating heterogeneity among 
socially anxious individuals has shed light on etiological variables that may 
explain the relationship between SAD and substance misuse. Specifically, 
research suggests that a subset of “atypical” socially anxious individuals are 
characterised by a number of impulsive-like traits and behaviours, including 
hostile interpersonal problems, aggression, novelty seeking, substance use, and 
risk-taking (Kachin, Newman, & Pincus, 2001; Kashdan, Elhai, & Breen, 2008; 
Kashdan & Hofmann, 2008; Kashdan, McKnight, Richey, & Hofmann, 2009). 
Although these findings may seem paradoxical considering the characteristics that 
are typically associated with SAD (i.e., behavioural inhibition, shyness and risk-
avoidance; Lorian & Grisham, 2010; Stein & Stein, 2008), these atypical 
characteristics may provide an etiological explanation as to why a subset of SAD 
sufferers develop substance use disorders while others do not. Considering the 
well-established relationship between high levels of impulsivity and the use and 
misuse of substances (Fergusson, Boden, & Horwood, 2008; Sher, Bartholow, & 
Wood, 2000), this thesis will expand on previous findings by examining whether 
a personality profile characterised by elevated impulsivity underlies the co-
occurrence of social anxiety and substance misuse.  
Whilst impulsivity is prominent in the substance misuse literature, it is 
important to acknowledge that this trait is central in several major theories of 
personality (e.g., Cloninger, 1987; Eysenck, 1987; Gray, 1987) and is a core 
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feature of several psychiatric diagnoses (American Psychiatric Association 
[APA], 2000). Thus, impulsivity is frequently measured construct within clinical 
literature. In spite of this, evidence suggests that several of the measures that are 
used to assess this trait are only modestly correlated (Caseras, Àvila, & Torrubia, 
2003; Dolan & Fullam, 2004; Monterosso & Ainslie, 1999), and are in fact 
capturing different aspects of impulsivity (Caseras et al., 2003; Miller, Joseph, & 
Tudway, 2004). To address this limitation, the present thesis will draw upon a 
series of factor analytic studies (e.g., Franken & Muris, 2006b; Quilty & Oakman, 
2004), which have consistently found that impulsivity consists of two distinct but 
related facets. Dawe and Loxton (2004) termed these two facets of impulsivity 
“reward sensitivity” and “rash impulsiveness”.  
 Theoretically, reward sensitivity is considered to be a part of the 
Behavioural Activation System (BAS), which stems from Gray’s Reinforcement 
Sensitivity Theory (RST; Gray, 1987). Gray (1987) held that those with BAS 
sensitivity are sensitive to signals of reward, which suggests that these individuals 
are more likely to engage in goal-directed action and experience positive 
emotions when they are exposed to signals of impending reward (Carver & 
White, 1994). The other facet of impulsivity, termed rash impulsiveness, is 
associated with disinhibition and the inability to stop engaging in approach 
behaviour despite the potential for negative consequences (Loxton, Nguyen, 
Casey, & Dawe, 2008).  
Importantly, this shift from a unidimensional perspective of impulsivity 
has significant implications for theory and clinical research. Specifically, the two-
facet conceptualisation of impulsivity captures the multidimensional nature of this 
trait, which will ultimately enhance knowledge about how rash impulsiveness and 
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reward sensitivity differentially relate to behaviours, psychological constructs, 
and diagnoses. In fact, it has been argued that distinguishing between different 
impulsive processes has the potential to enhance knowledge regarding specific 
personality risk (Dick et al., 2010). For example, Dawe and Loxton (2004) have 
proposed that reward sensitivity relates to the motivating factors that are behind 
the initial decision to use a substance, whereas rash impulsiveness is posited to 
relate to the decreased ability to cease using substances in spite of negative 
consequences. Notably, there is evidence supporting Dawe and Loxton’s 
contention that reward sensitivity and rash impulsiveness play differential roles in 
the onset and maintenance of substance misuse (see Gullo, Dawe, 
Kambouropoulos, Staiger, & Jackson, 2010; Kabbani & Kambouropoulos, 2013; 
Lyvers, Duff, Basch, & Edwards, 2012). 
Furthermore, research has begun to examine the involvement of rash 
impulsiveness and reward sensitivity in the etiology of comorbidity (i.e., the co-
occurrence of two psychiatric disorders or the co-occurrence of a psychiatric 
disorder with a substance use disorder), with a particular focus on the co-
occurrence of two disorders, which are appetitive in nature (e.g., bulimia nervosa 
and substance misuse; Kane, Loxton, Staiger, & Dawe, 2004). Specifically, Kane 
et al. (2004) proposed that elevated rash impulsiveness and reward sensitivity 
may represent a shared personality vulnerability underlying the co-occurrence of 
bulimia nervosa and substance misuse. In contrast, the relationship between 
impulsivity and anxiety has traditionally been conceived of as orthogonal (Barratt, 
1965; Gray, 1987). More recently however, it has been postulated that impulsivity 
and anxiety are dimensional traits (Corr, 2004). This suggests that is possible for 
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individuals to be characterised by elevated levels of anxiety and impulsivity 
concomitantly.  
In light of recent research suggesting that a subset of individuals with 
social anxiety symptomatology are characterised by impulsive-like traits, which 
are involved in the onset and maintenance of substance misuse (Fergusson et al., 
2008; Sher et al., 2000), this thesis argues that a subset of socially anxious 
individuals, who are characterised by elevated levels of rash impulsiveness and 
reward sensitivity, may be at higher risk of developing co-occurring substance 
misuse. Hence, the interaction between social anxiety and both facets of 
impulsivity may pose a specific risk for the development of comorbid substance 
misuse. This issue will be the main focus of this thesis.  
In summary, the findings of this thesis will be presented in seven chapters. 
Chapter one will provide an overview of co-occurring SAD and substance use 
disorders with reference to the clinical characteristics and diagnostic criteria 
associated with these mental health conditions. The theoretical models explaining 
this comorbidity will then be reviewed before discussing some of the limitations 
of current explanatory models and presenting the rationale for examining the role 
of personality in SAD and substance misuse comorbidity. 
 In chapter two, the two-facet conceptualisation of impulsivity will be 
proposed as a useful framework to examine the co-occurrence of SAD and 
substance misuse by reviewing past research that has demonstrated heterogeneity 
among socially anxious individuals. Furthermore, two systematic reviews of the 
literature will examine how previous studies have applied the two-facet 
conceptualisation of impulsivity to substance misuse and comorbidity research, 
respectively. 
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 In chapter three, the limitations within the clinical literature will be 
discussed with reference to the current proposed studies. Firstly, it will be argued 
that elevated rash impulsiveness and reward sensitivity may characterise a subset 
of socially anxious individuals with co-occurring substance use problems. 
Secondly, it will be argued that rash impulsiveness and reward sensitivity 
moderate the relationship between social anxiety symptoms and substance 
misuse.  
The primary aim of this thesis is; 
1. To investigate the utility of a two-facet conceptualisation of impulsivity in 
understanding the relationship between social anxiety and substance 
misuse. 
Two cross-sectional studies will be carried out to investigate this overall 
aim. In chapter four, the first study will expand on a series of previous studies 
(i.e., Kachin et al., 2001; Kashdan et al., 2008; Kashdan & Hofmann, 2008; 
Kashdan et al., 2009) by examining whether individuals in the community with 
elevated symptoms of social anxiety are characterised by qualitatively distinct 
personality profiles. Specifically, a latent class analysis will be carried out on 
symptoms typically associated with SAD, including social anxiety symptom 
severity and behavioural inhibition, and symptoms proposed to be involved in co-
occurring SAD and substance misuse; including reward sensitivity, rash 
impulsiveness and risk-taking. Consistent with the findings of previous studies it 
is expected that there will be two distinct subgroups of socially anxious 
individuals. The two social anxiety subgroups will then be compared on measures 
of substance use frequency and dependence to examine whether significant 
differences can be identified across social anxiety subgroups. Notably, this study 
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will be the first to investigate whether reward sensitivity and behavioural 
inhibition distinguish the two social anxiety subgroups and will contribute to the 
literature by utilising validated measures of substance misuse. 
In chapter five, the second study will investigate the moderating role of 
reward sensitivity and rash impulsiveness in the relationship between social 
anxiety and substance misuse. This study will be carried out in a clinical sample 
of individuals presenting for treatment of their substance use disorder with co-
occurring social anxiety symptomatology. Specifically, it will be hypothesised 
that the relationship between social anxiety and substance misuse is stronger 
among those with elevated rash impulsiveness and reward sensitivity. Whilst one 
previous study has examined the moderating role of reward sensitivity (Booth & 
Hasking, 2009), no previous studies have examined whether rash impulsiveness 
moderates the relationship between social anxiety and substance misuse. A 
secondary aim of this study is to describe the demographic and clinical 
characteristics of the sample, as there are a paucity of studies examining the 
relationship between social anxiety and substance misuse in a clinical sample of 
individuals seeking treatment for their substance use disorder. A subsequent 
chapter will present some post-hoc analyses that will inform the general 
discussion. 
Finally, the general discussion will summarise the results of the two 
studies reported in this thesis. The contribution of these findings to the clinical 
literature will be highlighted before the clinical and research implications are 
discussed. Lastly, the limitations of the studies reported in this thesis and avenues 
for future research are considered. 
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CHAPTER ONE 
Co-occurring Social Anxiety and Substance Misuse 
Overview  
The high prevalence of co-occurring SAD and substance misuse has been 
well documented in a large number of clinical (e.g., Bakken et al., 2005; Staiger 
et al., 2008; Staiger, Thomas, Ricciardelli, & McCabe, 2011) and epidemiological 
samples (e.g., Buckner et al., 2012; Schneier et al., 2010). Whilst there has been a 
predominant focus on the relationship between SAD and the use of central 
nervous system depressants, including alcohol and cannabis (e.g., Booth & 
Hasking, 2009; Buckner, Schmidt, et al., 2008), there is strong evidence to 
suggest that SAD also co-occurs with stimulant use, including amphetamines and 
cocaine (e.g., Bakken et al., 2005; Darke & Ross, 1997; Myrick & Brady, 1997). 
Interestingly, research suggests that individuals with subthreshold SAD 
symptomatology are at higher risk of developing a substance use disorder than 
those who meet the Diagnostic and Statistical Manual of Mental Disorders (DSM-
III; APA, 1980 and DSM-IV; APA, 1994) criteria for SAD (Crum & Pratt, 2001; 
Merikangas et al., 2002; Robinson et al., 2011). In spite of this finding, clinical 
research often excludes individuals who do not meet diagnostic criteria for SAD. 
Hence, the two studies reported in this thesis will specifically include individuals 
with subthreshold symptoms of SAD. 
The purpose of this chapter is to provide an overview of the clinical 
characteristics and diagnostic criteria for SAD and substance use disorders in 
isolation, before discussing the co-occurrence of these disorders. This will be 
followed by a review of the well-established theories that have been proposed to 
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explain the relationship between SAD and substance misuse before a personality-
based approach is proposed to examine the comorbidity between these diagnoses. 
Clinical Characteristics and Diagnostic Criteria  
Social anxiety disorder. 
Social anxiety disorder is characterised by a fear of humiliation or 
embarrassment in social situations (APA, 2000; Kashdan & Herbert, 2001). 
Consequently, for those suffering from SAD (also known as social phobia; 
Liebowitz, Heimberg, Fresco, Travers, & Stein, 2000), the fear of engaging in 
social situations is so excessive that it often leads to avoidance of social 
situations, ranging from specific situations to all interpersonal contact 
(Heckelman & Schneier, 1995). Hence, SAD significantly interferes with 
everyday functioning (Katzelnick et al., 2001). In fact, it is generally agreed that 
SAD follows a chronic, unremitting course without treatment (Keller, 2003).  
The DSM-IV-TR (APA, 2000) recognises two distinct patterns of SAD, 
referred to as generalised and non-generalised SAD. According to diagnostic 
criteria, generalised SAD should be specified if the social anxiety extends to most 
social situations. Conversely, non-generalised SAD should be specified if the 
social anxiety relates to specific social situations, such as public speaking (APA, 
2000).  
In terms of prevalence, SAD is the second most common anxiety disorder 
in the Australian population (Australian Bureau of Statistics [ABS], 2007). 
Consistent with recent international figures (e.g., Ohayon, & Schatzberg, 2010), 
the one-year prevalence rate of clinically significant diagnoses is approximately 
4.7% (ABS, 2007), with a lifetime prevalence rate of approximately 12.1% 
(Ruscio et al., 2008).  
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With regard to age of onset, SAD is often first diagnosed in childhood or 
early adolescence (Chavira & Stein, 2005) and generally precedes the onset of 
comorbid conditions (Buckner, Schmidt, et al., 2008; Lipsitz & Schneier, 2000), 
which are common among SAD sufferers. In fact, approximately 70 to 80% of 
individuals diagnosed with SAD will suffer from at least one comorbid mental 
health problem over the course of their illness (Magee, Eaton, Wittchen, 
McGonagle, & Kessler, 1996; Ruscio et al., 2008). Similarly, high rates of 
psychiatric comorbidity have also been identified among individuals with 
subthreshold SAD symptomatology (Fehm, Beesdo, Jacobi, & Fiedler, 2008). 
Hence, comorbidity in SAD is an important clinical and research concern.  
Subthreshold SAD. 
When an individual does not meet the full diagnostic criteria for a formal 
psychiatric diagnosis their presentation is often referred to as a “subthreshold” 
disorder (Helmchen & Linden, 2000). Crum and Pratt (2001) defined individuals 
with subthreshold SAD as those who are characterised by an unreasonable fear of 
specific social situations but who do not experience clinically significant 
impairment. Using this definition in a large-scale prospective study (n = 3481), 
Crum and Pratt found that compared to individuals who met diagnostic criteria for 
SAD, subthreshold SAD was associated with greater risk for harmful alcohol 
consumption, and alcohol abuse or dependence, during a follow-up period of 13 
years. Considering the longitudinal research design of Crum and Pratt’s study, 
this finding provides strong evidence to suggest that individuals with subthreshold 
SAD may be at greater risk of developing of comorbid substance misuse. 
The high prevalence of subthreshold SAD in the general population has 
led a number of researchers to recommend a dimensional approach to 
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conceptualising SAD (e.g., Merikangas et al., 2002; Ruscio, 2010). According to 
this approach, SAD symptoms would range along a continuum of severity, 
including subthreshold social anxiety, non-generalised and generalised SAD, and 
avoidant personality disorder, as opposed to representing a discrete diagnostic 
category (Merikangas et al., 2002; Schneier, Blanco, Antia, & Liebowitz, 2002; 
Stein, Torgrud, & Walker 2000). 
Consistent with this contention, studies have begun to empirically evaluate 
the concept of a dimensional approach for SAD diagnosis to inform modifications 
to the pre-existing diagnostic system in the forthcoming DSM-5. For example, 
Ruscio (2010) investigated the utility of the current DSM-IV-TR (APA, 2000) 
diagnostic system, and an alternative dimensional approach, in a large-scale 
sample (n = 2,166) of individuals who had a history of excessive social fear.  
The results of several taxometric procedures and reliability analyses were 
consistent with a dimensional solution, suggesting that SAD exists on a 
continuum with subthreshold symptoms of SAD (Ruscio, 2010). Notably, follow-
up analyses revealed that a dimensional approach to SAD diagnosis was a better 
predictor of important clinical outcomes, including comorbid mood pathology, 
suicidality, and treatment seeking, than the traditional DSM-IV-TR (APA, 2000) 
diagnostic categories (Ruscio, 2010). These findings are of particular relevance to 
the present thesis considering the focus on subthreshold symptoms of social 
anxiety and the high prevalence of subthreshold SAD among those with co-
occurring substance use disorders (Crum & Pratt, 2001; Merikangas et al., 2002; 
Robinson et al., 2011). 
 
 
 
12 
 Substance use disorders. 
Alcohol and drug abuse poses a significant threat to the health of 
individuals worldwide (Mortlock, Deane, & Crowe, 2011). In Australia, Collins 
and Lapsley (2008) estimated that the total social costs associated with drug and 
alcohol abuse accounted for $55.2 billion in 2004-2005, which is an increase of 
more than $20 billion from the 1998-1999 national estimates (Collins & Lapsley, 
2002). As a result, alcohol and drug abuse places a significant burden of suffering 
on individuals, families and communities (Hamilton, King, & Ritter, 2004).   
In terms of prevalence, the most recent Australian National Survey of 
Mental Health and Wellbeing indicated that the 12-month prevalence of any 
substance use disorder in Australia is 5.1%, while the lifetime prevalence is 
24.7% (Slade, Johnston, Browne, Andrews, & Whiteford, 2009). Notably, 
findings comparing Western nations suggest that Australia has significantly 
higher rates of illicit substance abuse and dependence than New Zealand and the 
United States (McBride et al., 2009; Slade et al., 2009). For example, recent 
statistics suggest that the 12-month prevalence rates for illicit substance 
dependence in Australia were 2.7%, which was nearly four times that of the 
United States (0.7%; Mcbride et al., 2009). Overall, cannabis was the second most 
commonly used substance after alcohol, while males were more likely to be 
dependent on any substance, excluding rates of stimulant abuse and dependence, 
which were similar across genders (McBride et al., 2009).  
With regard to substance use onset, longitudinal research has consistently 
demonstrated that the prevalence of substance use and substance-related problems 
increases throughout adolescence and reaches its peak in early adulthood 
(McGorry, Purcell, Goldstone, & Amminger, 2011). In part, the age of onset may 
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explain why SAD has been found to precede the onset of substance use disorders 
(e.g., Buckner, Schmidt, et al., 2008), as the onset of SAD is typically in 
childhood or early adolescence (Chavira & Stein, 2005). 
According to the DSM-IV-TR (APA, 2000), substance abuse and 
substance dependence are specified as two distinct substance use disorders.  
Substance dependence is characterised by significant cognitive, behavioural, and 
physiological symptoms, including tolerance and withdrawal (APA, 2000). These 
symptoms are directly related to the continued use of a substance despite the 
presence of significant substance-related problems (e.g., damage to internal 
organs or severe symptoms of depression; APA, 2000). Furthermore, substance 
dependence tends to adversely interfere with social, occupational and recreational 
functioning, which often results in several unsuccessful attempts to reduce 
substance use (APA, 2000).  
Substance abuse is similarly characterised by the repeated use of a 
substance despite the presence of significant adverse consequences (APA, 2000). 
These consequences may be in the form of recurrent failure to carry out day-to- 
day obligations, repeated substance use in situations in which it is hazardous, 
legal problems, and social and interpersonal problems related to ongoing 
substance use (APA, 2000). In contrast to the criteria for substance dependence, 
the criteria for substance abuse do not include symptoms of tolerance and 
withdrawal. Notably, a diagnosis of substance abuse is pre-empted by a diagnosis 
of substance dependence if an individual has ever met the diagnostic criteria for 
substance dependence for a particular class of substance (APA, 2000). 
 In this thesis the term “substance use disorder” will be used to refer to 
abuse or dependence on alcohol or illicit drugs as defined by the DSM-IV-TR 
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(APA, 2000). The term “substance misuse” will be used to refer to hazardous 
substance use more generally, where diagnosis may or may not be specified. The 
use of the term “substance misuse” in this context is consistent with the use of this 
term in the wider clinical literature (e.g., Dawe, Gullo, & Loxton, 2004; Staiger, 
Kambouropoulos, & Dawe, 2007). 
Social Anxiety and Substance Misuse Comorbidity  
Among adults seeking treatment for substance misuse the rates of SAD are 
significant, ranging between 23 and 55% (Bakken et al., 2005; Thomas, Thevos, 
& Randall, 1999; Tomasson, & Vaglum, 1995). An Australian study reported 
rates which are consistent with these international findings, with 47% of females 
and 36% of males seeking treatment for substance misuse also meeting DSM-IV 
(APA, 1994) criteria for SAD (Staiger et al., 2008). Notably, if a dimensional 
approach to SAD diagnosis is taken in the forthcoming DSM-5 this rate is likely 
to be significantly higher. 
The high prevalence of co-occurring SAD and substance misuse is 
worrying considering significant clinical differences have been found between 
individuals diagnosed with co-occurring SAD and substance misuse, and those 
with either SAD or substance misuse diagnoses in isolation. For example, 
Buckner, Timpano, et al. (2008) compared individuals diagnosed with SAD, with 
those suffering from co-occurring alcohol use disorders (AUD) and SAD. This 
study analysed a data set of over five thousand respondents in the United States, 
of which 794 met AUD or SAD diagnostic criteria. It was found that those 
suffering from comorbid AUD and SAD reported more severe SAD 
symptomatology, higher levels of psychiatric comorbidity, and more problems 
with physical health than those suffering from SAD alone (Buckner, Timpano, et 
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al., 2008). This finding has been replicated in other studies with AUD and SAD 
sufferers (Schneier et al., 2010).  
Similar findings have also been reported among patients diagnosed with 
an illicit substance use disorder in isolation, and those suffering from co-
occurring SAD. Specifically, Bakken et al. (2005) found that those with co-
occurring SAD and an illicit substance use disorder were more likely to have an 
additional axis one or two diagnosis. Further, these patients were more likely to 
abuse more than one illicit substance than those without co-occurring SAD 
(Bakken et al., 2005). 
Consistent with these findings, Buckner and colleagues (2012) reported 
that the co-occurrence of SAD and cannabis misuse was associated with lower 
levels of education, lower income, greater utilisation of welfare, and lower 
perceived health than either disorder in isolation. Moreover, converging with the 
findings of Bakken et al. (2005), co-occurring SAD and cannabis misuse was 
associated with higher rates of co-occurring axis one and two disorders (Buckner 
et al., 2012). 
Considering the impairments faced by this clinical population it is 
unsurprising that individuals suffering from co-occurring SAD are more likely to 
relapse following treatment for their AUD. Kushner et al. (2005) and Driessen et 
al. (2001) reported that in contrast to individuals presenting for treatment of their 
AUD alone, those presenting with a comorbid anxiety disorder were more likely 
to relapse after completing an inpatient treatment program for alcohol misuse. 
Although Driessen et al. did not differentiate between anxiety disorders, Kushner 
et al. reported that this finding was exacerbated among those who had co-
occurring SAD or panic disorder. 
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Furthermore, failure to identify co-occurring SAD may have implications 
for those presenting for treatment of their substance use disorder. This contention 
is consistent with the findings of Book, Thomas, Dempsey, Randall, and Randall 
(2009) who found that SAD influenced willingness to participate in substance 
misuse treatment activities. This may be partly due to the strong focus on group 
interventions in substance misuse treatment settings, including Therapeutic 
Communities, Alcoholics Anonymous and Narcotics Anonymous (Book et al., 
2009).  
Although there are well-established psychological interventions for SAD 
(Heimberg, 2002) and substance use disorders (Dutra et al., 2008) in isolation, 
little is known about how to effectively treat these disorders when they co-occur 
(see Morris, Stewart, & Ham, 2005 for a review). For example, a randomised 
controlled trial investigating this issue reported poorer outcomes among those 
who received a simultaneous treatment targeting co-occurring SAD and alcohol 
misuse, when compared to those who received treatment for alcohol misuse in 
isolation (Randall et al., 2001). Considering that evidence suggests long-term 
recovery from either disorder is compromised by failure to treat the comorbid 
diagnosis (Schneier et al., 2010), further research is needed to examine the 
mechanisms that underlie the co-occurrence of SAD and substance misuse. 
Arguably, such research will inform the development of treatment protocols that 
target the mechanisms involved in the onset and maintenance of these disorders. 
The following section will review the theoretical explanations that have been 
proposed to explain the relationship between SAD and substance misuse.  
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Theoretical explanations for SAD and substance misuse comorbidity.  
The most frequently cited explanation for SAD and substance misuse 
comorbidity is the self-medication hypothesis (see Carrigan & Randall, 2003 for a 
review; Kushner, Abrams, & Borchardt, 2000). Consistent with earlier 
explanatory models for SAD and substance misuse comorbidity, including the 
tension reduction hypothesis (Conger, 1956), and the stress-response dampening 
hypothesis (Levenson, Sher, Grossman, Newman, & Newlin, 1980), the self-
medication hypothesis posits that drugs and alcohol are used as a means to 
alleviate symptoms of mental health problems, and that the repeated use of 
substances in this context may lead to dependence (Khantzian, 1985). This 
hypothesis is consistent with retrospective self-reports, with symptoms of social 
anxiety reported long before the onset of drug or alcohol abuse (Buckner, 
Timpano, et al., 2008; Myrick & Brady, 1997; Randall et al., 2001).  
Furthermore, symptoms of social anxiety often remain at clinical levels 
following addictions treatment (Kushner et al., 2005; Liappas, Paparrigopoulos, 
Tzavellas, & Christodoulou, 2003). In contrast, retrospective self-reports suggest 
that comorbid depression frequently develops after the onset of substance misuse 
(Brook, Brook, Zhang, Cohen, & Whiteman, 2002; Marmorstein, Iacono, & 
Malone, 2009). Consequently, symptoms of depression often diminish after 
addictions treatment (e.g., Havard, Teesson, Darke, & Ross, 2006).  
Chutuape and de Wit (1995) outlined three assumptions of the self-
medication hypothesis. Firstly, it is assumed that psychiatric symptoms precede 
substance use; secondly, that the substance relieves these symptoms; and thirdly, 
that relief of psychiatric symptoms through the use of a particular substance leads 
to ongoing and excessive use of that substance (see Carrigan, & Randall, 2003 for 
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a review). Several studies lend support to these assumptions (see Carrigan & 
Randall, 2003 for a review; Merikangas, & Angst, 1995), with a large proportion 
of individuals seeking treatment for their substance use problem reporting that 
they use alcohol or drugs to cope with their social anxiety (e.g., Buckner et al., 
2012). However, there have also been some inconsistent findings regarding the 
role of self-medication within the literature.  
For example, a recent longitudinal investigation (n = 34, 653) found that 
self-medication with alcohol and illicit drugs was a robust predictor of SAD in 
different baseline populations (Robinson et al., 2011). Firstly, it was found that 
being diagnosed with a pre-existing substance use disorder at baseline was a 
predictor of SAD at follow-up (Robinson et al., 2011). Secondly, among those 
with subthreshold anxiety at baseline, endorsement of self-medication with 
alcohol or other drugs was associated with a diagnosis of SAD three years later 
(Robinson et al., 2011).  
Although the findings of Robinson et al. (2011) seem at odds with the 
self-medication hypothesis, arguably, the subthreshold anxiety symptoms at 
baseline are consistent with the literature that suggests individuals with 
subthreshold SAD are more likely to develop a co-occurring substance use 
disorder than those with a diagnosis of SAD (e.g., Crum & Pratt, 2001; 
Merikangas et al., 2002). However, these findings also provide evidence to 
suggest that SAD symptomatology does not always precede a substance use 
diagnosis. This is an important finding considering that longitudinal studies 
indicative of the temporal precedence of SAD and substance use diagnoses are 
sparse in the clinical literature. 
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Whilst the self-medication hypothesis provides partial explanation of the 
relationship between SAD and substance misuse, there is scope for a personality-
based approach to examine etiological processes that may underlie this 
relationship. Specifically, although SAD and substance misuse co-occur at a high 
rate, a substantial number of individuals with SAD do not develop co-occurring 
substance misuse (Buckner et al., 2012; Lecrubier et al., 2000; Ruscio et al., 
2008). Hence, some individuals suffering from SAD appear to be at greater risk of 
developing a co-occurring substance use disorder. In order to investigate this 
question the present thesis will examine personality traits that may underlie the 
relationship between co-occurring social anxiety and substance misuse.  
This is an important avenue for future research as the aforementioned 
theories have failed to identify personality-based predispositions that may be 
involved in the development of co-occurring SAD and substance use disorders. 
Hence, it is argued here that a personality-based approach may make significant 
contribution to understanding the co-occurrence of these two clinical diagnoses 
(Conrod & Stewart, 2005; Watt, Stewart, Conrod, & Schmidt, 2008).  
Summary 
SAD and substance use disorders are highly prevalent diagnoses, which 
co-occur at a high rate within clinical and epidemiological populations. This rate 
is particularly elevated among individuals with subthreshold SAD 
symptomatology. Although a number of well-established theories partially 
explain the relationship between SAD and substance misuse there have been some 
inconsistent findings, suggesting there is scope for an alternative approach in 
examining this relationship. Arguably, personality-based differences may explain 
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why some individuals with SAD develop co-occurring substance use disorders 
while others do not.  
The next chapter will examine the role of personality in co-occurring SAD 
and substance misuse by reviewing a series of studies investigating heterogeneity 
among socially anxious individuals. The findings of these studies are discussed 
with reference to co-occurring substance misuse and it is proposed that 
impulsivity may characterise a subset of SAD sufferers with co-occurring 
substance use problems. 
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CHAPTER TWO 
Personality in Social Anxiety and Substance Misuse Comorbidity  
Overview 
Over the past decade a series of studies have been investigating 
heterogeneity among SAD sufferers (i.e., Kachin et al., 2001; Kashdan & 
Hofmann, 2008; Kashdan et al., 2009) and among individuals with elevated 
symptoms of social anxiety (i.e., Kashdan, Collins, & Elhai, 2006; Kashdan et al., 
2008). The findings of these studies have consistently found that a subset of 
socially anxious individuals are characterised by personality traits and behaviours 
that are qualitatively different from those that are typically associated with SAD. 
Specifically, there is evidence to suggest that some individuals with symptoms of 
social anxiety are characterised by hostile interpersonal problems, novelty 
seeking, behavioural disinhibition, substance use and risk-taking (Kachin et al., 
2001; Kashdan et al., 2006; Kashdan et al., 2008; Kashdan & Hofmann, 2008; 
Kashdan et al., 2009). Taken together, these findings suggest that impulsive-like 
traits characterise a subset of SAD sufferers, including those with subclinical 
symptoms of social anxiety. 
Importantly, there is considerable evidence to suggest that a personality 
profile characterised by elevated impulsivity predicts the onset of substance use 
disorders (e.g., Fergusson et al., 2008; Sher et al., 2000). Furthermore, recent 
research has begun to examine the relevance of two facets of impulsivity in 
understanding comorbidity, with a particular focus on the co-occurrence of two 
disorders, which are appetitive in nature (e.g., bulimia nervosa and substance 
misuse; Kane et al., 2004). In this chapter it is argued that the impulsive-like traits 
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that have been found to characterise a subset of socially anxious individuals may 
underlie the comorbidity between social anxiety and substance misuse.  
In this chapter the construct of impulsivity will be reviewed, including the 
theoretical and biological underpinnings of a two-facet conceptualisation of 
impulsivity that stems from a series of factor-analytic studies (e.g., Quilty & 
Oakman, 2004). These two facets have been termed rash impulsiveness and 
reward sensitivity (Dawe & Loxton, 2004). Further, the well-established role of 
impulsivity in substance misuse will be discussed before studies examining the 
involvement of rash impulsiveness and reward sensitivity in substance misuse and 
comorbidity research are systematically reviewed.  
Heterogeneity in SAD 
Since SAD was first recognised as a diagnostic category in the DSM-III 
(APA, 1980) research examining heterogeneity in SAD has commonly examined 
differences between the generalised and non-generalised subtypes. Such research 
has consistently demonstrated that the generalised and non-generalised SAD 
subtypes differ quantitatively, with regard to number and types of feared or 
avoided social situations (e.g., Herbert, Hope, & Bellack, 1992; Kachin et al., 
2001). Specifically, it has been found that those with generalised SAD fear and 
avoid a larger range of social situations than those with non-generalised SAD. 
These findings are consistent with the contention that the generalised and non-
generalised subtypes are on a spectrum of SAD (see Merikangas et al., 2002; 
Schneier et al., 2002; Stein et al., 2000) rather than qualitatively distinct 
diagnostic entities.  
Whilst differences between diagnostic subtypes provide some utility in 
enhancing knowledge about SAD, there have been fewer examinations of whether 
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individuals suffering from SAD are characterised by qualitative differences. 
Specifically, qualitative differences would suggest that SAD subtypes differ on 
relevant clinical or theoretical variables (e.g., personality profile, symptoms), 
whereas quantitative differences would suggest that SAD is a single disorder with 
different levels of severity (Herbert et al., 1992).  
Currently, many treatment programs provide “one size fits all” treatment 
approaches for different psychiatric conditions, which account for quantitative 
differences in terms of variation in symptom severity. For example, it has been 
found that both subtypes of SAD respond to the same treatment (i.e., cognitive 
behavioural therapy), with equivalent levels of change over the course of 
treatment (Brown, Heimberg, & Juster, 1995; Turner, Beidel, Wolff, Spaulding, 
& Jacob, 1996). However, despite engaging in evidence-based psychotherapy for 
SAD, only 25 to 65% of SAD sufferers achieve clinically significant 
improvement in symptomatology after treatment completion (Davidson et al., 
2004; Rapee, Gaston, & Abbott, 2009; Stangier, Schramm, Heidenreich, Berger, 
& Clark, 2011).  
 One explanation for the abovementioned findings is that traditional 
therapies for SAD may only be suited for those with generalised or non-
generalised SAD who fit the typical personality profile associated with SAD (i.e., 
shy, behaviourally inhibited and risk-avoidant; Lorian & Grisham, 2010; Stein & 
Stein, 2008). For this reason, an examination of qualitative differences (e.g., 
impulsive-like traits) among socially anxious individuals may be particularly 
important in the development of more effective treatment protocols. To date, a 
small number of empirical papers have examined qualitative differences among 
individuals with a diagnosis of SAD and individuals with subclinical symptoms of 
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social anxiety. The findings of these studies are particularly important in forming 
the rationale for the two studies conducted in this thesis; hence these papers will 
be reviewed in the following section.  
Research Investigating Qualitative Differences Among Socially Anxious 
Individuals  
Kachin et al. (2001) were the first researchers to explicitly postulate and 
test a model exploring qualitative differences among individuals with SAD. Their 
study was based on the theory of pathoplasticity, which suggests a bi-directional 
relationship between psychopathology and personality (Klein, Wonderlich, & 
Shea, 1993; Widiger & Smith, 2008). Hence, pathoplasticity recognises that an 
individual’s response to their psychiatric symptomatology is based on an 
interaction with their personality disposition.  
This contention has strong utility in psychopathology research and has 
been examined in a number of psychiatric conditions, including depression (Cain 
et al., 2012), bulimia nervosa (Hopwood, Clarke, & Perez, 2007), and generalised 
anxiety disorder (Przeworski et al., 2011). Further, pathoplasticity has been 
shown to predict variability in response to psychological therapy (e.g. Alden & 
Capreol, 1993; Borkovec, Newman, Pincus, & Lytle, 2002). Hence, Kachin et al. 
(2001) argued that pathoplasticity is particularly relevant for research 
investigating heterogeneity in SAD and sought to examine whether individuals 
suffering from SAD use qualitatively distinct interpersonal strategies to cope with 
their social anxiety symptoms. 
Specifically, Kachin and colleagues (2001) argued that individuals with 
SAD, who find themselves in the same socially threatening situation, might utilise 
differential interpersonal behaviour to cope with and/or respond to the same 
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situation. To examine this question Kachin et al. administered the Inventory of 
Interpersonal Problems Circumplex Scales (IIP-C; Alden, Wiggins, & Pincus, 
1990) in a sample of 30 socially anxious individuals suffering from generalised 
SAD, 30 socially anxious individuals suffering from non-generalised SAD, and 
30 control participants (n = 90). Consistent with their hypotheses, Kachin et al. 
found that individuals suffering from SAD could not be reliably distinguished 
based on DSM-IV (APA, 1994) diagnostic subtypes (i.e., generalised and non-
generalised SAD), rather, they could be reliably differentiated on the basis of 
interpersonal problems.  
Using cluster analysis on the IIP-C, a two-cluster solution was consistently 
demonstrated across different clustering methods (Kachin et al., 2001). 
Specifically, one subgroup of SAD sufferers (n = 23) reported problems related to 
hostile, angry behaviour (R2 = .92), whereas the other SAD subgroup (n = 37) 
reported problems with unassertiveness, exploitability and over-nurturance (R2 = 
.96; Kachin et al., 2001). It was found that these subgroups were unrelated to the 
DSM-IV (APA, 1994) subtypes, which were a poor fit to the interpersonal 
circumference ideal (i.e., generalised SAD, R2 = .68, and non-generalised SAD, R2 
= .33). Despite the preliminary nature of these findings, the study carried out by 
Kachin et al. provided a strong rationale for researchers to continue examining 
qualitative differences among socially anxious individuals. 
Expanding on the findings of Kachin et al. (2001), Kashdan and his 
colleagues have carried out a series of studies examining heterogeneity among 
socially anxious individuals. Specifically, Kashdan et al. have examined whether 
individuals diagnosed with SAD (Kashdan & Hofmann, 2008; Kashdan et al., 
2009), or socially anxious individuals in the community (Kashdan et al., 2006; 
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Kashdan et al., 2008), could be distinguished based on their reliance on inhibited 
responses and avoidance strategies, compared to a reliance on approach strategies, 
including disinhibited responses and impulsive behaviours (Kashdan, & 
McKnight, 2010). Taken together, these studies have provided strong evidence to 
suggest that there is important heterogeneity in SAD that is not being accounted 
for, which the present thesis argues is relevant to the co-occurrence of social 
anxiety and substance misuse. These studies will be reviewed below.  
In the first of a series of studies, Kashdan et al. (2006) examined whether 
a community sample of socially anxious individuals (n = 84), with positive 
outcome expectancies regarding risk-taking behaviours, would report more risk-
prone behavioural intentions than those expecting less desirable outcomes. Their 
findings converged with their hypotheses in the domains of unsafe sexual 
practices and aggression. That is, socially anxious individuals expecting desirable 
outcomes in the domains of aggression and unsafe sexual practices reported more 
risk-taking intentions.  
Surprisingly, Kashdan et al. (2006) found no evidence to suggest that 
positive outcome expectancies moderated the relationship between social anxiety 
and heavy drinking, or illicit drug use, but found an independent relationship 
between social anxiety and intentions to use illicit drugs. One possible 
explanation for these unexpected findings is that positive outcome expectancies 
do not interact with social anxiety to predict substance misuse. Alternatively, the 
findings may relate to the statistical methodology, which did not allow for 
heterogeneity in the sample. That is, Kashdan et al. (2006) examined relationships 
between variables rather than exploring whether different subsets of socially 
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anxious individuals could be identified. Hence, the statistical methodology used 
in Kashdan and colleagues’ (2006) study may explain their unexpected findings.  
Addressing this limitation in a later study, Kashdan et al. (2008) sought to 
investigate whether qualitatively distinct subsets of individuals with symptoms of 
social anxiety could be identified based on approach-avoidance appraisal patterns. 
Using cluster analysis in a community sample of undergraduate university 
students (n = 280), three qualitatively different groups were found. Of these 
distinct subgroups, two were characterised by elevated levels of social anxiety, 
and one subgroup was characterised by minimal anxiety. Subgroups were 
determined by social anxiety symptom severity and subjective appraisals about 
risky activities, including aggression, sex, substance use and socialising. 
The findings of Kashdan et al. (2008) indicated that the two subgroups 
characterised by elevated symptoms of social anxiety reported divergent appraisal 
patterns. One socially anxious subgroup was characterised by disinhibited 
appraisal patterns and indicated that risk-taking would offer opportunities to 
satisfy curiosity and enhance social status. Conversely, the second socially 
anxious subgroup was characterised by inhibited appraisal patterns and indicated 
that risk-taking would be hazardous and offer minimal opportunities to satisfy 
curiosity or enhance social status (Kashdan et al., 2008).  
Upon tracking the behaviour of participants over the course of a three 
month summer period, using a calendar based tracking method (i.e., the Timeline 
Followback; Sobell & Sobell, 1992), Kashdan et al. (2008) found that the 
disinhibited subgroup reported engaging in more frequent social interactions, 
risky sexual behaviour, aggression, and substance use than the other socially 
anxious subgroup. The findings of Kashdan et al. (2006, 2008) paved the way for 
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further research exploring underlying mechanisms that may be accounting for the 
relationship between social anxiety and risk-taking behaviours.  
Expanding on the abovementioned studies, Kashdan and Hofmann (2008) 
explored whether novelty seeking tendencies could be used to identify two 
qualitatively distinct subgroups of people suffering from generalised SAD (n = 
82). Using cluster analysis, Kashdan and Hofmann found that one SAD subgroup 
was characterised by low novelty seeking tendencies, whereas the other SAD 
subgroup was characterised by high novelty seeking tendencies. These subgroups 
could not be differentiated on the basis of SAD severity.  
Despite the well-established relationship between novelty seeking and 
substance misuse (Fergusson et al., 2008) participants with a comorbid substance 
use disorder were excluded from Kashdan and Hofmann’s (2008) study. In spite 
of this, it was reported that clinician severity ratings provided preliminary 
evidence to suggest that substance use may be greater in the high novelty seeking 
SAD subgroup. Thus, Kashdan and his colleagues sought to expand on previous 
research by replicating earlier findings and specifically examining co-occurring 
substance use problems in a recent study.  
Kashdan et al. (2009) conducted a latent class analysis on risk-prone 
behaviour items derived from a large-scale comorbidity survey (n = 1822). Latent 
class analysis was used due to its superiority over previously used cluster analytic 
procedures, which Kashdan and colleagues (2009, p. 561) reported are known to 
be “unstable”. Converging with the findings of previous studies examining 
heterogeneity in social anxiety, Kashdan et al. (2009) found evidence for two 
SAD classes. The largest SAD class (79% of the sample) was characterised by a 
prototypical pattern of risk-aversion, and the second SAD class (21% of the 
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sample) was characterised by an atypical pattern of risk-prone behaviour, 
including elevated levels of aggression and sexual impulsivity. 
Furthermore, the risk-prone subgroup reported more substance use 
problems than the prototypical SAD subgroup, based upon their responses to 
seven binary questions (e.g., in the past 12 months have you had a 
strong/irresistible urge to drink?), which were derived from a larger survey for the 
purposes of the study (Kashdan et al., 2009). Unfortunately, Kashdan et al. (2009) 
were unable to comment on the severity of substance use problems in the risk-
prone SAD subgroup due to the binary format of their substance misuse 
questionnaire and the lack of validated measurement tools used to assess 
substance misuse (with regard to frequency, quantity and severity of 
symptomatology). 
Overall, the aforementioned findings suggest that a series of impulsive-
like traits (e.g., novelty seeking, aggression and risk-taking) characterise a subset 
of socially anxious individuals. Considering the strong links between a 
personality style characterised by impulsivity and the onset of substance misuse 
(Fergusson et al., 2008; Sher et al., 2000), which will be reviewed later in this 
chapter, it is argued that impulsivity may underlie the co-occurrence of social 
anxiety and substance misuse. To date, no previous studies have conceptualised 
impulsivity as explaining the comorbidity between social anxiety and substance 
misuse. The following section will discuss the theoretical and clinical relevance 
of impulsivity in psychopathology research and review evidence supporting a 
two-facet conceptualisation of impulsivity. 
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Impulsivity 
Impulsivity is a multidimensional construct that can be broadly defined as 
the tendency to engage in inappropriate or maladaptive behaviours with little or 
inadequate forethought (Evenden, 1999). In psychopathology research, 
impulsivity is a frequently measured construct, which is related to its prominence 
in major theories of personality and in psychiatric diagnoses. For example, 
impulsiveness is a core element of three major personality frameworks proposed 
by Cloninger (1987), Eysenck (1967), and Gray (1987). Furthermore, in the 
DSM-IV-TR (APS, 2000) a number of psychiatric diagnoses specify impulsivity 
as a core symptom. Notably, there is also a chapter dedicated to “impulse control 
disorders” (APS, 2000). However, it is important to acknowledge that impulsivity 
is not only prevalent in psychopathology but is widely classified as a personality 
trait that varies across individuals as a dimension of normal behaviour (de Wit, 
2009). 
Consistent with the theoretical and clinical significance of impulsivity, it 
is unsurprising that a number of questionnaires have been developed to measure 
this construct. However, over the past decade it has been demonstrated that many 
commonly used measures are capturing different aspects of impulsivity, or related 
constructs (Caseras et al., 2003; Miller et al., 2004). In fact, research suggests that 
there are only modest correlations between many measures of impulsivity 
(Caseras et al., 2003; Dolan & Fullam, 2004; Monterosso & Ainslie, 1999).  
This finding is consistent with Depue and Collins’ (1999) well-known 
definition of impulsivity, which states “impulsivity comprises a heterogeneous 
cluster of lower-order traits that includes terms such as impulsivity, sensation 
seeking, risk-taking, novelty seeking, boldness, adventuresomeness, boredom 
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susceptibility, unreliability, and unorderliness” (p. 495). Hence, lack of 
consistency is a prominent issue that has long faced the measurement of 
impulsivity (de Wit, 2009).  
To address this issue a number of researchers have carried out studies 
using factor analytic and principal components analyses on measures of 
impulsivity (e.g., Quilty & Oakman, 2004; Zelenski & Larsen, 1999). The results 
of these analyses have consistently demonstrated that impulsivity measures tend 
to load on two separate factors, reflecting two different facets of impulsivity (see 
Table 2.1 for an overview of studies). Dawe and Loxton (2004) termed these two 
distinct but related components of impulsivity “reward sensitivity” and “rash 
impulsiveness”.  
Whilst findings have largely converged across factor analytic studies, it is 
important to acknowledge that there have been some inconsistent findings with 
regard to particular impulsivity scales. For example, the Fun Seeking subscale of 
Carver and White’s (1994) Behavioural Inhibition System and Behavioural 
Activation System (BIS/BAS) scales tend to correlate with measures that load on 
both facets of impulsivity (Caseras et al., 2003; Zelenski & Larsen, 1999). In spite 
of this, it has been argued that the items on the BAS Fun Seeking scale tend to 
reflect the measurement of rash impulsiveness rather than measurement of reward 
sensitivity (Dawe et al., 2004). Similarly, the Reward Dependence subscale of the 
Tridimensional Personality Questionnaire (TPQ; Cloninger, 1987) fails to 
consistently load on either impulsivity domain. Dawe and Loxton (2004) argue 
that this subscale measures dependence on social approval rather than a range of 
rewarding stimuli, which is inconsistent with other measures of rash 
impulsiveness or reward sensitivity. In fact, it has been demonstrated that the 
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Reward Dependence subscale is a good predictor of behavioural inhibition 
(Mardaga & Hansenne, 2007), which is purported to be orthogonal to the 
measurement of impulsivity (Gray, 1987).  
 
Table 2.1 
Overview of Factor Analytic and Principal Components Analyses Reflecting Two 
Facets of Impulsivity 
Domain Measures/Subscales  
Rash 
Impulsiveness 
 
 
Impulsiveness Scale of the Eysenck Impulsiveness Questionnaire 
(Eysenck, Pearson, Easting, & Allsopp, 1985)1, 2, 4, 6 
Novelty Seeking Subscale of the Tridimensional Personality 
Questionnaire (Cloninger, 1987)1, 2, 3, 5 
Barratt Impulsiveness Scale (Patton, Stanford, & Barratt, 1995)4, 5 
Sensation Seeing Scale (Zuckerman, Eysenck, & Eysenck, 1978)5 
The BAS Fun-Seeking subscale of the BIS/BAS scales (Carver & 
White, 1994)1, 2, 4, 6 
Reward Sensitivity 
 
The BAS Drive and Reward Responsiveness subscales of the 
BIS/BAS scales (Carver & White, 1994)1, 2, 4, 5, 6 
The Sensitivity to Reward subscale of the Sensitivity to 
Punishment and Sensitivity to Reward Questionnaire (Torrubia, 
Ávila, Moltó, & Caseras, 2001)1, 2, 3, 5 
Note.  Adapted from “The role of impulsivity in the development of substance use and eating 
disorders” by S. Dawe and N. J. Loxton, 2004, Neuroscience and Biobehavioral Reviews, 28(3), p. 
345. 
 
1 Caseras et al. (2003) 
2 Franken and Muris (2006b) 
3 Ibáñez et al. (2010) 
4 Miller et al. (2004) 
5 Quilty and Oakman (2004) 
6 Zelenski and Larsen (1999) 
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Consistent with the findings of factor-analytic studies presented in Table 
2.1, there is now a general consensus within the literature that impulsivity is a 
multifaceted construct that comprises at least two distinct but related facets (see 
de Wit & Richards, 2004; Franken & Muris, 2006b). Importantly, this shift from a 
unidimensional perspective of impulsivity is likely to have significant theoretical 
and clinical implications.  
For example, different measures of impulsivity have been shown to 
predict different outcomes (Curcio, Mak, & George, in press; Dick et al., 2010), 
and to predict substance use through differential pathways (Gullo, Dawe, et al., 
2010; Kabbani & Kambouropoulos, 2013). Hence, the measurement of both 
facets of impulsivity in future research will advance current knowledge regarding 
how each facet relates to different behaviours, psychological constructs and 
diagnoses. 
Consistent with this contention, Dick et al. (2010) argue that substantive 
conclusions cannot be made about the meaning of findings when a single score is 
used to represent processes that only correlate modestly with each other (e.g., 
measures of rash impulsiveness and reward sensitivity). Smith and Combs (2010) 
contend that this leads to theoretical and scientific imprecision. Such imprecision 
has implications for research attempting to identify neurobiological and genetic 
bases to psychological phenomena, as constructs need to be homogenous for this 
type of research (Smith, McCarthy, & Zapolski, 2009).  
Ultimately, progress in understanding how rash impulsiveness and reward 
sensitivity relate to specific outcomes may have been limited by the plethora of 
heterogeneous measures capturing the construct of impulsivity. It is argued here 
that future research should utilise the two-facet conceptualisation of impulsivity 
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to address the abovementioned limitations of using a unidimensional measure of 
impulsivity to capture a multidimensional construct. The following two sections 
discuss the theoretical and biological underpinnings of reward sensitivity and rash 
impulsiveness, respectively.  
Reward sensitivity.  
Reward sensitivity reflects a drive to acquire rewarding stimuli (Dawe & 
Loxton, 2004). Theoretically, reward sensitivity is considered to be part of the 
BAS, which stems from Gray’s RST (Gray, 1970, 1987)1. Reinforcement 
sensitivity theory is a biologically based model of personality that has its basis in 
animal learning research (Gray, 1970, 1981, 1991). This theory posits that 
individual differences in personality can be attributed to variation across major 
brain systems. Two of the primary systems proposed by Gray (1987) are termed 
the BAS (i.e., reward sensitivity) and Behavioural Inhibition System (BIS), which 
are proposed to relate to impulsivity and anxiety, respectively.  
Gray (1987) held that those with BAS sensitivity are sensitive to signals of 
reward, which suggests that these individuals are more likely to engage in goal-
directed action and experience positive emotions (e.g., elation, hope) when they 
are exposed to cues that signify impending reward (Carver & White, 1994). 
Recent findings have also documented links between anger and BAS activation 
(Carver, 2004; Harmon-Jones, & Sigelman, 2001). This finding supports the 
contention that reward sensitivity may characterise a subset of socially anxious 
individuals given previous research has documented aggression among a subset of 
individuals suffering from SAD (see Kachin et al., 2001; Kashdan et al., 2009).  
                                                 
1 While there has been a revision of RST (Gray & McNaughton, 2000) the present thesis will draw 
upon the original RST (Gray 1970, 1981, 1987, 1991) due to its ongoing prominence in the clinical literature 
and the well-validated measures that are used to capture the different components of this theory (Bijttebier, 
Beck, Claes, & Vandereycken, 2009). Further, this is consistent with recent research examining RST in social 
anxiety (e.g., Booth & Hasking, 2009; Kimbrel, Mitchell, & Nelson-Gray, 2010). 
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Gray posited that variation in dopaminergic neurotransmissions underlie 
individual differences in reward sensitivity (Pickering & Gray, 1999). 
Specifically, Pickering and Gray (1999) hypothesise that the expression of reward 
sensitive behaviour is reflected in less efficient inhibitory dopaminergic synapses. 
Consistent with the propositions of Pickering and Gray, Dawe et al. (2004) 
contend that the primary neural pathway involved in reward sensitive behaviour is 
the mesolimbic dopaminergic pathway. Notably, the mesolimbic dopaminergic 
pathway is hypothesised to underlie the reinforcing effects of substances of abuse 
(Goldstein & Volkow, 2002; Jentsch & Taylor, 1999) and a number of rewarding 
activities, including eating and sex (Blum et al., 2012; Davis et al., 2007). 
 Importantly, RST explicitly posits that self-report personality 
questionnaires can be used to assess the sensitivity of BIS and BAS functioning 
(Pickering & Gray, 1999). Although there are a number of measures that have 
been developed to assess BAS sensitivity, which is akin to the measurement of 
reward sensitivity, two measures have been prominent in the literature and 
demonstrate good reliability and validity. These measures are the BAS subscales 
of Carver and White’s (1994) BIS/BAS scales and the Sensitivity to Reward (SR) 
subscale of the Sensitivity to Punishment and Sensitivity to Reward Questionnaire 
(SPSRQ; Torrubia et al., 2001). Differences between these measures will be 
discussed in greater detail in a systematic review reported later in this chapter.  
Whilst RST is relevant to understanding the theoretical basis of reward 
sensitivity, it also provides a framework for conceptualising SAD. 
Neurobiologically, Gray (1982) posited that the BIS was mediated by the septo-
hippocampal system, however more recent research indicates that the amygdala 
plays a central role in BIS sensitivity (i.e., the expression of anxiety; see Barros-
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Loscertales et al., 2006; LeDoux, 1994). Consistent with Gray’s (1976) 
contention that BIS is the biologically based personality substrate for anxiety, 
several researchers have found a positive relationship between social anxiety and 
BIS. For example, heightened BIS sensitivity has been positively correlated with 
symptoms of social anxiety in community (Kashdan & Roberts, 2006; Kimbrel, 
Cobb, Mitchell, Hundt, & Nelson-Gray, 2006) and clinical samples (Morgan et 
al., 2009).  
Although an examination of RST is beyond the scope of this thesis, it is 
important to acknowledge the well-established relationship between BIS and 
SAD, as the present thesis posits that reward sensitivity, which has been found to 
be negatively correlated (Coplan, Wilson, Frohlick, & Zelenski, 2006; Kashdan, 
2002), and uncorrelated with SAD (Kashdan & Roberts, 2006), may play a role in 
the relationship between social anxiety and substance misuse. Although this may 
initially seem counterintuitive, this examination is consistent with the paradoxical 
symptoms (e.g., novelty seeking, aggression and risk-taking see pp. 24-29) that 
have been identified among a subset of socially anxious individuals and may help 
identify biologically based personality differences that underlie the comorbidity 
between social anxiety and substance misuse. 
Rash impulsiveness. 
Rash impulsiveness is conceptually related to Eysenck and Eysenck 
(1985), Cloninger (1987), Zuckerman (1984), and Barratt’s (1985) early 
descriptions of impulsivity. These theoretical propositions will be briefly 
reviewed to demonstrate their convergence on one facet of impulsivity (i.e., rash 
impulsiveness) in a series of factor analytic studies (see p. 32). 
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 Stemming from Eysenck’s (1967) earlier theoretical propositions, 
Eysenck and Eysenck (1985) proposed a personality taxonomy based on three 
biologically based personality dimensions. They termed these three dimensions; 
psychoticism, extraversion and neuroticism, with the sub-facet of impulsivity 
subsumed within the primary dimension of psychoticism (Eysenck & Eysenck, 
1985). In its broadest sense, psychoticism reflects the extent to which people are 
anti-social, egocentric, tough-minded, and unempathic (Eysenck & Eysenck, 
1985, p. 14). More specifically, the sub-facet of impulsivity reflects risk-taking, 
lack of planning, and acting without forethought (Eysenck & Eysenck, 1985).   
Eysenck and Eysenck’s (1985) conceptualisation of impulsivity shares 
striking similarities with impulsivity as later described by Cloninger (1987), 
Zuckerman (1984), and Barratt (1985). Cloninger’s (1987) original theory 
similarly proposed a three-facet model of personality, including facets termed 
harm avoidance, novelty seeking and reward dependence. Of these facets 
Cloninger’s conceptualisation of novelty seeking closely aligns with Eysenck and 
Eysenck’s (1985) description of impulsivity. According to Cloninger (1987, p. 
575), novelty seeking involves active-approach and thrill-seeking behaviour in 
response to novel stimuli.   
In contrast to the abovementioned theories, Zuckerman (1984) and Barratt 
(1985) did not propose tri-dimensional theories of personality. Zuckerman (1969) 
initially introduced the construct termed sensation seeking based on the theory of 
individual differences in optimal levels of arousal. Zuckerman (1969, 1979) 
posited that sensation seeking individuals were in a basal state of under arousal 
and thus required additional stimulation to reach an optimal level of arousal. Like 
the abovementioned definitions of impulsivity, sensation seeking is characterised 
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by the need to seek out novel forms of sensation and experience, and a 
willingness to engage in these experiences regardless of the risks involved 
(Zuckerman, 1979, p.10).  
Barratt (1985), on the other hand, developed a well-known questionnaire 
termed the Barratt Impulsiveness Scale, which is currently in its eleventh revision 
(Patton et al., 1995). In his attempt to relate impulsivity to psychomotor efficiency 
(Stanford et al., 2009), Barratt conceptualised impulsivity as comprising three 
main sub-facets, which pertain to cognition, motor processing, and non-planning. 
Aligned with these sub-facets impulsivity was defined by Barratt as acting 
without thinking, making quick cognitive decisions, and having a present 
orientation, as opposed to thinking about future consequences. 
Whilst each of the abovementioned theories utilise different terminology 
in their conceptualisation of impulsivity, and report subtle differences in their 
definition, the underlying features of impulsivity in each theory involve an 
element of risk-taking and lack of planning. This is reflected in the convergence 
of the measures that were derived from the abovementioned theories on a single 
factor (see p. 32). More recently, rash impulsiveness has been described as the 
tendency to act rashly and the inability to stop engaging in approach behaviour 
despite the potential for negative consequences (Loxton, Nguyen, et al., 2008). 
Hence, rash impulsiveness is related to cognitive processes, namely lack of 
inhibitory control (Loxton, Nguyen, et al., 2008). 
Although each of the aforementioned theories proposed underlying neural 
processes for impulsivity, current knowledge, which is based on theory and 
advances in neurobiology, suggest that individual differences in rash 
impulsiveness involve the orbitofrontal cortex and the ventromedial prefrontal 
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cortex (Dawe et al., 2004). Jentsch and Taylor (1999) have previously argued that 
individual differences in the functioning of these brain regions are a consequence 
of chronic drug use. However, Dawe et al. (2004) propose that the areas of the 
brain involved in rash impulsiveness reflect individual differences in functioning 
(and hence individual differences in the expression of rash impulsive behaviour), 
which are exacerbated by chronic drug use. Notably, there is preliminary support 
for this hypothesis (see Goldstein & Volkow, 2002; Horn, Dolan, Elliott, Deakin, 
& Woodruff, 2003; Schoenbaum & Shaham, 2008). Furthermore, akin to reward 
sensitivity, evidence suggests that the dopamine system plays a principal role in 
rash impulsiveness (Leyton et al., 2002). However, there is also evidence for the 
role of serotonin in rash impulsiveness, particularly within the orbitofrontal cortex 
(Cools, Roberts, & Robbins, 2008).  
Although there are a number of measures that capture rash impulsiveness, 
the Impulsiveness subscale of the Eysenck Impulsiveness Questionnaire (I7; 
Eysenck et al., 1985) will be utilised in the two studies reported in this thesis. 
Another commonly used measure of rash impulsiveness is the Novelty Seeking 
subscale of the TPQ; however, this measure has been shown to correlate with 
anxiety measures (Caseras et al., 2003), which violates the theoretical assumption 
that these constructs are orthogonal (Barratt, 1965; Gray, 1987).  
It is important to note, that although rash impulsiveness and reward 
sensitivity are related, they are thought to represent distinct systems (Franken & 
Muris, 2006b; Quilty & Oakman, 2004). Consistent with this proposition, rash 
impulsiveness and reward sensitivity are posited to relate to different aspects of 
substance misuse. Specifically, Dawe and Loxton (2004) proposed that reward 
sensitivity relates to the motivating factors that are behind the initial decision to 
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use a substance, whereas rash impulsiveness relates to the decreased ability to 
cease using substances in spite of negative consequences. Hence, reward 
sensitivity and rash impulsiveness are posited to relate to substance use initiation 
and maintenance, respectively. The following section will review the well-
established role of impulsivity in predicting the onset of substance misuse, and 
related clinical outcomes, before reviewing more recent studies examining the 
utility of a two-facet conceptualisation of impulsivity in research investigating 
substance misuse. 
Impulsivity in Substance Misuse 
Biologically based theories of personality make two fundamental 
assumptions about personality traits. Firstly, they posit that traits are stable over 
time, and secondly they propose that traits directly influence behaviour 
(Matthews, Deary, & Whiteman, 2003). Research examining impulsivity has 
largely been consistent with this contention, in that a personality style 
characterised by elevated impulsivity has repeatedly been shown to predict the 
onset of later problematic substance use (i.e., the onset of heavy substance use or 
a diagnosis of substance abuse or dependence; e.g., Fergusson et al., 2008; Masse 
& Tremblay, 1997; Sher et al., 2000).  
In one such study, Sher et al. (2000) examined the cross-sectional and 
prospective role of personality variables in predicting later substance misuse 
diagnoses. Sher et al. administered the TPQ, Eysenck’s Personality Questionnaire 
(EPQ; Eysenck & Eysenck, 1975), and completed structured interviews to 
ascertain substance use diagnosis in a large sample (n = 489) of undergraduate 
students. Across Cloninger (1985) and Eysenck’s (1975) personality taxonomies 
it was found that Cloninger’s Novelty Seeking subscale and Eysenck’s 
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Psychoticism subscale were the most consistent predictors of substance use 
disorders both cross-sectionally and at six-year follow up (n = 457). That is, 
individuals with high baseline scores on the Novelty Seeking or Psychoticism 
subscale were more likely to receive a substance use diagnosis at follow-up (Sher 
et al., 2000). 
Similarly, in the cross-sectional analyses these subscales were 
significantly related to all substance use disorders (Sher et al., 2000). 
Interestingly, psychoticism was shown to be a reliable predictor of prospective 
alcohol use disorders, whereas novelty seeking was shown to be a reliable 
predictor of illicit drug use disorders and tobacco use. It is likely that these 
findings reflect subtle differences between the measurement of psychoticism and 
novelty seeking. As previously discussed, the Novelty Seeking subscale is a 
measure of rash impulsiveness, whereas the Psychoticism subscale is a broader 
measure of a number of sub-traits, including impulsivity. Considering the 
longitudinal nature of Sher et al.’s (2000) study, their findings provide support for 
the etiological role of impulsive traits in predicting the onset of substance use 
disorders. 
More recently, Fergusson et al. (2008) reported the findings of a 
longitudinal study examining prospective predictors of illicit drug use and 
abuse/dependence. The sample was drawn from a 25-year longitudinal study of 
1265 New Zealand children, with Fergusson et al. analysing measures across a 
range of individual and familial domains, including measures of substance 
misuse, and a measure of rash impulsiveness (i.e., the Novelty Seeking subscale 
of the TPQ). Information for Fergusson et al.’s study was obtained at four time 
points, when participants were aged 16, 18, 21, and 25. 
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Based on the findings of analyses, Fergusson et al. (2008) reported that 
40% of the cohort reported using illicit drugs at least once, and 10% met DSM-IV 
(APA, 1994) criteria for a substance use disorder. To specifically examine the 
contribution of a range of risk factors in the development of illicit drug use and 
abuse/dependence over the nine-year time period, a three-stage regression 
analysis was carried out.  
In the first stage of the analysis, several factors were identified as 
statistically significant predictors of illicit drug use (Fergusson et al., 2008). 
These factors included, exposure to childhood sexual abuse, gender, rash 
impulsiveness, conduct problems between the ages of 7 and 13, and parental illicit 
drug use (Fergusson et al., 2008). In the second and third stages of the analysis, 
fixed and time-dynamic covariates and lagged illicit drug use were included to 
examine causality.  
Notably, the final model indicated that accounting for time-dynamic 
variables reduced many of the associations between childhood fixed factors and 
illicit drug abuse/dependence to statistical non-significance, with the exception of 
rash impulsiveness and illicit drug use, which remained statistically significant 
(Fergusson et al., 2008). Although these findings suggest that a number of 
childhood factors account for later substance use diagnoses, the findings of 
Fergusson and colleagues (2008) provide strong evidence that impulsivity plays 
an important role in predicting prospective illicit drug use and illicit drug use 
diagnoses.  
Whilst the abovementioned longitudinal studies utilised self-report 
measures of impulsivity there have also been a number of studies that have 
administered behavioural measures to examine associations with substance 
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misuse. One common behavioural measure of impulsivity is known as “delayed 
discounting”, which refers to the preference for smaller immediate rewards over 
larger but delayed rewards (Rachlin & Green, 1972). For example, Coffey, 
Gudleski, Saladin and Brady (2003) administered a delayed discounting task 
whereby participants were presented with hypothetical immediate and delayed 
rewards (including monetary and substance rewards), with 16 delay conditions 
ranging from five minutes to 25 years. The objective value of the monetary and 
substance rewards ranged from $1 to $1,000. Behaviourally, this task can be 
administered in an interview format (see Coffey et al., 2003) or through a 
computer program (see Stanger et al., 2012). This behavioural measure of 
impulsivity is considered to reflect rash impulsiveness (Dawe & Loxton, 2004). 
Consistent with broad definitions of impulsivity, individuals with a high 
rate of delayed discounting tend to be driven by immediate gains rather than 
future concerns (Dawe & Loxton, 2004). This has been examined extensively in 
animal (e.g., Monterosso & Ainslie, 1999) and human studies (e.g., Kirby, Petry, 
& Bickel, 1999). Unfortunately, a majority of studies carried out within substance 
using populations have examined delayed discounting in those who are already 
substance dependent and compare the findings to a control group (e.g., Coffey et 
al., 2003; Kirby et al., 1999). Hence, the temporal precedence of delayed 
discounting and substance misuse cannot be inferred from these studies. 
In a recent study addressing this limitation, Anokhin, Golosheykin, Grant, 
and Heath (2011) examined the heritability of delayed discounting and the 
longitudinal association of delayed discounting with a number of outcomes, 
including substance misuse. Their study was carried out in a sample of adolescent 
twins (n = 744) who were assessed on a range of behavioural and self-report 
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measures at age 12 and 14. Analyses indicated that delayed discounting was 
significantly associated with substance use over the past year at age 14, whereas 
these results did not reach significance at age 12 (Anokhin et al., 2011). However, 
the onset of substance misuse tends to peak in older adolescence and early 
adulthood (McGorry et al., 2011), hence this finding is consistent with the 
literature.  
Further, Anokhin and colleagues (2011) found that delayed discounting 
was significantly associated with a self-report measure of rash impulsiveness, 
with individuals scoring higher on delayed discounting similarly scoring higher 
on rash impulsiveness at age 12 and 14 than those who did not. Lastly, Anokhin et 
al. found a moderate to strong influence of genetic heritability on delayed 
discounting. At age 12, heritability was estimated at 30%, whereas at age 14 this 
was estimated at 51%. The findings of this study provide evidence to support 
early theoretical models that proposed impulsivity is a biologically based 
personality trait (e.g., Eysenck & Eysenck, 1985; Gray, 1987). 
Whilst the aforementioned heritability and prospective studies provide 
evidence to support the genetic basis of impulsivity, it is equally important to 
acknowledge research examining the impact substance misuse has on the 
expression of impulsivity. In this way, impulsivity has been described as both a 
predictor and a consequence of drug use (de Wit, 2009; Verdejo-García, 
Lawrence, & Clark, 2008). For example, substance use itself tends to increase 
risk-taking and impulsive behaviours, including risky sex and driving while under 
the influence of substances (de Wit, 2009; Goldstein & Volkow, 2002). Hence, 
although there is strong evidence to suggest that impulsivity predicts later 
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substance misuse, substance misuse tends to exacerbate engagement in impulsive 
behaviours.  
In light of this finding, it is unsurprising that those who present for 
treatment of their substance use disorder, with elevated levels of impulsivity, tend 
to have poorer treatment outcomes. In one such study, Stanger et al. (2012) 
examined the impact of delayed discounting on substance misuse treatment 
outcomes in a sample of adolescents (n = 165) seeking treatment for marijuana 
abuse or dependence. Whilst a majority of participants in the sample discounted 
the smaller reward ($100) for the larger reward ($1000), those who chose the 
smaller magnitude reward were less likely to abstain from marijuana use during 
treatment (Stanger et al., 2012). Abstinence was measured over 14 weeks and was 
on the basis of urine tests, parental and individual self-report. Further, this finding 
was consistent across the three alternative treatment conditions in the study. 
Specifically, the three alternative treatment conditions were: (1) cognitive 
behavioural therapy only; (2) cognitive behavioural therapy in addition to 
contingency management (i.e., escalating monetary rewards for abstinence, with a 
reset procedure for substance use; see Stanger et al., 2012, p. 207); and (3) 
cognitive behavioural therapy, contingency management and a family 
management curriculum.  
Similarly, Patkar and colleagues (2004) sought to examine whether 
impulsivity predicts treatment outcome in a sample of African American 
individuals (n = 145) seeking treatment for cocaine misuse. Using two measures 
of rash impulsiveness, scores on the Sensation Seeking Scale (Zuckerman et al., 
1978) showed a significant negative correlation with days in treatment, number of 
negative urine tests, and a significant positive correlation with treatment dropout. 
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Similarly, scores on the Barratt Impulsiveness Scale were negatively correlated 
with days in treatment.  
Although there is evidence to suggest that there is a genetic basis to 
impulsivity (Anokhin et al., 2011), it is important to acknowledge that the 
behavioural effects of impulsivity appear to be modifiable through therapeutic 
intervention (e.g., Conrod, Castellanos-Ryan, & Strang, 2010; O'Leary-Barrett, 
Mackie, Castellanos-Ryan, Al-Khudhairy, & Conrod, 2010). However, to date, 
personality-based interventions have focused on early intervention in adolescence 
and childhood. Hence, these interventions have not been commonly integrated 
into substance misuse treatment programs. Considering the impact impulsivity 
has on substance misuse, alongside important clinical outcomes, interventions 
aimed at modifying the behavioural effects of impulsivity warrant consideration 
in future research (Staiger et al., 2007).  
Whilst it is beyond the scope of this thesis to review all studies in the 
clinical literature that have examined the relationship between impulsivity and 
substance misuse, the abovementioned studies demonstrate the well-established 
role of impulsivity in predicting substance misuse and treatment outcomes. 
Consistent with the wider clinical literature, the reviewed studies utilised 
measures that reflect rash impulsiveness, including self-report measures of 
Novelty Seeking (Cloninger, 1987), Sensation Seeking (Zuckerman et al., 1978), 
and the behavioural measure of delayed discounting (Rachlin & Green, 1972).  
Converging with factor-analytic studies supporting the two-facet 
conceptualisation of impulsivity, it has only been more recently that studies have 
begun including measures of reward sensitivity in substance misuse research 
(Gullo, Ward, Dawe, Powell, & Jackson, 2011). Considering that the two-facet 
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conceptualisation of impulsivity is central to the present thesis, the following 
section will systematically review all literature examining the influence of rash 
impulsiveness and reward sensitivity on substance misuse. 
Systematic Review: Two Facets of Impulsivity in Substance Misuse Research 
A review of the literature was carried out so that all articles measuring 
rash impulsiveness, reward sensitivity and substance misuse were systematically 
reviewed. With regard to substance misuse, there were no limitations on class of 
substance or type of measurement (e.g., severity, diagnosis, frequency or quantity 
measure). The review included peer-reviewed journal articles of varied 
methodological quality, which were written in the English language. There were 
no limitations on age of participants, type of study (i.e., cross-sectional, 
prospective or experimental), type of sample (i.e., community or clinical), or date 
of publication. Exclusion criteria included animal studies and studies 
investigating one-facet of impulsivity.  
A database search was conducted on PsycARTICLES, PsychINFO, 
Academic Search Complete, Psychology and Behavioural Sciences Collection, 
MEDLINE Complete, and Science Direct (Social Sciences and Humanities 
Collection). Articles were obtained using permutations of the following key 
words: substance misuse, rash impulsiveness and reward sensitivity. The 
reference lists of retrieved articles were scanned for additional relevant 
publications. Refer to Appendix A for a detailed method of the review, inclusion 
and exclusion criteria, search terms (see Table A1) and a flowchart depicting the 
flow of information through different phases of the review (Figure A1).  
The review indicated that 16 studies had examined the two-facet 
conceptualisation of impulsivity in relation to measuring substance misuse (see 
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Table A2 for the characteristics of included studies). With regard to specific 
substance misuse measurement, nine studies measured alcohol misuse, two 
studies measured drug misuse, and five studies administered measures of both 
drug and alcohol misuse. Of these studies, three carried out their study in a 
clinical sample, while the remaining 13 studies were conducted in a community 
sample.  
It is important to note that an examination of the two-facet 
conceptualisation of impulsivity in substance misuse was not the sole focus of all 
studies included in the review. Hence, only those findings pertaining to rash 
impulsiveness and reward sensitivity in substance misuse will be discussed.  
Specific findings of individual studies will be reviewed in the following sections.  
Two-facet conceptualisation in alcohol misuse. 
Three cross-sectional studies included in the present review utilised 
hierarchical regression analysis to examine the contribution of rash impulsiveness 
and reward sensitivity in the prediction of alcohol misuse (Gullo, Jackson, & 
Dawe, 2010; Lyvers et al., 2012; Willem, Bijttebier, & Claes, 2010). In Gullo, 
Jackson and Dawe’s (2010) study it was found that the Impulsiveness subscale of 
the I7, and the SR subscale of the SPSRQ, made a unique contribution to 
predicting alcohol misuse in a sample of college students (n = 165). Specifically, 
measures of reward sensitivity and rash impulsiveness predicted greater 
hazardous alcohol use (i.e., drinking at harmful levels according to the Alcohol 
Use Disorders Identification Test [AUDIT] cut off scores; Saunders, Aasland, 
Babor, De La Fuente, & Grant, 1993), with each facet of impulsivity explaining 
4% and 5% unique variance, respectively.  
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 Similarly, Lyvers et al. (2012) sought to investigate whether hazardous 
drinking was related to elevated reward sensitivity and rash impulsiveness in a 
sample of university students (n = 124). To test the hypothesis that rash 
impulsiveness and reward sensitivity would predict scores on the AUDIT, the 
Barratt Impulsiveness Scale and the SR subscale of the SPSRQ were 
administered. In step one of the regression analysis age and gender were entered, 
which accounted for 9% variance in AUDIT scores. In step two, rash 
impulsiveness scores accounted for a further 14% variance, while in step three the 
addition of both reward sensitivity and punishment sensitivity (i.e., BIS) 
accounted for a further 7% variance. Importantly, when controlling for the 
variance due to other variables, rash impulsiveness and reward sensitivity made 
the strongest unique contributions to explaining AUDIT scores (Lyvers et al., 
2012). 
 Furthermore, using suggested cut-off scores for the AUDIT, Lyvers et al. 
(2012) found that young adults who were classified as harmful drinkers scored 
significantly higher than low risk and hazardous drinking groups on measures of 
rash impulsiveness and reward sensitivity. These findings converged with an 
earlier study by Lyvers, Duff, and Hasking (2011), where the same measures of 
reward sensitivity and rash impulsiveness were positively associated with risky 
drinking as defined by the AUDIT cut off scores. 
In the third study utilising hierarchical regression analysis, Willem et al. 
(2010) found that BAS Fun Seeking uniquely predicted age of first alcohol use 
and quantity of alcohol consumed in a high school sample (n = 284). Willem et al. 
also found that BAS Drive and BAS Fun Seeking were significantly positively 
associated with quantity of alcohol consumed, and negatively associated with age 
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of first alcohol use. However, BAS Reward Responsiveness, a measure of reward 
sensitivity, was not significantly associated with any alcohol use variables in 
Willem et al.’s study.  
Using a differential statistical methodology, Gullo, Dawe, et al. (2010) 
tested a structural equation model examining the cognitive mechanisms through 
which rash impulsiveness and reward sensitivity represent risk factors for alcohol 
misuse. An equivalent model was tested within a sample of young adults (n = 
342) and a sample of individuals seeking treatment for substance misuse (n = 
121). It was found that rash impulsiveness, as measured by the Impulsiveness 
subscale of the I7, and reward sensitivity, as measured by BAS Drive, and the SR 
subscale of the SPSRQ, were directly related to distinct cognitive mechanisms 
(i.e., drinking refusal self-efficacy and positive alcohol expectancy, respectively), 
which were related to hazardous alcohol use.  
The findings of Gullo, Dawe, et al. (2010) provide support for the 
hypothesis that both facets of impulsivity differentially relate to substance misuse 
(Dawe et al., 2004; Dawe & Loxton, 2004). Furthermore, this finding adds 
strength to the contention that rash impulsiveness and reward sensitivity are 
distinct facets of impulsivity, both of which should be included in empirical 
research to capture the multidimensional nature of impulsivity.   
In another study included in the review, Ibáñez et al. (2010) administered 
a Spanish version (Gutierrez-Zotes et al., 2004) of the Novelty Seeking subscale 
of the Temperament Character Inventory (Cloninger, Przybeck, Svrakic, & 
Wetzel, 1994), and the SR subscale of the SPSRQ, to examine personality traits 
that are involved in the onset of alcohol consumption. Based on a principal 
components analysis, which included several personality measures, four factors 
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were identified. Specifically, one factor included the measure of rash 
impulsiveness and another factor included the measure of reward sensitivity, both 
of which predicted alcohol consumption in a Spanish sample of undergraduate 
students (n = 539). Unfortunately, the analyses combined a series of personality 
measures, making it difficult to ascertain the unique role of each facet of 
impulsivity in predicting alcohol consumption (Ibáñez et al., 2010). In spite of 
this, the findings of Ibáñez et al. (2010) converge with the findings of a series of 
other studies (e.g., Quilty & Oakman, 2004; Zelenski & Larsen, 1999), which 
have consistently demonstrated that measures of impulsivity are heterogeneous 
and tend to load on two distinct factors in factor analytic and principal 
components analyses. 
Only one study included in the present review utilised a measure of 
alcohol ingestion to examine the relationship between heart rate, alcohol 
intoxication, and personality (Brunelle et al., 2004). Specifically, participants (n = 
37) ingested one millilitre of alcohol per kilogram of body weight (Brunelle et al., 
2004). Using a physiological measure of heart rate response, it was found that 
those with a high heart rate response to alcohol reported significantly higher 
reward sensitivity, as measured by the SR subscale of the SPSRQ, and higher 
Sensation Seeking scores, as measured by the Substance Use Risk Profile Scale 
(Woicik, Stewart, Pihl, & Conrod, 2009), than those with low heart-rate responses 
to alcohol. Although Brunelle et al. utilised cross-sectional methodology, their 
overall findings provide preliminary support to etiological hypotheses, which 
posit that sensitivity to the rewarding properties of alcohol place individuals at 
higher risk of developing alcohol use problems (see Conrod, Pihl, & Vassileva, 
1998).  
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Overall, studies that utilised the AUDIT tended to find that hazardous 
drinkers reported significantly higher levels of rash impulsiveness and reward 
sensitivity than non-hazardous drinkers (Hamilton, Sinha, & Potenza, 2012; 
Lyvers et al., 2011; Lyvers et al., 2012). A recent study by Kabbani and 
Kambouropoulos (2013) similarly utilised the AUDIT as a measure of alcohol 
misuse, and found a significant direct effect of reward sensitivity, as measured by 
the SR subscale of the SPSRQ, on alcohol misuse. However, contrary to 
hypotheses, Kabbani and Kambouropoulos failed to find a significant direct effect 
of rash impulsiveness, as measured by the Impulsiveness subscale of the I7, on 
alcohol misuse. However, it was noted that their sample was relatively small (n = 
132), which may account for this unexpected finding. 
Similarly, Hamilton et al. (2012) and Lyvers et al. (2011) reported 
findings inconsistent with their hypotheses. Specifically, Hamilton et al. found no 
significant differences between hazardous and non-hazardous drinking groups on 
measures of BAS Drive but found significant differences between groups on BAS 
Reward Responsiveness (n = 446). Similarly, Lyvers et al. (2011) reported that 
rash impulsiveness scores, which were measured using the Barratt Impulsiveness 
Scale, contributed little to the prediction of AUDIT scores, whereas the 
relationship between disinhibition and drinking behaviour was partially mediated 
by the SR subscale of the SPSRQ. Importantly, both Hamilton et al. and Lyvers et 
al. carried out their studies in community samples, which were comprised of a 
relatively low rate of hazardous drinkers. Hence, this limits the capacity to 
generalise their findings to clinical samples. 
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Two-facet conceptualisation of impulsivity in drug misuse. 
Two studies included in the present review specifically examined rash 
impulsiveness and reward sensitivity in samples of individuals who reported 
using illicit drugs. In both studies, which were carried out in divergent samples, 
similar findings were reported. Firstly, in an adult community sample (n = 207), 
Egan, Kambouropoulos, and Staiger (2010) compared ecstasy users and non-
ecstasy using controls. Egan et al. administered the Impulsiveness subscale of the 
I7 as a measure of rash impulsiveness, and the SR subscale of the SPSRQ as a 
measure of reward sensitivity. Consistent with hypotheses, there were 
significantly higher levels of reward sensitivity (η2 = .08) and rash impulsiveness 
(η2 = .05) among ecstasy users.  
Similarly, Loxton, Wan, et al. (2008) compared a sample of club-drug 
users (n = 360) and non-drug users from Hong Kong. Loxton, Wan, et al. (2008) 
used the Sensation Seeking Scale (Zuckerman, 1994), and BAS Fun Seeking scale 
as measures of rash impulsiveness, and the BAS Drive and BAS Reward 
Responsiveness subscales as measures of reward sensitivity. It was found that 
club-drug users scored significantly higher on the Sensation Seeking, BAS Fun 
Seeking, and BAS Drive subscales. Consistent with a number of the 
abovementioned findings, there were no significant effects for BAS Reward 
Responsiveness.   
Two-facet conceptualisation of impulsivity in alcohol and drug 
misuse. 
Lastly, studies that utilised measures of both alcohol and drug misuse will 
be discussed. Franken and Muris (2006a) found that BAS Drive and BAS Fun 
Seeking were positively correlated with the number of illicit drugs used in a 
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sample of undergraduate university students (n = 276). Further, BAS Fun Seeking 
was positively correlated with binge drinking and drinking quantity. Inconsistent 
with hypotheses, but consistent with the findings of other studies in the present 
review, Franken and Muris (2006a) found that BAS Reward Responsiveness was 
not significantly correlated with any substance misuse variables. 
Similarly, Voigt et al. (2009) utilised the abovementioned measures of 
impulsivity in a sample of undergraduate university students (n = 1014) and found 
that BAS Fun Seeking was significantly correlated with alcohol, tobacco and drug 
use. However, in this sample BAS Drive failed to reach significance. 
Furthermore, inconsistent with hypotheses, Voigt et al. reported that BAS Reward 
Responsiveness was significantly negatively correlated with alcohol, tobacco, and 
drug use. The conflicting findings associated with the BAS Reward 
Responsiveness subscale will be discussed in detail in the review conclusion.  
Only two studies included in the present review conducted their study in a 
clinical sample of substance users and compared these findings with a control 
group (Franken, Muris, & Georgieva, 2006; Meda et al., 2009). Although both 
studies used different measures of rash impulsiveness and reward sensitivity they 
both reported similar findings. Specifically, Meda et al. (2009) found that 
participants with a family history of alcohol abuse, and drug dependent 
participants, scored significantly higher than controls on the Barratt 
Impulsiveness Scale and the SR subscale of the SPSRQ. 
Similarly, Franken et al. (2006) reported that there were significant 
differences between drug misuse inpatients, alcohol misuse inpatients, and 
controls, on the BAS Fun Seeking and BAS Drive subscales. Consistent with the 
findings of other studies included in this review, there were no significant 
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differences across groups on the BAS Reward Responsiveness subscale (e.g., 
Franken & Muris, 2006a; Loxton, Wan, et al., 2008; Willem et al., 2010). It is 
important to note that both Franken et al. and Meda et al. (2009) used substance 
use status (e.g., inpatient, family history) as an indicator of substance misuse. 
That is, no measure of substance use frequency or severity was administered. 
The last study to be discussed in the present review was carried out by 
Gullo and colleagues (2011). This study specifically evaluated the utility of the 
two-facet conceptualisation of impulsivity over the well-established one-facet 
conceptualisation of impulsivity, which has long been assumed in empirical 
research (e.g., Masse & Tremblay, 1997; Fergusson et al., 2008). Considering the 
relevance of this study to the present thesis, the methodology and findings will be 
discussed in detail.  
In the study of Gullo et al. (2011), it was hypothesised that the two-facet 
conceptualisation of impulsivity would provide a better fit to the data than a one-
facet conceptualisation. Specifically, a one-facet conceptualisation of impulsivity 
predicts a direct relationship between a single measure of impulsivity (i.e., either 
rash impulsiveness or reward sensitivity) and substance misuse. It was also 
hypothesised that both rash impulsiveness and reward sensitivity would account 
for unique variance in the prediction of substance misuse.  
Among Australian (n = 271) and British (n = 183) young adults who 
completed several self-report questionnaires pertaining to reward sensitivity, rash 
impulsiveness, and hazardous substance use, the results of a series of structural 
equation modelling analyses were consistent with hypotheses (Gullo et al., 2011). 
That is, a two-facet conceptualisation of impulsivity was a better fit to the data 
than the one-facet conceptualisation. In the British sample, the hypothesised 
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model accounted for 26% of the variance in hazardous alcohol use and 27% of the 
variance in illicit drug use. In the Australian sample, the hypothesised model 
accounted for 14% of the variance in hazardous alcohol use and 6% of the 
variance in illicit drug use.  
To verify the abovementioned findings Gullo et al. (2011) contrasted their 
hypothesised model with two alternative models. As previously mentioned, the 
first comparison model included a single facet of impulsivity directly predicting 
substance misuse. Based on an examination of the chi-square and goodness of fit 
indices, the results indicated that this model was a poor fit to the data. The second 
comparison model was similar to the hypothesised model, but removed the direct 
relationship between reward sensitivity and illicit drug use, as this is a more 
recent conceptualisation of impulsivity based on factor analytic studies (e.g., 
Quilty & Oakman, 2004). Whilst this model provided a reasonable fit to the data, 
the goodness of fit statistics (e.g., Akaike’s Information Criterion) and the chi-
square test indicated that the hypothesised model, whereby the two facets of 
impulsivity directly predicted substance misuse, was the best fit to the data. This 
recent study carried out by Gullo et al. (2011) provides strong evidence to suggest 
that the two facets of impulsivity uniquely contribute to the prediction of 
substance misuse.  
Review conclusion.  
Overall, the findings of the review suggest that rash impulsiveness and 
reward sensitivity have strong utility in predicting various aspects of substance 
misuse. In particular, measures of rash impulsiveness and reward sensitivity were 
consistently positively associated with a range of substance use variables, 
including hazardous alcohol use (Gullo, Dawe, et al., 2010; Gullo, Jackson, 
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Dawe, 2010; Gullo et al., 2011; Kabbani & Kamboutopoulos, 2013; Lyvers et al., 
2011; Lyvers et al., 2012; Voigt et al., 2009), quantity of alcohol consumed 
(Willem et al., 2010), illicit drug use (Gullo et al., 2011; Voigt et al., 2009), and 
number of illegal substances used (Franken & Muris, 2006a). Consistent with 
these findings, both measures of impulsivity were significantly negatively 
correlated with age of first alcohol use (Lyvers et al., 2012; Willem et al., 2010). 
Moreover, measures of rash impulsiveness and reward sensitivity were 
consistently shown to be significantly higher among hazardous substance users, 
when compared to non-substance using individuals, or substance users fitting 
criteria for non-hazardous substance use (Egan et al., 2010; Franken et al., 2006; 
Hamilton et al., 2012; Kabbani & Kambouropoulos, 2013; Loxton, Wan, et al., 
2008; Lyvers et al., 2012; Meda et al., 2009; Willem et al., 2010). 
For those studies that reported the eta squared (η2) measure of effect size, 
it was found that η2 ranged from .04 to .14 for measures of rash impulsiveness 
(Egan et al., 2010; Hamilton et al., 2012; Lyvers et al., 2012), and from .01 to .10 
for measures of reward sensitivity (Egan et al., 2010; Hamilton et al., 2012; 
Lyvers et al., 2012; Lyvers et al., 2011) in relation to the measurement of 
substance misuse. Loxton, Wan, et al. (2008) reported a population based measure 
of effect size and found that omega squared (ω2) ranged from .06 to .08 for two 
measures of rash impulsiveness, and from .00 to .02 for two measures of reward 
sensitivity in contrasting club-drug users and non-drug users. Overall these 
findings suggest that effect sizes for rash impulsiveness ranged from small to 
large, whereas effect sizes for reward sensitivity ranged from small to medium in 
the prediction of substance misuse (see Morse, 1999). Notably, the scale reporting 
an effect size of ω2 =  .00 was the BAS Reward Responsiveness subscale, which is 
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not surprising given several inconsistent findings have been reported using this 
subscale within the present review (i.e., Franken & Muris, 2006a; Franken et al., 
2006; Hamilton et al., 2012; Loxton, Wan, et al., 2008; Voigt et al., 2009; Willem 
et al., 2010). 
Indeed, the findings of this review indicate that the BAS Reward 
Responsiveness subscale often failed to differentiate hazardous substance users 
from controls (Franken et al., 2006; Loxton, Wan, et al., 2008). Further, this 
measure was found to be unrelated to substance use variables (Franken & Muris, 
2006a; Willem et al., 2010). Paradoxically, one study found a significant negative 
relationship between BAS Reward Responsiveness and substance misuse (Voigt 
et al., 2009), whereas another study found a positive relationship (Hamilton et al., 
2012). In light of this finding, the two studies reported in this thesis will utilise the 
SR subscale of the SPSRQ, as the present review demonstrated greater 
consistency with this measure of reward sensitivity. It would be advantageous for 
future research to examine individual items on the BAS Reward Responsiveness 
subscale to determine whether this measure accurately captures the construct of 
reward sensitivity. Such research may explain why this measure is inconsistently 
related to substance misuse.  
Furthermore, the findings were remarkably consistent across a diverse 
range of clinical and non-clinical samples and demonstrated preliminary evidence 
that findings are cross-culturally applicable (Ibáñez et al., 2010; Loxton, Wan, et 
al., 2008). Cross-cultural validation adds further credence to the contention that 
impulsivity is a biologically based personality trait.  
It is important to acknowledge that the minor inconsistencies evident 
across studies may be related to differential methodological approaches. For 
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example, substance misuse measures varied largely across studies, with some 
studies using diagnosis, frequency of use, ingestion or quantity measures. 
Furthermore, there are other considerations, such as age of the sample or whether 
the sample comprised of university students, which limits generalisability.   
 One important limitation of the studies included in the present review is 
that all studies used cross-sectional research designs. Although there have been a 
number of longitudinal studies examining one facet of impulsivity in the 
prediction of substance misuse (e.g., Fergusson et al., 2008; Sher et al., 2000) 
there have been no longitudinal studies examining the two facets of impulsivity. It 
is important for future empirical studies to consider these methodologies. 
Although the above systematic review focused on research examining the 
two-facet conceptualisation of impulsivity in substance misuse, studies have 
begun to examine the involvement of rash impulsiveness and reward sensitivity in 
the etiology of comorbidity (i.e., the co-occurrence of two psychiatric diagnoses 
or the co-occurrence of a psychiatric diagnosis and a substance use disorder). 
Such research is of specific relevance to the present thesis as the two studies 
reported in this thesis are investigating the involvement of rash impulsiveness and 
reward sensitivity in the co-occurrence of social anxiety and substance misuse. 
Considering that little is known about the relationship between social anxiety, 
impulsivity and substance misuse, the following review may inform the rationale 
for the two studies reported in this thesis. Therefore, the following section will 
systematically review all studies that have utilised the two-facet conceptualisation 
of impulsivity to examine comorbidity. 
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Systematic Review: Two Facets of Impulsivity in Comorbidity Research 
A review of the literature sought to systematically review all studies that 
have examined the involvement of rash impulsiveness and reward sensitivity in 
the co-occurrence of two psychiatric diagnoses, or the co-occurrence of a 
psychiatric diagnosis and a substance use disorder. Consistent with the previous 
systematic review reported in this thesis, the present review included peer-
reviewed journal articles, which were written in the English language. There were 
no limitations on methodological quality, age of participants, type of study (i.e., 
cross-sectional, prospective or experimental), type of sample (i.e., community or 
clinical), or date of publication. Exclusion criteria included animal studies and 
studies investigating one-facet of impulsivity.  
A database search was conducted on PsycARTICLES, PsychINFO, 
Academic Search Complete, Psychology and Behavioural Sciences Collection, 
MEDLINE Complete, and Science Direct (Social Sciences and Humanities 
Collection). Articles were obtained using permutations of the following key 
words: comorbidity, rash impulsiveness and reward sensitivity. The reference lists 
of retrieved articles were scanned for additional relevant publications. Refer to 
Appendix B for a detailed method of the review, inclusion and exclusion criteria, 
search terms (see Table B1), and a flowchart depicting the flow of information 
through different phases of the review (Figure B1). The review found three 
articles relevant to the aim of the review (see Table B2 for the characteristics of 
the included studies).  
The review indicated that all three studies examined the two-facet 
conceptualisation of impulsivity in psychiatric diagnoses that co-occur with 
substance misuse. Each of the three studies examined different psychiatric 
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diagnoses, including bulimia nervosa (Kane et al., 2004), bipolar disorder (Alloy 
et al., 2009), and psychopathy (Hopley & Brunelle, 2012). In the study of Alloy et 
al. (2009) and Kane et al. (2004) it was proposed that rash impulsiveness and 
reward sensitivity may represent a shared personality vulnerability underlying the 
co-occurrence of both disorders. In contrast, Hopley and Brunelle (2012) 
measured a range of different personality variables to investigate the relationship 
between psychopathy and substance misuse. Hence, Hopley and Brunelle did not 
specifically examine the two-facet conceptualisation of impulsivity in 
psychopathy and substance misuse comorbidity; rather they sought to use an 
exploratory approach by measuring a range of potentially relevant personality 
variables. As there are only three studies in the present review, the findings of 
each study will be discussed in detail below. 
Kane et al. (2004) sought to investigate the utility of the two-facet 
conceptualisation of impulsivity in explaining the comorbidity between alcohol 
misuse and bulimia nervosa. As previously discussed, impulsivity has been found 
to predict the onset of substance misuse (Fergusson et al., 2008). Similarly, 
impulsivity is associated with symptoms of bulimia nervosa, including binge 
eating (Kemps & Wilsdon, 2009). Kane et al. tested the hypothesis that measures 
of rash impulsiveness and reward sensitivity would be elevated among those 
suffering from comorbid bulimia nervosa and alcohol misuse (n = 23), compared 
to those with bulimia nervosa alone (n = 22), and controls (n = 21). To test these 
hypotheses, the Impulsiveness subscale of the I7 and BAS Fun Seeking subscale 
were administered as measures of rash impulsiveness, and the BAS Drive and 
Reward Responsiveness subscales were administered as measures of reward 
sensitivity. Further, the Card Arranging Reward Responsiveness Objective Test 
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(CARROT; Powell, al-Adawi, Morgan, & Greenwood, 1996) was administered as 
a behavioural measure of reward sensitivity.  
The findings of Kane et al. (2004) indicated that there were significant 
differences across all measures of impulsivity, excluding the BAS Fun Seeking 
subscale, across the three subgroups. Planned comparisons found that the 
comorbid group reported significantly higher levels of rash impulsiveness, as 
measured by the Impulsiveness subscale, and non-significantly higher levels of 
reward sensitivity, as measured by the CARROT, than those with bulimia nervosa 
alone. However, it is important to note that the power (.52) to detect a significant 
difference between groups was compromised by the small sample size (Kane et 
al., 2004). Despite this, the findings of Kane et al. provide preliminary evidence 
to suggest that elevated rash impulsiveness and reward sensitivity may underlie 
the co-occurrence of bulimia nervosa and alcohol misuse. These findings warrant 
replication in a larger sample. 
In a similar study, Alloy et al. (2009) utilised the two-facet 
conceptualisation of impulsivity to enhance current knowledge about the 
etiological mechanisms underlying co-occurring bipolar disorder and substance 
use disorders. Consistent with the study carried out by Kane et al. (2004), 
impulsivity was posited to be a shared characteristic underlying both co-occurring 
disorders. Akin to bulimia nervosa, which is characterised by an impulsive 
symptom profile (Kemps & Wilsdon, 2009), impulsivity is a characteristic that 
underlies the appetitive component of mania in bipolar disorder (Corr, 2008).  
With regard to specific hypotheses, Alloy et al. (2009) sought to examine 
reward sensitivity and rash impulsiveness as predictors of bipolar and substance 
use diagnosis, and as predictors of the comorbidity between the disorders, in a 
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sample of young adults with bipolar spectrum disorders (n = 132) and 
demographically matched controls (n = 153). Self-report measures of reward 
sensitivity (i.e., BAS Reward Drive and BAS Reward Responsiveness subscales) 
and rash impulsiveness, including the BAS Fun Seeking subscale and the 
Impulsive Nonconformity Scale (Chapman et al., 1984), were administered to 
participants.  
Consistent with hypotheses, higher reward sensitivity and rash 
impulsiveness predicted bipolar diagnosis and substance misuse at one-year 
follow-up (Alloy et al., 2009). Further, reward sensitivity and rash impulsiveness 
mediated the association between bipolar diagnosis and prospective substance use 
problems. Consistent with the assumptions of mediation (see Frazier, Tix, & 
Barron, 2004), these findings suggest a temporal, causal relationship between 
bipolar disorder, impulsivity, and the onset of substance use disorders. Further 
longitudinal research is warranted to verify this contention (i.e., the temporal 
precedence of diagnoses and personality characteristics). On the basis of their 
findings, Alloy and colleagues (2009) concluded that reward sensitivity and rash 
impulsiveness may partly explain the comorbidity between these diagnoses. 
In spite of these promising findings reported by Alloy et al. (2009), it is 
important to consider some of the limitations of their study. Firstly, Alloy and 
colleagues (2009) used the BAS total score as a measure of reward sensitivity; 
hence this measure included BAS Fun Seeking, which is widely considered a 
measure of rash impulsiveness (Dawe et al., 2004). When subscales were 
examined individually, all impulsivity measures significantly distinguished 
between the bipolar and control group and were significantly associated with 
diagnostic status. However, BAS Reward Responsiveness and BAS Drive 
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subscales did not individually mediate or predict prospective substance misuse. 
Further, although the Impulsive Nonconformity scale (Chapman et al., 1984) was 
used as a measure of rash impulsiveness, this measure has not been validated as a 
measure of rash impulsiveness in factor analytic studies. These limitations should 
be taken into account in future studies examining the two-facet conceptualisation 
of impulsivity in comorbidity. 
More recently, Hopley and Brunelle (2012) used an exploratory approach 
to examine which personality variables underlie the relationship between 
psychopathy and substance misuse in male offenders (n = 92). Aligned with the 
previous studies reported in this review, impulsivity is known to be a key feature 
of psychopathy, which is a serious personality disorder (Morgan, Gray, & 
Snowden, 2011).  
To examine which personality variables mediated the relationship between 
psychopathy and substance misuse, two personality inventories were 
administered. Firstly, the SPSRQ was administered to measure behavioural 
inhibition and reward sensitivity, the two components of Gray’s (1987) original 
RST. The second measure administered was the Substance Use Risk Profile 
Scale. This scale measures a motivational model of substance misuse that has 
been proposed by Conrod, Pihl, Stewart and Dongier (2000). Subscales include, 
Anxiety Sensitivity, Introversion-Hopelessness, Sensation Seeking and 
Impulsivity (Woicik et al., 2009). Based on the items included in measures, the 
present review considered Sensation Seeking and Impulsivity subscales to be 
measures of rash impulsiveness.  
Hopley and Brunelle (2012) argued that although the relationship between 
psychopathy and substance misuse is well-established, the personality based 
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mechanisms underlying these relationships are poorly understood.Hence, they 
used an exploratory approach to examine the potential role of both personality 
models in mediating the relationship between psychopathy and substance misuse.  
Whilst rash impulsiveness and reward sensitivity were significantly 
correlated to psychopathy, only those personality constructs that were 
significantly related to both psychopathy and substance dependence were 
examined as possible mediators. Based on statistically significant correlations, the 
Impulsivity and Sensation Seeking subscales of the Substance Use Risk Profile 
Scale were examined as potential mediators of the relationship between 
psychopathy and stimulant use, and psychopathy and hallucinogen dependence. 
Findings of mediational analyses provided evidence for the role of rash 
impulsiveness mediating the relationship between psychopathy and substance 
misuse (i.e., stimulant and hallucinogen use). 
 Surprisingly, Hopley and Brunelle (2012) found that the SR subscale of 
the SPSRQ was not significantly correlated with substance misuse, meaning this 
measure could not be examined as a potential mediator of the relationship 
between psychopathy and substance misuse. This is consistent with the criteria for 
mediation as outlined by Barron and Kenny (1986). With regard to the Substance 
Use Risk Profile Scales future studies should consider including these in factor-
analytic studies to determine whether the Sensation Seeking and Impulsivity 
subscales reflect the measurement of rash impulsiveness.  
Review conclusion. 
Overall, the three studies included in the present review provide 
preliminary evidence to suggest that rash impulsiveness and reward sensitivity 
may represent a shared personality vulnerability underlying the co-occurrence of 
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diagnoses that are characterised by shared impulsive symptomatology. Given the 
limited number of studies that have examined this shared-vulnerability model, the 
findings of this review suggest that more research is warranted so that substantive 
conclusions can be made, which may have implications for the treatment of co-
occurring disorders that are characterised by shared impulsive symptomatology.   
There are some important limitations of the abovementioned studies, 
including limited power due to sample size concerns (Kane et al., 2004) and 
methodological concerns regarding the measurement of rash impulsiveness (Alloy 
et al., 2009; Hopley & Brunelle, 2009). This thesis will utilise a validated measure 
of rash impulsiveness to address this limitation.    
It is important to note that the studies included in the present review 
investigated comorbidity where psychiatric symptoms and behaviours are 
appetitive in nature (i.e., binge-eating and substance use; Kane et al., 2004), and 
in which impulsivity is deemed an important diagnostic and clinical characteristic 
of both disorders. In contrast, SAD tends to be associated with aversive 
motivation (Gray, 1987), and impulsivity has only recently been identified among 
a subset of SAD sufferers (e.g., Kashdan et al., 2009).  
Despite the counterintuitive nature of the relationship between impulsivity 
and anxiety, this is an important avenue for research due to the high prevalence of 
co-occurring anxiety disorders and substance use disorders (Slade et al., 2009). 
Additionally, it has been posited that anxiety and impulsivity may be dimensional 
(Corr, 2004), and hence, it is possible that elevated levels of these traits may co-
occur within an individual. Based on the findings of the above review, no 
previous studies have specifically examined the two-facet conceptualisation of 
impulsivity in the co-occurrence of an anxiety disorder with another diagnosis 
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characterised by impulsive symptomatology (e.g., substance misuse). Considering 
the relevance of such research to the rationale for the two studies reported in this 
thesis, the following section consists of a review of two studies, which have 
examined the co-occurrence of an anxiety disorder with another disorder 
characterised by impulsive symptomatology. 
The Co-occurrence of Anxiety and Impulsivity 
The relationship between anxiety and impulsivity has previously been 
described as “controversial” (Askénazy et al., 2003, p. 220). In part, this is due to 
Barratt (1965) and Gray’s (1987) descriptions of anxiety and impulsivity as 
orthogonally related, and the inconsistent relationship observed between these 
variables in the clinical literature. For example, there is a high comorbidity 
between anxiety disorders and disorders characterised by impulsive 
symptomatology (e.g., substance use disorders; Slade et al., 2009), yet several 
studies have reported no correlation between anxiety and impulsivity (Askénazy, 
Caci, Myquel, Darcourt, & Lecrubier, 2000; Mobini, Pearce, Grant, Mills, & 
Yeomans, 2006). Perugi et al. (2011) postulated that anxiety and impulsivity may 
only be related in certain circumstances, which may be related to the presence of 
comorbidity. 
Perugi et al. (2011) specifically examined this proposition in the co-
occurrence of anxiety disorders and cyclothymia, which is a chronic and 
fluctuating mood disorder that is characterised by periods of hypomanic and 
depressive symptoms (APA, 2000). Notably, several symptoms of hypomania are 
characterised by elevated impulsivity (Richardson & Garavan, 2010). Participants 
were 47 individuals with a diagnosis of any anxiety disorder and 45 
demographically matched controls. The Barratt Impulsiveness Scale was 
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administered as a measure of rash impulsiveness and the Immediate and Delayed 
Memory Task (Dougherty, Marsh, & Mathias, 2002) was administered as a 
measure of behavioural impulsivity.  
Consistent with hypotheses, the findings of a series of one-way Analyses 
of Variance (ANOVA) indicated that those with co-occurring anxiety and 
cyclothymia scored significantly higher on self-report and behavioural measures 
of impulsivity, when compared to those with anxiety alone, and controls (Perugi 
et al., 2011). Although preliminary, Perugi et al. (2011) concluded that 
impulsivity may not be directly related to the anxiety disorder diagnosis, but to 
the co-occurrence with cyclothymia.  
The findings of Perugi et al. (2011) shed light on the potential role of 
impulsivity underlying the relationship between co-occurring anxiety and 
cyclothymia there are some limitations that need to be considered. Firstly, their 
clinical sample was divided into two smaller sub-samples, comparing those with 
an anxiety diagnosis in isolation (n = 21), and those with co-occurring anxiety and 
cyclothymia (n = 26). Hence, their findings warrant replication in a larger sample 
to enhance generalisability. Further, Perugi et al. did not consider recent research 
advocating the measurement of two facets of impulsivity, with the Barratt 
Impulsiveness Scale capturing rash impulsiveness and the Immediate and Delayed 
Memory Task capturing the general construct of behavioural impulsivity 
(Dougherty et al., 2002). It would be advantageous to examine this question in 
future research as similar patterns of findings may not hold for reward sensitivity.  
Similarly, Booth and Hasking (2009) examined the involvement of a 
single facet of impulsivity in the co-occurrence of anxiety and impulsive 
symptomatology. Specifically, Booth and Hasking examined the moderating role 
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of reward sensitivity, alongside alcohol expectancies, in the co-occurrence of 
social anxiety and alcohol consumption. In a community sample of young adults 
(n = 454), Booth and Hasking (2009) found evidence for three-way relationships 
between two measures of reward sensitivity (i.e., BAS Reward Responsiveness 
and BAS Drive), alcohol expectancies, and symptoms of social anxiety, in the 
prediction of alcohol consumption. Using separate anxiety and avoidance 
subscales in the measurement of social anxiety symptoms, it was found that for 
those with elevated reward sensitivity (i.e., elevated BAS Drive), there was a 
positive relationship between social anxiety (anxiety subscale) and drinking, for 
those with strong tension reduction expectancies (Booth & Hasking, 2009). 
Whilst similar findings were not found for the social anxiety avoidance subscale, 
this is not surprising given individuals in community samples with subclinical 
symptoms are more likely to experience anxiety in social situations but not avoid 
them (i.e., they lack the significant impairment associated with a full-threshold 
diagnosis; Crum & Pratt, 2001).  
Additionally, similar findings were not found for the BAS Reward 
Responsiveness subscale. Specifically, it was found that for those with low levels 
of BAS Reward Responsiveness there was a positive relationship between social 
anxiety (anxiety subscale) and drinking for those with strong tension reduction 
expectancies (Booth & Hasking, 2009). Whilst this is in contrast to the previous 
finding using the BAS Drive subscale, this is not surprising given the inconsistent 
findings demonstrated with the BAS Reward Responsiveness subscale in several 
studies included in a previous systematic review of the literature (see pp. 57-58 
for an overview). Indeed, Voigt et al. (2009) found that BAS Reward 
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Responsiveness was significantly negatively correlated with alcohol, tobacco, and 
drug use.  
Despite some inconsistencies with regard to different measures, the 
findings of Booth and Hasking (2009) provide preliminary evidence to suggest 
that elevated levels of reward sensitivity may play an important moderating role 
in the co-occurrence of social anxiety and alcohol consumption. This is an 
important finding, as Booth and Hasking were the first to examine whether a 
personality trait, namely reward sensitivity, moderates the comorbidity between 
social anxiety and substance misuse. In contrast, several studies have previously 
examined the moderating role of cognitive variables in isolation, such as alcohol 
expectancies (e.g., Eggleston et al., 2004; Kushner, Sher, Wood, & Wood, 1994; 
Tran, Haaga, & Chambless, 1997).  
Whilst it is difficult to delineate the unique role of reward sensitivity in the 
co-occurrence of social anxiety and alcohol consumption due to the three-way 
relationships observed between alcohol expectancies, reward sensitivity and 
social anxiety, the findings of Booth and Hasking (2009) suggest that reward 
sensitivity warrants further examination regarding the role it plays in social 
anxiety and substance misuse comorbidity. In particular, the second study 
reported in this thesis will extend on the findings of Booth and Hasking by 
investigating the moderating role of reward sensitivity and rash impulsiveness in a 
clinical sample of socially anxious individuals with co-occurring substance use 
disorders. 
Taken together, the abovementioned studies provide evidence to suggest 
that elevated anxiety and impulsivity can exist concomitantly, and that this may 
underlie the co-occurrence of an anxiety disorder with a disorder characterised by 
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impulsive symptomatology. Consistent with Perugi et al.’s (2011) contention 
regarding the relationship between anxiety, impulsivity and cyclothymia, SAD 
itself may not represent a risk for the co-occurrence of substance misuse but a 
personality style characterised by elevated impulsivity may be involved in 
etiology of such comorbidity. The first study reported in this thesis will examine 
this contention in a community sample.  
Summary 
It has been demonstrated that a subset socially anxious individuals are 
characterised by impulsive-like traits. It was argued that this atypical symptom 
profile may explain the relationship between co-occurring social anxiety and 
substance misuse. The clinical and theoretical significance of impulsivity was 
reviewed and the evidence supporting a two-facet conceptualisation of 
impulsivity was presented. 
Two systematic reviews of the literature demonstrated the utility of the 
two-facet conceptualisation of impulsivity in research examining substance 
misuse, and provided preliminary evidence to suggest that these traits may 
underlie the comorbidity between diagnoses characterised by shared impulsive 
symptomatology. In contrast, it was argued that for a subset of socially anxious 
individuals, a personality profile characterised by elevated impulsivity may 
underlie the co-occurrence of substance misuse. The following chapter will 
review the gaps in the clinical literature before presenting the overall aim of this 
thesis and the two studies that will be conducted to address this aim. 
 
 
 
 
 
 
72 
CHAPTER THREE 
Aims of this Thesis 
Following a comprehensive review of the clinical literature in the previous 
chapter, it was argued that elevated levels of rash impulsiveness and reward 
sensitivity may underlie the relationship between co-occurring social anxiety and 
substance misuse. The present chapter provides an overview of the gaps evident 
in the clinical literature and presents the overall aim of this thesis. Lastly, the two 
studies that will be carried out to address this overall aim will be outlined.  
Limitations of Prior Research  
There are a number of important gaps in the clinical literature that this 
thesis aims to address. Firstly, previous research has failed to examine 
personality-based differences that may account for the high prevalence of co-
occurring SAD and substance misuse. For example, the self-medication 
(Khantzian, 1985) and tension-reduction (Conger, 1956) hypotheses do not make 
reference to personality-based differences that may explain why a subset of 
socially anxious individuals develop substance use problems while others do not. 
Moreover, research examining the role of cognitive variables (such as alcohol 
expectancies; see Eggleston et al., 2004; Kushner et al., 1994; Tran et al., 1997) in 
social anxiety and substance misuse comorbidity may be enhanced through 
research examining personality-based differences. For example, it is possible that 
personality-based mechanisms influence the development of alcohol expectancies 
(e.g., the expectation that alcohol consumption will enhance social interaction; 
Eggleston et al., 2004), which are posited to play a role in the development of 
substance misuse among a subset of socially anxious individuals (Gilles et al., 
2006). Hence, personality-based research may inform the development of 
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preventative and treatment interventions that target the mechanisms underlying 
the co-occurrence of social anxiety and substance misuse. The present thesis will 
contribute to the literature by utilising a two-facet conceptualisation of 
impulsivity to examine etiological mechanisms that may underlie the relationship 
between social anxiety and substance misuse.  
Secondly, as reviewed in chapter two, a series of studies have examined 
heterogeneity among socially anxious individuals by measuring a range of 
impulsive-like traits and behaviours, including hostile interpersonal problems, 
aggression, novelty seeking and risk-taking (i.e., Kachin et al., 2001; Kashdan et 
al., 2006; Kashdan & Hofmann, 2008; Kashdan et al., 2008; Kashdan et al., 
2009). Although rash impulsiveness (i.e., novelty seeking; Kashdan et al., 2009) 
has previously been identified among a subset of SAD sufferers no previous 
studies have utilised measures of reward sensitivity to examine heterogeneity 
among socially anxious individuals. It is argued that the measurement of both 
facets of impulsivity will enhance consistency in future research and capture the 
multidimensional nature of impulsivity, which will ultimately enhance knowledge 
regarding how each facet of impulsivity conveys risk for the co-occurrence of 
social anxiety and substance misuse. Specifically, the present thesis will utilise 
impulsivity measures based on the findings of factor-analytic studies (e.g., Quilty 
& Oakman, 2004), and two systematic reviews of the literature, which were 
carried out in chapter two.  
Moreover, the studies reported in this thesis will include participants with 
subthreshold symptoms of social anxiety. This is consistent with research 
suggesting that co-occurring substance misuse is more prevalent among those 
with subthreshold social anxiety symptomatology (Crum & Pratt, 2001; 
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Merikangas et al., 2002; Robinson et al., 2011). Further, there are a paucity of 
studies in the clinical literature that have utilised a clinical sample of individuals 
seeking treatment for their substance use disorder to examine the co-occurrence of 
social anxiety and substance misuse. Hence, the second study in the thesis will 
add to the literature by describing the clinical and demographic characteristics of 
the sample.  
Lastly, this thesis will address measurement issues evident in previous 
studies by utilising validated measures of substance use severity. For example, 
previous studies examining heterogeneity among socially anxious individuals 
relied on clinician-rated severity of substance use (Kashdan & Hofmann, 2008), 
self-reported substance use over a three-month period (Kashdan et al., 2008), and 
responses to seven binary questions derived from a comorbidity dataset (Kashdan 
et al., 2009). Hence, the use of validated measures will enable the studies in this 
thesis to comment on the severity of substance misuse (i.e., abuse or dependence, 
hazardous or non-hazardous) among participants. 
Overall Aim of the Present Thesis 
It has been argued that elevated rash impulsiveness and reward sensitivity 
may characterise a subset of socially anxious individuals with co-occurring 
substance use problems. Furthermore, it has been argued that the interaction 
between social anxiety and both facets of impulsivity may predict substance 
misuse. 
The overall aim of this thesis is: 
1. To investigate the utility of a two-facet conceptualisation of impulsivity in 
understanding the relationship between social anxiety and substance 
misuse. 
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Two studies will be carried out to investigate this overall aim. The first 
study will expand on a series of previous studies (i.e., Kachin et al., 2001; 
Kashdan et al., 2008; Kashdan & Hofmann, 2008; Kashdan et al., 2009) by 
examining whether individuals in the community with social anxiety 
symptomatology are characterised by qualitatively distinct personality profiles. 
Specifically, a latent class analysis will be carried out on symptoms typically 
associated with SAD, including social anxiety symptom severity and behavioural 
inhibition, and symptoms proposed to be involved in co-occurring social anxiety 
and substance misuse; including reward sensitivity, rash impulsiveness and risk-
taking. Consistent with the findings of previous studies it is expected that there 
will be two distinct subgroups of socially anxious sufferers. The two social 
anxiety subgroups will then be compared on measures of substance use frequency 
and dependence to examine whether significant differences can be identified 
across the two subgroups. 
The second study will investigate the moderating role of reward sensitivity 
and rash impulsiveness in the relationship between social anxiety and substance 
misuse. This study will be carried out in a clinical sample of individuals with 
social anxiety symptomatology and a co-occurring diagnosis of substance abuse 
or dependence. It will be argued the relationship between social anxiety 
symptoms and substance misuse is stronger among those with elevated rash 
impulsiveness and reward sensitivity. A secondary aim of this study is to describe 
the demographic and clinical characteristics of the sample as there are a paucity of 
studies examining the relationship between social anxiety and substance misuse in 
a clinical sample seeking treatment for their substance use disorder.  
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Summary 
To date, a two-facet conceptualisation of impulsivity has not been 
examined in co-occurring social anxiety and substance misuse. Considering 
previous findings (e.g., Booth & Hasking, 2009; Kashdan et al., 2009), it is 
possible that a subset of socially anxious individuals are characterised by elevated 
levels of rash impulsiveness and reward sensitivity, and that the interaction 
between social anxiety and each facet of impulsivity predicts co-occurring 
substance misuse. This thesis will expand on previously reviewed studies and 
address a number of gaps evident in the clinical literature.  
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CHAPTER FOUR 
Study One: When Social Anxiety Co-occurs with Impulsivity and Risk-
Taking: Does Substance Misuse Characterise this Subset of Socially Anxious 
People?  
Overview 
The preceding chapter identified the gaps evident in the clinical literature, 
which followed from a comprehensive review of the literature in chapter two. The 
overall aim of this thesis was presented and the two studies that will address this 
aim were outlined. This chapter presents the rationale, methodology, results, and 
discussion of the first study. The primary aim of this study is to expand on a series 
of studies that were reviewed in chapter two (i.e., Kachin et al., 2001; Kashdan et 
al., 2006; Kashdan & Hofmann, 2008; Kashdan et al., 2008; Kashdan et al., 2009) 
by utilising a two-facet conceptualisation of impulsivity to investigate 
heterogeneity among socially anxious individuals. It is argued that the 
measurement of both facets of impulsivity will enhance current knowledge 
regarding a specific personality profile, which may characterise individuals with 
co-occurring social anxiety symptomatology and substance use problems. 
Specifically, it is hypothesised that rash impulsiveness and reward sensitivity, 
alongside risk-taking, will distinguish individuals with social anxiety symptoms 
into two qualitatively distinct subgroups. Further, it is hypothesised that substance 
use problems will differentiate the two socially anxious subgroups.  
Rationale  
According to the literature, individuals suffering from SAD can generally 
be described as behaviourally inhibited and risk-avoidant (APA, 2000; Lorian & 
Grisham, 2010; Stein & Stein, 2008). As discussed in chapter two, recent 
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empirical research has identified a subset of socially anxious individuals who are 
characterised by a paradoxical personality profile, including a series of impulsive-
like traits (Kachin et al., 2001; Kashdan et al., 2006; Kashdan et al., 2008; 
Kashdan & Hofmann, 2008; Kashdan et al., 2009). To date, this profile has been 
infrequently discussed in the clinical literature with only five empirical papers 
identifying this atypical presentation of social anxiety (i.e., Kachin et al., 2001; 
Kashdan et al., 2006; Kashdan et al., 2008; Kashdan & Hofmann, 2008; Kashdan 
et al., 2009), of which the majority are from the same research group. 
Although each of the aforementioned studies utilised different measures to 
examine impulsive-like traits among socially anxious individuals, the findings 
have been consistent. Specifically, the studies found that individuals with 
symptoms of social anxiety can be classified into two qualitatively distinct 
subgroups. One subgroup, which has been termed the “typical social anxiety” 
subgroup, are characterised by a prototypical SAD profile, including risk-aversion 
(Kashdan et al., 2008; Kashdan et al., 2009), and interpersonal problems 
characterised by unassertiveness and exploitability (Kachin et al., 2001). 
Conversely, the “atypical social anxiety” subgroup are characterised by risk-
taking (Kashdan et al., 2009), novelty seeking (Kashdan & Hofmann, 2008), 
aggression (Kachin et al., 2001; Kashdan et al., 2009), and hostile interpersonal 
problems (Kachin et al., 2001). 
Three of the aforementioned studies examining heterogeneity in social 
anxiety suggested that substance use problems may differentiate the two socially 
anxious subgroups (i.e., Kashdan & Hofmann, 2008; Kashdan et al., 2008; 
Kashdan et al., 2009), yet this contention was only specifically investigated in one 
of these studies (Kashdan et al., 2009). As previously discussed, a limitation of 
 
 
 
79 
the abovementioned studies was their failure to utilise validated measures to 
establish the severity of substance misuse among the atypical social anxiety 
subgroup. Hence, this study will utilise validated measures of alcohol and drug 
misuse to examine the severity of substance misuse among the typical and 
atypical social anxiety subgroups. 
Consistent with the findings of a systematic review of the literature, which 
was reported in chapter two (see p. 47), it has been demonstrated that the two-
facet conceptualisation of impulsivity has strong utility in substance misuse 
research. Furthermore, it has been argued that future research examining 
impulsivity should employ the two-facet conceptualisation of impulsivity, which 
will ultimately enhance knowledge regarding how each facet of impulsivity 
coveys risk for specific diagnoses and behaviours. As previously discussed, rash 
impulsiveness and reward sensitivity have been found to predict substance use 
through differential pathways (Gullo, Dawe, et al., 2010; Kabbani & 
Kambouropoulos, 2013). Hence, if both of these facets are implicated in SAD and 
substance misuse comorbidity there will be distinct preventative and treatment 
implications. Whilst Kashdan and Hofmann (2008) found evidence to suggest that 
rash impulsiveness characterises the atypical social anxiety subgroup, the present 
study will expand on this finding by examining whether reward sensitivity 
similarly characterises this subset of socially anxious individuals. 
With regard to statistical analysis, three of the aforementioned studies 
utilised cluster analysis (Kachin et al., 2001; Kashdan et al., 2008; Kashdan & 
Hofmann, 2008), whereas the other study utilised latent class analysis (Kashdan et 
al., 2009). The data analytic procedure used in this study will align with Kashdan 
et al. (2009), as latent class analysis is superior to cluster analytic procedures 
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(Flensborg Damholdt, Shevlin, Borghammer, Larsen, & Østergaard, 2012; 
Reinke, Herman, Petras, & Ialongo, 2008). 
An additional aim of this study is to replicate the findings of Kashdan and 
Hofmann (2008) and Kashdan et al. (2009), who found that the atypical and 
typical social anxiety subgroups did not differ on measures of social anxiety 
severity. Consistent with this finding, the present study will administer a measure 
of social anxiety severity, alongside a measure of behavioural inhibition (i.e., BIS 
sensitivity), which is hypothesised to be the biological substrate for anxiety (Gray, 
1987). Whilst it has previously been argued that anxiety and impulsivity are 
orthogonal traits (Barratt, 1965; Gray, 1987), it is possible that these traits are 
dimensional in nature (Corr, 2004). Hence, a subset of socially anxious 
individuals may be characterised by elevated reward sensitivity and BIS 
concomitantly.  
Although a measure of BIS sensitivity has not previously been used in 
research examining the atypical and typical social anxiety subgroups, it is 
expected that scores on a measure of BIS will be equivalent across classes. This 
contention is consistent with the abovementioned findings, which suggest that 
there is no difference in severity and impairment of social anxiety symptoms 
across the two social anxiety subgroups (Kashdan & Hofmann, 2008; Kashdan et 
al., 2009).  
Lastly, it is important to comment on the present research being carried 
out in a community sample, akin to the study carried out by Kashdan et al. (2008). 
Consistent with the findings of Kashdan et al. (2008), it is expected that there will 
be at least one subgroup in the dataset that is not characterised by elevated 
symptoms of social anxiety. Arguably, individual subgroups characterised by 
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minimal levels of anxiety can be used as a point of comparison and to 
demonstrate that the two social anxiety subgroups can be differentiated from 
individuals in the community. 
In summary, this study argues that a two-facet conceptualisation of 
impulsivity, which has been supported by a series of factor-analytic studies (see p. 
32), may help conceptualise the relationship between co-occurring social anxiety 
and substance misuse. In particular, this research may help identify personality 
dimensions that underlie the comorbidity between these diagnoses. 
Hypotheses  
1) Consistent with the findings of Kachin et al. (2001), Kashdan et al. (2008), 
Kashdan and Hofmann (2008), and Kashdan et al. (2009) it is 
hypothesised that two classes with elevated symptoms of social anxiety 
will be present in the dataset; 
a) It is hypothesised that the two social anxiety classes will be 
characterised by elevated levels of social anxiety and behavioural 
inhibition but divergent patterns of rash impulsiveness, reward 
sensitivity, and risk-taking behaviour.  
2) It is hypothesised that there will be significant differences on substance 
use variables across the two social anxiety classes. Specifically, it is 
hypothesised that the atypical social anxiety class will report significantly 
more substance use problems than the typical social anxiety class.    
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Method 
Participants 
Three hundred and fifty one adult participants ranging in age from 18 to 
74 years (M = 34.17, SD = 12.94) completed a battery of self-report 
questionnaires. All participants met the study inclusion criteria, which required 
participants to be 18 years of age or older. There were 249 females (70.9%), 91 
males (26%) and 11 participants (3.1%) who chose not to specify their gender. All 
participants completed the questionnaires electronically (see Appendix C for a 
copy of the online questionnaires). Participant demographic information is 
presented in Table 4.1. 
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Table 4.1  
Participant Demographics for Study One 
Characteristic Grouping % Grouping % Grouping % Grouping % 
Ethnicity Australian  75.8% New Zealand  6% United Kingdom 5.4% Other 12.8% 
Education Some high school 5.4% High school 20.5% Certificate/trade 
qualification 
16% University qualification 58% 
Treatment for SAD Yes 26% No 74%     
 Treatment type Therapy only 54.9% Medication only 13.2% Therapy and medication 29.7% Unspecified  2.2% 
How long go? Currently in 
treatment 
25% Less than 6 months ago 8.7% Between 6 and 12 months 
ago 
15.2% More than 12 months ago 51.1% 
Treatment for 
alcohol misuse 
 
Yes 
 
5.1% 
 
No 
 
94.3% 
    
 
Treatment type Therapy only 44.4% Medication only 11.1% AA 16.7% Combined treatment 27.8% 
 How long ago? Currently in 
treatment 
26.7% Less than 6 months ago 13.3% Between 6 and 12 months 
ago 
26.7% More than 12 months ago 33.3% 
Treatment for drug 
misuse  
Yes 3.7% No 95.7%     
 
Treatment type 
 
Therapy  
 
53.8% 
 
Medication 
 
7.7% 
 
Detox 
 
15.4% 
 
Combined treatment 
 
23.1% 
 How long ago? Currently in 
treatment 
0% Less than 6 months ago 18.2% Between 6 and 12 months 
ago 
18.2% More than 12 months ago 63.6% 
  
84 
Measures 
Demographic information.  
A set of self-report demographic questions were included pertaining to 
age, gender, ethnicity and education. Participants were also asked to indicate 
whether they had ever received treatment for SAD, alcohol use or drug use 
problems. If participants responded “yes” to any of these questions they were 
asked to provide information about their treatment history.  
The Alcohol Use Disorders Identification Test. 
The AUDIT (Saunders et al., 1993) is a 10-item self-report measure with 
three subscales. It was developed in conjunction with the World Health 
Organisation to assess hazardous alcohol consumption. In addition to a total 
score, which reflects alcohol-risk, the AUDIT can be scored to reflect three 
subscales, including (1) alcohol consumption (three items that assess quantity and 
frequency of alcohol consumption), (2) alcohol-dependence (three items that 
assess cognitive and behavioural symptoms associated with dependence on 
alcohol), and (3) adverse consequences of drinking (four items that assess the 
frequency of negative events resulting from alcohol consumption; Saunders et al., 
1993). For the purposes of this study, the three subscales were utilised. The first 
eight items are scored on a 5-point Likert scale (0 = never to 4 = 4 or more times 
a week, for the first question; 0 = 1 or 2 to 4 = 10 or more, for the second 
question; 0 = never to 4 = daily or almost daily, for items 3 to 8). The last two 
questions are scored on a 3-point scale (from 0 = No, 2 = Yes, but not in the last 
year, and 4 = Yes, during the past year). Total scores on the AUDIT range from 0 
to 40, and scores of 8 or above have been used to identify individuals who may be 
at risk, or may be experiencing problems related to their alcohol use (Conigrave, 
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Hall, & Saunders, 1995). It has been demonstrated that the AUDIT has good 
internal consistency (α = .82) in a community sample (Bergman & Källmén, 
2002). Cronbach’s alpha was .87 in the present study. 
Drug Abuse Screening Test.  
The Drug Abuse Screening Test (DAST-10; Bohn, Babor, & Kranzler, 
1991) is a 10-item version of the original DAST (Skinner, 1982) that was 
designed to identify problems related to drug misuse in the previous year. The 
DAST-10 is self-report and dichotomously scored with yes/no items. Before 
commencing the questionnaire participants were informed that “drug” refers to 
use of prescription drugs not prescribed to them, or used in a manner not intended 
by the prescribing clinician, or the use of illicit drugs (e.g., marijuana, cocaine, 
ecstasy). Participants who responded “yes” to the first question indicating that 
they had used drugs in the past 12 months were asked to respond to the remaining 
questions (e.g., “are you always able to stop using drugs when you want to?”). 
Research suggests that if a respondent positively endorses three or more DAST-
10 items this is considered a “positive screening result”, which is indicative of 
possible drug abuse or dependence (French, Roebuck, McGeary, Chitwood, & 
McCoy, 2001; Maisto, Carey, Carey, Gordon, & Gleason, 2000). The original 
DAST and DAST-10 have been used in clinical and non-clinical samples to detect 
drug misuse (Bohn et al., 1991; McCabe, 2008; Skinner, 1982). Cronbach’s alpha 
was .81 in this study. 
Drug use frequency measure. 
A measure of drug use frequency was developed for the purposes of this 
study. This measure obtained information regarding the use of substances other 
than alcohol (e.g., cannabis, cocaine, opioids) over the past 12 months. Questions 
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were rated on a 5-point Likert scale where 0 = not at all and 4 = four or more 
times per week.  
The Sensitivity to Punishment and Sensitivity to Reward 
Questionnaire.  
The SPSRQ (Torrubia et al., 2001) is a 48-item scale with dichotomous 
yes/no items. A 35-item version (O’Connor, Colder, & Hawk, 2004), which was 
developed to enhance factor structure and item properties, was administered in 
this study. The SPSRQ was selected for the present study because the two 
subscales, termed SR and Sensitivity to Punishment, were developed to assess 
reward sensitivity and BIS functioning, respectively (Torrubia et al., 2001). The 
Sensitivity to Punishment subscale consists of 18 items (e.g., “Comparing 
yourself to people you know, are you afraid of many things?”), and the SR 
subscale consists of 17 items (e.g., “Do you often do things to be praised?”). The 
35-item version of the SPSRQ has demonstrated good reliability (Simons, 
Dvorak, & Lau-Barraco, 2009). In this study, the Cronbach’s alpha was .89 and 
.80 for the Sensitivity to Punishment and SR subscales, respectively. 
The Eysenck Impulsiveness Questionnaire. 
The I7 (Eysenck et al., 1985) is a 54-item dichotomously scored yes/no 
questionnaire with three subscales; Impulsiveness (19 items), Venturesomeness 
(16 items), and Empathy (19 items). In this study the Impulsiveness subscale was 
administered as a measure of rash impulsiveness. This subscale measures 
impulsivity related to decision making without consideration of the potential risks 
involved (e.g., “Do you usually make up your mind quickly?’’). This subscale has 
been used in other non-clinical samples and has demonstrated good reliability (r = 
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0.87; Whiteside & Lynam, 2001). Cronbach’s alpha for the Impulsiveness 
subscale was .87 in this study. 
The Reckless Behaviour Questionnaire. 
The Reckless Behaviour Questionnaire (RBQ; Arnett, 1989) is a 10-item 
self-report measure of reckless behaviour in the past year. This measure was 
utilised as a measure of risk-taking in the present study. Behaviours were selected 
for inclusion in the questionnaire if they had the potential for immediate and/or 
dire negative consequences (e.g., use of alcohol while driving, vandalism and 
shoplifting). Each item is responded to using a 5-point Likert scale (0 = never to 4 
= more than 10 times), yielding one overall score. For the purposes of this study 
participants were given the option of responding “Not Applicable” to question 
two which asked participants to rate whether they had “had sex without using 
contraceptives” in the past 12 months. This option recognises that participants 
may be trying to fall pregnant, may have reached menopause, or may be in a 
long-term relationship. Strong test-retest reliability of the RBQ with a college 
sample has been demonstrated (r = 0.80; Shaw, Wagner, Arnett, & Aber, 1992). 
Cronbach’s alpha was .87 in this study. 
The Liebowitz Social Anxiety Scale: Self-report version. 
The Liebowitz Social Anxiety Scale (LSAS; Liebowitz, 1987) is a 
commonly used measure of social anxiety. The LSAS requires participants to rate 
their fear/anxiety and avoidance of 24 social interaction and performance 
situations. Participants were asked to indicate their level of anxiety or fear for 
each situation, in the past week, based on a four-point Likert scale (from 0 = no 
fear to 3 = severe fear). Similarly, participants rated their level of avoidance of 
each situation on a four-point Likert scale (0 = never avoid to 3 = usually avoid). 
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Scores range from 0 to 144, with scores of 30 or above indicative of non-
generalised SAD, and scores of 60 or higher indicative of generalised SAD 
(Mennin et al., 2002). It has been found that the LSAS is reliable and internally 
consistent in both clinical (α = .95) and non-clinical (α = .94) samples (Fresco et 
al., 2001). Cronbach’s alpha was .97 in the present study. 
Procedure 
An online questionnaire was advertised via the use of paid online 
advertisements (Facebook), as well as snowballing techniques, whereby 
participants were invited to pass on information about the study to contacts whom 
they deemed appropriate (Lovatt, Mason, Brett, & Peters, 2010). These multiple 
methods of data sampling were carried out to ensure that all participants did not 
come from the one subject pool. The method of online data collection was utilised 
due to the ease of administration, convenience for participants, and improved 
confidentiality, which is especially important for participants when disclosing 
information regarding illicit drug use (Miller & Sønderlund, 2010). Moreover, 
substantial research now suggests that delivering traditional psychological 
measures in an online format is a reliable method of data collection (Jones, 
Fernyhough, de-Wit, & Meins, 2008; Riva, Teruzzi, & Anolli, 2003).  
Prior to completing the questionnaire, participants were required to read 
the plain language statement, which is presented in Appendix D. The plain 
language statement provided information regarding the purpose of the study and 
consent, which was indicated when participants submitted their online 
questionnaire. Furthermore, participants were informed that they had the 
opportunity to enter a draw to win one of six $50 Coles-Myer vouchers. 
Participants were instructed to enter their email address upon completing the 
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online questionnaire if they would like to enter the draw. The plain language 
statement also provided participants with contact details for Beyond Blue and 
Directline in case they felt distressed in response to any of the items on the 
questionnaire. The questionnaire was untimed but it was expected that it would 
take approximately 20 minutes to complete.  
Data Analysis  
To meet the aims of the present investigation latent class analysis (LCA) 
was used to identify latent, or unobserved, subgroups within the data. Classes 
were derived based on observed response patterns on continuous measures of 
social anxiety, behavioural inhibition, rash impulsiveness, reward sensitivity and 
risk-taking. This approach is conceptually similar to cluster analysis but is 
probabilistic, which offers several advantages over traditional cluster analytic 
procedures (Magidson, & Vermunt, 2002). For example, the LCA approach 
provides fit and classification indices to help researchers determine the number of 
classes present in the data (Nylund, Bellmore, Nishina, & Graham, 2007). 
Furthermore, this approach allows outcome variables to be included 
simultaneously (i.e., distal outcomes; Nylund, Bellmore, et al., 2007).  
Analyses were conducted for a series of latent classes, beginning with the 
most parsimonious (i.e., one class) and then increasing successively up to five 
latent classes. Consistent with the literature, the optimal number of latent classes 
was evaluated using both statistical and substantive theory (Nagin, 2005; Nylund, 
Asparouhov, & Muthén, 2007; Weich et al., 2011). This dual approach is 
recommended because a solution with a large number of latent classes may 
statistically discriminate between classes without adding practical value.  
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In terms of statistical evaluation, there is no single statistical indicator of 
model fit (Nylund, Bellmore, et al., 2007). Accordingly, the classes were 
compared using a range of goodness-of-fit statistics, including the Bayesian 
Information Criterion (BIC), the Bootstrapped Parametric Likelihood Ratio Test 
(BLRT), and the Lo-Mendell-Rubin Test (LMR). In general, lower BIC values 
are indicative of a better model. Both the BLRT and LMR are likelihood-based 
tests, which provide a p-value that can be used to determine whether the k-1 
model should be rejected in favour of the k class model (Nylund, Asparouhov, & 
Muthén, 2007). That is, whether there is a significant improvement in fit for the 
addition of one more class. 
 In a recent simulation study, Nylund, Asparouhov, and Muthén (2007) 
examined the performance of likelihood-based tests (i.e., LMR and BLRT) and 
conventionally used information criterion (i.e., BIC) for determining the number 
of classes in mixture modelling. Across all mixture models, including LCA, the 
BIC performed the best of the information criteria and the BLRT was the most 
consistent indicator of the optimal number of classes (Nylund, Asparouhov, & 
Muthén, 2007). However, it was noted that the BLRT has its disadvantages. In 
particular, the BLRT depends on model assumptions (Nylund, Asparouhov, & 
Muthén, 2007). Hence, if the data in the class are skewed or there are outliers 
within a class, the p-value estimate for the BLRT may be incorrect.  
Conversely, the LMR is based on the variance of parameter estimates, 
which are robust under a variety of model and distributional assumptions. 
Ultimately, Nylund, Asparouhov, and Muthén (2007) recommended that 
researchers use the BLRT and LMR alongside the BIC to determine the optimal 
number of classes. Consistent with these recommendations the present study 
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compared the BIC, LMR and BLRT across classes to help determine the optimal 
number of classes. 
Moreover a measure of classification quality, termed entropy, was 
compared across classes (perfect entropy = 1.0). This value helps determine how 
well latent classes can be distinguished, with higher values indicating a clearer 
separation of classes (Celeux & Soromenho, 1996). Moreover, successful 
convergence and high posterior probabilities (near 1.0) for most likely class 
membership are important statistical considerations (Jung & Wickrama, 2008). 
To avoid problems with local maxima 1000 iterations were performed on each of 
the final models. 
It is important to note that LCA does not rely on traditional modelling 
assumptions including; linearity, normality and homogeneity of variance 
(Magidson & Vermunt, 2002). Consistent with this assumption, the Maximum 
Likelihood with Robust Standard Errors and Chi-square estimator was used, 
which is robust to normality violations. Latent class analysis was performed using 
Mplus, Version – 6.12 (Muthén & Muthén, 2010). 
Results  
Data Screening 
Preliminary data analyses were conducted on measures of social anxiety, 
substance use, rash impulsiveness, reward sensitivity, behavioural inhibition and 
risk-taking. Variables were examined for out of range values, univariate outliers 
and missing values. One participant only completed one of eight scales and was 
deleted from the dataset, leaving a total of 350 cases for further analyses. Table 
4.2 below depicts scale range, means, standard deviations and minimum and 
maximum scores for all measured variables. 
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Table 4.2 
Scale Range, Mean, Standard Deviation, Minimum and Maximum Scores of all 
Measures 
Variable Scale 
Range 
Minimum 
Score 
Maximum 
Score 
Mean (SD) 
Social Anxiety Symptoms 0-144 0 126 38.70(25.85) 
Rash Impulsiveness 0-19 0 19 5.52(4.51) 
Reward Sensitivity 0-17 0 17 5.61(3.72) 
Behavioural Inhibition 0-18 0 18 8.78(5.07) 
Risk-taking 0-40 0 35 7.51(8.45) 
AUDIT Total 0-40 0 33 8.43(6.75) 
Alcohol Consumption 0-12 0 12 4.80(2.71) 
Alcohol Dependence  0-12 0 10 1.11(1.78) 
Alcohol Consequences 0-16 0 15 2.52(3.13) 
DAST-10 0-10 0 10 1.33(1.98) 
Drug Frequency 0-28 0 15 2.32(3.26) 
Note. Participant responses on the AUDIT indicated that 97.5% of the sample consumed alcohol 
in the past 12 months, whereas responses on the DAST-10 indicated that 52% of the sample 
consumed drugs in the past 12 months. 
 
Analyses were conducted to determine whether missing values were 
missing completely at random. Little’s Missing Completely at Random (MCAR) 
test (χ2 [18050.93] = 177784, p = .08) was non-significant, indicating that data 
was missing completely at random. Examination of the missing values 
determined that there were 1.13% missing values across the dataset and less than 
5% missing data on any single item. Subsequently, expectation maximisation was 
utilised to impute missing values.   
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According to Tabachnick and Fidell (2007), univariate outliers are cases 
with standardised scores exceeding 3.29 (p <.001). Utilising this criteria there 
were nineteen univariate outliers in the dataset. Specifically, six outliers were 
from the AUDIT, eight were from the DAST-10, three were from the drug 
frequency measure, and two were from the LSAS. 
Akin to the approach taken by Wu, Zumbo and Siegel (2011) outliers 
were retained for the final analyses. This approach is consistent with the 
theoretical underpinnings of LCA, as this procedure classifies individuals from a 
heterogeneous population into smaller homogenous subgroups (Klonsky, & 
Olino, 2008; Muthén & Muthén, 2000). Hence, within each class the distribution 
of scores is assumed to be normal (Wu et al., 2011). Furthermore, this assumption 
is consistent with the present research question, which is investigating an atypical 
presentation of social anxiety. Hence, the outliers across measures were deemed 
relevant and legitimate cases sampled from the population.      
Latent Class Analysis 
The relative fit and classification indices were examined for one, two, 
three, four and five-class models. All solutions successfully converged in 1000 
iterations. Table 4.3 shows the overall fit and classification indices. As shown in 
Table 4.3, the LMR statistic indicated that the k class model was significantly 
better than the k-1 model until a five-class solution was examined (p = .17). That 
is, the LMR statistic indicated that the five-class model was not a significantly 
better fit than the four-class model (p = .04). Further, the entropy value (.88) 
demonstrated optimal classification in the four-class solution.  
In contrast, the BLRT did not distinguish between classes in the present 
sample, as demonstrated by its continued significance in the five-class solution. 
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With regard to the BIC value, it can be seen that this continued to reduce as 
parsimony increased. However, relative to the five-class model the four-class 
model provided a very similar BIC value (BIC difference = 58.13). Based on the 
statistics presented in Table 4.3 the LMR and entropy favoured the four-class 
model.  
To help validate the selection of the four-class model, four and five-class 
models were compared on a theoretical basis. On examination, the four-class 
solution was more interpretable and clinically informative than the five-class 
solution with the theoretically relevant classes remaining consistent in both 
solutions. Consistent with recommendations (Nagin, 2005; Nylund, Asparouhov, 
& Muthén, 2007; Weich et al., 2011), the four-class model was selected based on 
both statistical and theoretical considerations. 
 
Table 4.3  
Model Fit and Entropy of Latent Class Models with Increasing Numbers of 
Classes   
Classes  BIC LMR BLRT Entropy  
1  5019.86 - - - 
2  4716.86 0.00 0.00 0.86 
3  4615.96 0.00 0.00 0.84 
4  4528.04 0.04 0.00 0.88 
5 4469.91 0.17 0.00 0.86 
Note. LMR, BLRT and entropy values cannot be calculated for a one-class model.  
 
Average latent class probabilities for most likely latent class membership 
are shown in Table 4.4. Class one comprises 12% of participants, class two is the 
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largest class with 57% of all participants, whilst class three has 20% of 
participants, and class four has 11% of participants.  
Table 4.4 
 Posterior Probabilities for Most Likely Class Membership  
Latent Classes 1 
(n = 42) 
2 
(n = 201) 
3 
(n = 69) 
4 
(n = 38) 
1 .90 .07 .00 .03 
2 .02 .94 .04 .00 
3 .00 .08 .92 .00 
4 .04 .00 .02 .95 
 
Table 4.5 shows the descriptive data concerning the indicator variables for 
each class. Standardised mean scores on indicator variables are graphically 
displayed in Figure 4.1. Based on the information presented in Table 4.5 and 
Figure 4.1, class one was termed the “minimal anxiety/risk prone class”, class two 
the “normative class”, class three the “typical social anxiety class” and class four 
was termed the “atypical social anxiety class”. It is important to note that these 
names were selected to be consistent with prior research and with the patterns of 
observed responses across latent classes.  
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Table 4.5 
Descriptive Statistics of Indicator Variables for each Latent Class 
Latent 
Classes 
Social 
Anxiety 
M          SE 
Rash  
Impulsiveness 
M           SE 
Reward 
Sensitivity 
 M         SE 
Behavioural 
Inhibition 
M          SE 
Risk-taking 
 
M            SE 
1 23.71  3.59    6.72      0.90    7.56    0.84      5.88    0.95      19.62    1.93    
2 25.89  1.66 3.83      0.27    4.70    0.31      6.22    0.49      3.58      0.37    
3 66.69  5.92    6.07      0.63    5.58 0.51      14.50 0.65     3.32 0.44    
4 69.57 5.43    11.98    1.11    8.26    0.75      14.59  0.57      22.38    1.15    
 Note. LSAS scores (i.e., Social Anxiety) over 30 are indicative of non-generalised SAD and 
scores over 60 are indicative of generalised SAD (Mennin et al., 2002). M = Mean and SE = 
Standard Error.  
 
 
 
Figure 4.1. Standardised mean scores on indicator variables for each class. 
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Examining distal outcomes.  
Figure 4.2 depicts mean differences on substance use variables across the 
four classes. Table 4.6 shows the mean values and standard errors on substance 
use variables across the four classes, whereas Table 4.7 depicts the significance 
values, based on chi-square difference scores, comparing the different classes 
across substance use variables. As can be seen in Table 4.7 the atypical social 
anxiety class and minimal anxiety/risk-prone class reported significantly more 
substance use problems than the normative class and the typical social anxiety 
class. Whilst the minimal anxiety/risk-prone class and the atypical social anxiety 
class reported similar levels of alcohol consumption, the atypical social anxiety 
class reported significantly higher scores on all other substance use measures. The 
normative and typical social anxiety class reported similar levels of substance use 
problems, with non-significant differences across all variables.  
Exploratory analysis: Age as a distal outcome. 
Given the wide age range of participants in the present study (see p. 82) it 
was decided to conduct an exploratory analysis to examine the influence of age 
across the four latent classes. It was found that participants in the normative class 
(M  = 36.74, SE  = 1.00) were significantly older (p = <.05) than participants in 
the minimal anxiety/risk prone class (M  = 30.00, SE  = 1.38), the typical social 
anxiety class (M  = 31.80, SE  = 1.62), and the atypical social anxiety class (M  = 
30.34, SE  = 1.66). All other classes did not significantly differ with regard to age 
(p  = >.05). 
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Figure 4.2. Mean differences across the four classes on substance use variables. 
 
 
Table 4.6 
Means and Standard Errors Across the Four Classes on Substance Use Variables 
Latent 
Classes 
Alcohol 
Consumption 
Alcohol 
Dependence 
Alcohol 
Problems 
DAST-10 Drug 
Frequency 
 M SE M SE M SE SE M SE M 
1  6.65 0.41 1.84  0.29 4.04  0.49 2.49    0.32 4.25  0.58 
2  4.30     0.17 .59    0.07 1.60  0.16 0.77    0.09 1.34    0.16 
3  3.89     0.32 .86 0.20 2.05  0.35 0.86    0.20 1.44    0.26 
4  7.07 0.50 3.50  0.48 6.54  0.72 3.82    0.53 6.96  0.78 
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Table 4.7 
Chi-Square Significance Values Comparing Classes Across Substance Misuse Variables 
Latent 
Classes 
Alcohol Consumption Alcohol Dependence Alcohol Problems DAST-10 Drug Frequency 
 Chi-Square P-value Chi-Square P-value Chi-Square P-value Chi-Square P-value Chi-Square P-value 
1 vs. 2 27.34 .00*** 17.41 .00*** 22.18 .00*** 26.46 .00*** 22.75 .00*** 
1 vs. 3 28.69       .00*** 7.80           .01*  11.15 .00** 18.65 .00*** 19.33 .00*** 
1 vs. 4 .41     .52 8.58 .00** 7.89 .01* 4.32 .04* 7.38 .01* 
2 vs. 3 1.16 .28 1.65    .20 1.30 .25 0.15 .70 0.12 .73 
2 vs. 4 27.89 .00*** 36.19 .00*** 44.48 .00*** 31.52 .00*** 49.91 .00*** 
3 vs. 4 28.48 .00*** 25.76 .00*** 30.99 .00*** 26.86 .00*** 45.29 .00*** 
Note. * = p <.05, ** = p<.01, *** = p<.001
  
100 
 
Discussion 
The primary aims of the present study were to examine whether two 
qualitatively distinct social anxiety subgroups could be identified by utilising a 
two-facet conceptualisation of impulsivity, and to investigate whether these 
subgroups could be differentiated on the basis of co-occurring substance use 
problems. Specifically, the first hypothesis expected that individuals with 
symptoms of social anxiety could be meaningfully separated into two distinct 
classes based on characteristics typically associated with SAD, including social 
anxiety symptom severity and behavioural inhibition, and those posited to 
characterise the atypical subset of socially anxious individuals; including rash 
impulsiveness, reward sensitivity and risk-taking. The data supported this 
hypothesis. The second hypothesis expected that the two social anxiety classes 
would report significantly different levels of substance use. The data supported 
this hypothesis.  
Heterogeneity in Social Anxiety 
The findings of this study align with a series of studies investigating the 
clinical characteristics of a distinct subgroup of individuals characterised by 
atypical social anxiety symptomatology (i.e., Kachin et al., 2001; Kashdan et al., 
2006; Kashdan et al., 2008; Kashdan & Hofmann, 2008; Kashdan et al., 2009). In 
particular, the findings are consistent with Kashdan et al. (2009) who classified 
individuals with SAD into distinct subgroups using risk-prone behaviour items. In 
this study, risk-taking clearly distinguished between the atypical and typical 
social anxiety subgroups.  
The findings of this study are also consistent with the findings of Kashdan 
and Hofmann (2008), who used a measure of rash impulsiveness (i.e., novelty 
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seeking) to differentiate between SAD subgroups. The present study adds to the 
clinical literature by utilising a two-facet conceptualisation of impulsivity, with 
findings suggesting that both facets of impulsivity distinguished between the 
atypical and typical social anxiety subgroups.  
Furthermore, both social anxiety subgroups reported similar levels of 
social anxiety symptom severity and behavioural inhibition, which is consistent 
with hypotheses. This finding provides further evidence to suggest that the 
atypical and typical social anxiety subgroups report similar levels of social 
anxiety symptomatology (Kashdan & Hofmann, 2008; Kashdan et al., 2009). 
Moreover, this finding is consistent with Gray’s (1987) RST, which posits that 
BIS is the biological substrate of anxiety.  
The findings of this study also add strength to Corr’s (2004) contention 
that BIS and reward sensitivity are dimensional traits. This was especially 
prominent in the atypical social anxiety class, where individuals were 
characterised by elevated levels of BIS and reward sensitivity. Hence, these 
findings suggest that it is possible for a subset of socially anxious individuals to 
be characterised by elevated reward sensitivity and BIS concomitantly.  
Notably, the findings of exploratory analyses indicated that the atypical 
and typical social anxiety classes were comprised of individuals who were of a 
similar age. This finding suggests that age did not confound the differential 
symptom profiles identified among social anxious individuals. Future research in 
this area should attempt to replicate this novel finding. 
Interestingly, the data suggested that there were two classes in the dataset 
with minimal social anxiety symptomatology. The normative class aligns with the 
findings of Kashdan et al. (2008) who found a subgroup of participants with 
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below average scores on all variables of interest. Notably, the normative class 
comprised of participants who were significantly older than participants in the 
other three classes, suggesting that symptoms of social anxiety, substance misuse, 
and the comorbidity of these symptoms, may decrease with age. Indeed there is 
research to support this contention (see Kerfoot, Petrakis, & Rosenheck, 2011). 
 In contrast to the findings of Kashdan et al. (2008), the present study also 
found evidence for another subgroup, termed the minimal anxiety/risk prone 
class, who reported minimal levels of social anxiety, elevated levels of rash 
impulsiveness, reward sensitivity and risk-taking. This finding is not surprising 
considering that impulsive traits do not solely co-occur with SAD and often occur 
in those with substance use disorders in isolation (e.g., Bornovalova, Daughters, 
Hernandez, Richards, & Lejuez, 2005a). This is consistent with the findings of the 
present study, with the minimal anxiety/risk prone class reporting elevated levels 
of substance use.   
Moreover, the two classes with minimal levels of social anxiety and 
differential patterns across latent class indicator variables provide evidence of 
specificity. This is consistent with Kashdan et al. (2009) who extended their LCA 
to include individuals without elevated symptoms of social anxiety, and Kashdan 
et al. (2008) who carried out their research in a community sample with one class 
reporting minimal levels of social anxiety. Hence, consistent with the approaches 
taken by these studies, it can be said that the differential patterns identified across 
the four latent classes provide evidence that the pattern of symptoms identified 
among those with elevated social anxiety symptoms does not hold for the general 
population.  
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Atypical Social Anxiety and Co-occurring Substance Use Problems 
The findings of this study were consistent with hypotheses and support the 
contention that substance use problems may characterise the atypical subset of 
socially anxious individuals. Whilst the role of substance use was implicated in 
previous studies (Kashdan et al., 2008; Kashdan & Hofmann, 2008; Kashdan et 
al., 2009), appropriate measures had not been used to investigate the severity of 
substance misuse among the atypical social anxiety subgroup. 
Worryingly, the atypical social anxiety subgroup reported a mean of more 
than three on the DAST-10, which is indicative of a “positive screening result”, 
denoting risk for possible drug abuse or dependence (French et al., 2001; Maisto 
et al., 2000). Consistent with this finding, the results indicated that the atypical 
social anxiety subgroup reported the highest frequency of drug use. Similarly, the 
combined alcohol use score on the AUDIT was well above the cut-off score of 
eight, which has been used as an indicator of significant alcohol-related harm 
(Conigrave et al., 1995).  
In contrast, the typical social anxiety subgroup was characterised by 
prototypical SAD symptoms, including behavioural inhibition and risk-aversion, 
with minimal levels of self-reported substance use across all measures. Consistent 
with hypotheses, the atypical social anxiety subgroup reported significantly 
higher levels of substance use problems than the typical social anxiety subgroup. 
Whilst the aforementioned findings are indicative of significant substance 
use problems characterising the atypical social anxiety subgroup, two competing 
hypotheses should be considered. Firstly, as researchers have previously 
contended, SAD tends to precede the onset of co-occurring mental health 
problems, including substance misuse (Buckner, Schmidt, et al., 2008; Lipsitz & 
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Schneier, 2000). In this circumstance, it is possible that socially anxious 
individuals, who are characterised by an impulsive personality profile, are at 
greater risk of developing co-occurring substance use problems. Whilst this is a 
plausible explanation of the abovementioned findings, it is also possible that 
substance use precedes the development of social anxiety symptomatology in a 
subset of cases (see Bakken et al., 2005; Buckner et al., 2012; Ross, Glaser, & 
Germanson, 1988; Schneier et al., 2010). 
As previously discussed, research suggests that substance use can lead to 
increased impulsivity (de Wit, 2009), which may explain why impulsivity, a 
paradoxical clinical characteristic, characterises the atypical social anxiety 
subgroup. A longitudinal study would be needed to determine whether there are 
differential pathways through which social anxiety and substance misuse co-occur 
to examine differences in temporal precedence of social anxiety symptoms, 
impulsivity, and substance misuse. 
Future Directions 
The findings of this study, taken together with the findings of previous 
research, may have implications for the development of treatment protocols. For 
example, evidence based treatment for SAD does not incorporate specific 
strategies or modules to reduce impulsivity, risk-taking behaviour and address co-
occurring substance use problems. It is possible that the individuals who dropout 
or fail to improve over the course of treatment for SAD or substance misuse have 
a distinct symptom profile from those who demonstrate improvement in 
symptomatology. 
Furthermore, considering the present study has provided evidence to 
suggest that reward sensitivity and rash impulsiveness characterise those with co-
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occurring social anxiety and substance misuse this could have specific 
preventative and treatment implications. For example, Dawe and Loxton (2004) 
propose that reward sensitivity is involved in the initiation of substance misuse, 
whereas rash impulsiveness is involved in the maintenance of substance misuse. 
Hence, preventative interventions for individuals with subthreshold symptoms of 
social anxiety might incorporate strategies specifically targeted at reward 
sensitivity, whereas individuals presenting with co-occurring social anxiety and 
substance misuse in clinical settings may require specific interventions targeting 
both aspects of impulsivity. Indeed it has previously been argued that matching 
interventions to relevant personality traits is likely to improve treatment outcomes 
(Staiger et al., 2007). 
To date, only one randomised controlled study has attempted to develop a 
treatment for individuals with co-occurring SAD and alcohol misuse (see Randall 
et al., 2001), however this study was met with equivocal findings. Hence, further 
research elaborating on this topic will play an important role in informing the 
development of effective treatments.   
Limitations 
There are some important limitations that should be taken into account 
when interpreting the findings of this study. Firstly, the method of this research 
was cross-sectional in nature and limited to self-report questionnaires. Although 
this methodology has provided important preliminary insights into the 
relationship between social anxiety and substance misuse, experimental and 
longitudinal designs are needed to infer causality.  
With regard to the self-report questionnaires utilised in the present study it 
is possible that the different time frames used for reference had an impact on the 
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overall findings. Specifically, the LSAS required participants to reflect on the past 
week regarding symptomatology, whereas the DAST and the AUDIT required 
participants to reflect on the past 12 months. Therefore, it is possible that 
participants who experienced symptoms of social anxiety in the past twelve 
months, but not in the past week, were not reflected in the atypical social anxiety 
subgroup. In contrast, participants who experienced substance misuse 
symptomatology in the past 12 months are likely to have been reflected in the 
atypical social anxiety subgroup. It would be advantageous for future studies to 
take this into consideration when selecting questionnaires for inclusion in 
research examining the co-occurrence of social anxiety and substance misuse. 
Moreover, the two social anxiety classes that were identified in this study 
were limited to the variables that were included in the analyses. Although similar 
findings have been found in other clinical and non-clinical samples (i.e., Kachin 
et al., 2001; Kashdan et al., 2006; Kashdan et al., 2008; Kashdan & Hofmann, 
2008; Kashdan et al., 2009) it is important to acknowledge that additional 
variables may be important in conceptualising the relationship between social 
anxiety and substance misuse.   
Furthermore, all the participants in this study were self-selected, which 
has the potential to limit generalisability. Indeed, it is possible that the individuals 
who self-selected to participate in this research study were qualitatively distinct 
from those who did not. Future research should consider using a different 
sampling methodology to address this limitation. 
Lastly, it is important to acknowledge that although this study drew on the 
findings of Kashdan and Hofmann (2008) and Kashdan et al. (2006, 2008, 2009), 
this research does not contend that the current DSM-IV-TR (APA, 2000) 
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diagnostic criteria insufficiently characterises different subgroups of people with 
SAD (see Kashdan & McKnight, 2010). Conversely, the current study contends 
that the atypical symptoms identified among socially anxious individuals may be 
conceptualised within a model of co-occurring social anxiety and substance 
misuse. To verify this contention identification of these patterns in clinical 
samples would be useful. 
Conclusion  
On the basis of the data there is evidence to suggest that high levels of 
rash impulsiveness, reward sensitivity, and risk-taking may characterise a subset 
of socially anxious individuals with co-occurring substance use problems. These 
findings have implications for future studies examining the co-occurrence of these 
disorders and may inform the development of treatment protocols in future 
research.  
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CHAPTER FIVE 
Study Two: Co-occurring Social Anxiety and Substance Misuse: Evaluating 
the Moderating Effects of Rash Impulsiveness and Reward Sensitivity 
The previous chapter presented findings, which indicated that a subset of 
socially anxious individuals are characterised by elevated rash impulsiveness, 
reward sensitivity, risk-taking and substance use problems. Drawing from the 
findings of the first study, alongside the findings of several studies reviewed in 
chapter two (i.e., Booth & Hasking, 2009; Kachin et al., 2001; Kashdan et al., 
2006; Kashdan et al., 2008; Kashdan & Hofmann, 2008; Kashdan et al., 2009), it 
is argued here that socially anxious individuals who misuse substances may be 
characterised by elevated rash impulsiveness and reward sensitivity. That is, the 
interaction between social anxiety and both facets of impulsivity may underlie co-
occurring substance misuse. Hence, the primary aim of this study is to examine 
whether rash impulsiveness and reward sensitivity moderate the relationship 
between social anxiety and substance misuse in a clinical sample. As a dearth of 
empirical studies have utilised a clinical sample of individuals suffering from co-
occurring social anxiety and substance misuse, a secondary aim of this study is to 
describe the clinical and demographic characteristics of the sample.  
Rationale  
The rationale for the second study is based on a series of studies reviewed 
in chapter two (i.e., Booth & Hasking, 2009; Kachin et al., 2001; Kashdan et al., 
2006; Kashdan et al., 2008; Kashdan & Hofmann, 2008; Kashdan et al., 2009), 
and the findings of the first study of this thesis. Firstly, a series of studies have 
consistently demonstrated that a subset of socially anxious individuals are 
characterised by impulsive-like traits (Kachin et al., 2001; Kashdan et al., 2006; 
  
109 
Kashdan et al., 2008; Kashdan & Hofmann, 2008; Kashdan et al., 2009). This 
finding was confirmed in the first study, where a subset of socially anxious 
individuals were characterised by elevated rash impulsiveness, reward sensitivity, 
risk-taking and substance misuse. This finding was in stark contrast to a subgroup 
of socially anxious individuals who were characterised by minimal levels of 
impulsivity, risk-taking and substance use. 
Thus, a subset of individuals with elevated symptoms of social anxiety 
may be more likely to misuse substances if they also have elevated levels of rash 
impulsiveness and reward sensitivity, suggesting these traits may play a 
moderating role. For moderation to be evident, the interaction between social 
anxiety and each facet of impulsivity would need to significantly improve 
prediction of substance misuse, after first accounting for the variance in outcome 
directly attributable to reward sensitivity, rash impulsiveness, and social anxiety 
separately (Barron & Kenny, 1986). Considering the high prevalence of co-
occurring SAD among those seeking treatment for substance misuse (Bakken et 
al., 2005; Staiger et al., 2008; Thomas et al., 1999), the present study will test this 
hypothesis in a sample of individuals who are seeking treatment for substance 
misuse and report co-occurring social anxiety symptomatology.  
The argument for moderation is consistent with the findings of a recent 
study, which was carried out by Booth and Hasking (2009). Specifically, Booth 
and Hasking found evidence to suggest that reward sensitivity, in conjunction 
with alcohol expectancies, moderated the relationship between social anxiety 
symptoms and alcohol consumption. Although these findings are promising, 
Booth and Hasking’s study was carried out in a community sample making it 
difficult to generalise their findings to clinical samples. Whilst there are 
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advantages of using community samples in research examining clinical disorders, 
it is equally important to investigate whether the findings of community based 
research can be generalised to clinical samples. Further, Booth and Hasking did 
not examine the moderating role of rash impulsiveness despite the involvement of 
this trait in the onset and maintenance of substance misuse (Dawe et al., 2004; 
Fergusson et al., 2008; Gullo et al., 2011; Sher et al., 2000). Hence, the present 
study will extend the findings of Booth and Hasking by utilising a clinical sample 
to examine whether rash impulsiveness and reward sensitivity moderate the 
relationship between social anxiety and substance misuse.  
Surprisingly, previous studies have tended to focus on the relationship 
between social anxiety and alcohol use in isolation (e.g., Booth & Hasking; see 
Morris et al., 2005 for a review), despite evidence suggesting that SAD co-occurs 
with a number of different substances of abuse (Bakken et al., 2005; Darke & 
Ross, 1997; Myrick & Brady, 1997). For this reason, the present study will 
examine substance misuse more generally, including individuals who suffer from 
a range of different substance use diagnoses. In summary, this study argues that 
the interaction between social anxiety and both facets of impulsivity may predict 
substance misuse.  
Hypotheses  
Consistent with the findings of the first study reported in this thesis, and 
the findings of Booth and Hasking (2009), it is hypothesised that; 
1) Rash impulsiveness will moderate the relationship between social anxiety 
and substance misuse. Specifically, it is hypothesised that the relationship 
between social anxiety and substance misuse will be strongest when rash 
impulsiveness is elevated.  
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2) Reward sensitivity will moderate the relationship between social anxiety 
and substance misuse. Specifically, it is hypothesised that the relationship 
between social anxiety and substance misuse will be strongest when 
reward sensitivity is elevated. 
Whilst it has been argued here that reward sensitivity and rash 
impulsiveness moderate the relationship between social anxiety and substance 
misuse, it is important to acknowledge that these variables may serve as 
mediators. As previously mentioned, moderation explains when variables are 
related, whereas mediation explains why variables are related (Baron & Kenny, 
1986). This dual approach, whereby variables are examined as both moderators 
and mediators, is consistent with studies broaching new areas of research in the 
clinical literature (e.g., Alloy et al., 2009; Bleil, Ramesh, Miller, & Wood, 2000; 
Eggleston et al., 2004; Vanhalst, Luyckx, Raes, & Goossens, 2012).  
In particular, this approach is often taken where the relationship between 
variables has been established but the pathways through which the relationship 
exists have not been identified (Bleil et al., 2000). Consistent with the relatively 
unexplored nature of the relationships between social anxiety, impulsivity and 
substance misuse, an exploratory approach will be taken to examine whether rash 
impulsiveness and reward sensitivity mediate the relationship between social 
anxiety and substance misuse.  
Method 
Participants 
As part of larger study 74 adult participants were recruited from Odyssey 
House, an addiction treatment facility located in Melbourne, Australia. A total of 
45 males (60.8%) and 29 females (39.2%) ranging in age from 21 to 56 (M = 
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32.89, SD = 7.43) participated in the study. See Table 5.1 for participant 
demographic data. All individuals who applied for inclusion in the residential 
rehabilitation treatment program provided through Odyssey House were eligible 
to participate in the study if they met the inclusion criteria, which is detailed 
below. 
Inclusion and exclusion criteria.   
Study inclusion criteria included: 1) meeting the criteria for a substance 
use disorder as defined by the DSM-IV (APS, 1994), 2) identifying at least one 
moderate symptom of social anxiety on the LSAS (utilised as an indicator of 
subthreshold symptoms of social anxiety), and 3) being deemed eligible by 
Odyssey House clinicians for inclusion into the Therapeutic Community 
treatment program. 
Participants were excluded if: 1) they were under the age of 18 years, 2) 
they were experiencing symptoms of a current and active psychotic episode based 
on the DSM-IV (APS, 1994) criteria, 3) they reported active suicidal ideation, 4) 
they were unable to read English, or 5) they became ineligible for admission to 
the Therapeutic Community as judged by Odyssey House clinicians. Participants 
were advised that their participation was optional and would not affect their time 
on the wait list nor their eligibility to partake in the residential rehabilitation 
program. Two hundred and ninety-five participants were excluded from 
participation in the study on the basis of the abovementioned inclusion and 
exclusion criteria.
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Table 5.1 
Participant Demographics for Study Two 
Characteristic Grouping % Grouping % Grouping % Grouping % 
 
Ethnicity Australian  82.4% New 
Zealand/Oceania 
 
5.4% Asia 4.1% Other 8.1% 
 
Education Some high school 54.1% Competed VCE or 
equivalent 
12.2% Certificate/trade 
qualification 
27% University 
qualification 
6.8% 
 
 
Relationship 
status 
Single (never 
married) 
48.6% Married/living with 
partner 
 
9.5% Separated/divorced 27% In a relationship but 
not living together 
14.9% 
Employment 
status 
Unemployed 89.2% Part-time/casual 
employment 
 
5.4% Employed full-time 2.7% Other 2.7% 
Usual occupation Technician/trade 
worker 
20.3% Sales 14.9% Community/personal 
services worker 
 
10.8% Other 54% 
Place of 
residence  
Rented 24.3% Public housing 12.2% Parents or other family 
members house 
 
44.6% Other 19% 
Welfare 
payments 
Yes 73% No 27%     
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Measures 
Assessment information was obtained from semi-structured clinical 
interviews and self-report questionnaires. Clinician-administered questionnaires 
included demographic information, a diagnostic assessment tool, and two 
standardised substance misuse questionnaires. Registered psychologists and 
doctoral-level psychology students, who had received training in the 
administration of all measures, administered all clinician-administered 
questionnaires at assessment. A copy of the clinician-administered demographic 
and substance misuse questionnaires are presented in Appendix E. Self-report 
questionnaires included a social anxiety measure, rash impulsiveness, and reward 
sensitivity measure. The self-report questionnaires used in this study were 
described in detail in study one so they are only briefly described here. Each 
participant completed an initial intake assessment with the intake team at Odyssey 
House as well as an assessment with the Deakin University research team.  
Clinician-administered measures. 
 Demographic information. 
A set of self-report demographic questions was included pertaining to age, 
gender, ethnicity, country of birth, marital status, level of education achieved, 
occupation, employment status, access to welfare payments, sources of social 
support, and living conditions. Furthermore, information was obtained regarding 
primary substance of abuse (i.e., the most frequently used substance), age at onset 
of substance use problems, duration of problematic alcohol or drug use, most 
problematic substance of abuse in the past three months (i.e., the substance 
perceived to be the most problematic in terms of social, occupational or 
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psychological functioning), previous treatment attempts, and mental health 
history. 
Mini International Neuropsychiatric Interview – Screen. 
The Mini International Neuropsychiatric Interview – Screen (MINI-
Screen; Sheehan et al., 1998) is a clinical screening measure that was 
administered at entry to the service by Odyssey House clinicians as part of their 
normal intake procedures. This is a shortened version of the full MINI and was 
used to guide diagnosis of SAD, substance use disorders and other relevant 
mental health disorders as outlined in the DSM-IV (APA, 1994). 
Mini International Neuropsychiatric Interview Version 6.0.0. 
The MINI (Sheehan et al., 1998) is a short, structured diagnostic 
interview, which is used to diagnose a number of mental health disorders as 
described in the DSM-IV (APA, 1994). Notably, the diagnostic criteria outlined 
in the current DSM-IV-TR (APA, 2000) are equivalent with criteria outlined in 
the DSM-IV (APA, 1994). The MINI takes approximately 15 minutes to 
administer and demonstrates high reliability and good concordance with other 
diagnostic measures, including the Composite International Diagnostic Interview 
and Structured Clinical Interview DSM-III-R-Patients (Lecrubier et al., 1997; 
Sheehan et al., 1997). The MINI was administered at assessment to clinically 
assess all potential diagnoses identified from the MINI-Screen. All participants 
were administered the sections assessing SAD, alcohol use disorders, illicit 
substance use disorders (i.e., abuse and dependence on substances other than 
alcohol), and antisocial personality disorder. 
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Alcohol, Smoking and Substance Involvement Screening Test. 
The Alcohol, Smoking and Substance Involvement Screening Test 
(ASSIST; World Health Organisation [WHO] ASSIST Working Group, 2002) is 
a reliable and valid screening test that was developed to assess problematic and 
risky substance use. For the purposes of this study the ASSIST was used as a 
measure of substance misuse. Eight dichotomous yes/no questions assess lifetime 
use of alcohol, tobacco, cannabis, cocaine, amphetamines, inhalants, sedatives, 
hallucinogens, opiates, and other miscellaneous drugs. For those drugs endorsed 
with a “yes” response to lifetime use, a series of questions are asked concerning 
the perceived impact of each drug on general health and lifestyle. For the 
purposes of this study the global continuum of substance risk score was obtained 
by summing the scores for each item, across all substances (Newcombe, 
Humeniuk, & Ali, 2005). The ASSIST has a maximum score of 208. Australian 
(Newcombe et al., 2005) and international studies (Humeniuk et al., 2008) 
indicate that the ASSIST is a valid screening tool for substance misuse in a 
diverse range of individuals who report varying degrees of substance use. 
Cronbach’s alpha was .77 in this study. 
Timeline Followback Method. 
The Timeline Followback Method (TLFB; Sobell & Sobell, 1992) is an 
established calendar-based assessment tool that was created to gather 
retrospective estimates of substance use over a desired time period. In this study, 
the TLFB was used to ascertain quantity and frequency of alcohol use, and 
frequency of drug use, over the 90 days preceding each participant’s initial 
assessment. Studies of the psychometric properties of the TLFB have shown high 
temporal stability, convergent and discriminant validity with other substance 
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misuse measures, and concordance with information obtained from informants 
regarding patient substance use (Fals-Stewart, O'Farrell, Freitas, McFarlin, & 
Rutigliano, 2000; Robinson, Sobell, Sobell, & Leo, 2012).  
Self-report measures.   
The Sensitivity to Punishment and Sensitivity to Reward Questionnaire.  
The short form of the SPSRQ (O’Connor et al., 2004) consists of 35 
dichotomous yes/no items. This measure has two subscales, termed the Sensitivity 
to Punishment and SR subscale, which were developed to assess BIS and BAS 
functioning, respectively (Torrubia et al., 2001). For the purposes of this study the 
SR subscale was utilised as a measure of reward sensitivity. Cronbach’s alpha 
was .73 in the present study. 
The Eysenck Impulsiveness Questionnaire. 
The I7 (Eysenck et al., 1985) is a 54 item dichotomously scored yes/no 
questionnaire with three subscales: Impulsiveness (19 items), Venturesomeness 
(16 items), and Empathy (19 items). In this study the Impulsiveness subscale was 
used as a measure of rash impulsiveness. Cronbach’s alpha for the Impulsiveness 
subscale was .79 in this study. 
The Liebowitz Social Anxiety Scale. 
The LSAS (Liebowitz, 1987) is a commonly used measure of social 
anxiety. The LSAS requires participants to evaluate their fear or anxiety and 
avoidance of 24 social interaction and performance situations. Participants 
completed the LSAS twice; once during their intake assessment with Odyssey 
House staff to determine eligibility for the study, and secondly when they 
attended their assessment with the Deakin University research team. Cronbach’s 
alpha was .94 in this study. 
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Procedure 
Odyssey House intake staff administered the nominated screening tool 
(i.e., the LSAS) to all potential clients of Odyssey House during their standard 
intake assessment. Those who marked one or more situations in the fear/anxiety 
column of the LSAS as moderate or severe, and indicated that they avoided one 
or more situations were invited to participate in the study (i.e., the minimum 
LSAS score required was three). Subsequently, Deakin University researchers 
contacted potential participants who had given their permission to be contacted 
regarding the study. During this phone call potential participants were informed 
about the nature of the study including the requirements for participation and 
reimbursement for travel expenses and study participation. If verbal consent was 
provided, potential participants were invited to attend a structured interview at 
Odyssey House, with Deakin University researchers, which they were advised 
would take approximately two hours. Upon attending the interview, participants 
were invited to read and sign the consent form if they agreed to participate in the 
study. The consent form is displayed on the final page of the plain language 
statement, which is presented in Appendix F. At this point participants engaged in 
the clinician-administered component of the interview and subsequently 
completed the self-report questionnaire. Participants were reimbursed with a train 
ticket to cover their travel expenses and were given a $20 Coles-Myer voucher to 
reimburse them for their time. Lastly, participants were thanked for their 
involvement and invited to ask the researcher any questions about the study.  
Data Analysis  
To meet the aims of the present investigation, SPSS 19.0 was used to 
conduct mediation and moderation analyses. Consistent with the 
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recommendations prescribed by Aiken and West (1991) and Frazier et al. (2004), 
moderation analysis was conducted using hierarchical multiple regression. As 
recommended, continuous variables entering into interactions (i.e., social anxiety, 
rash impulsiveness and reward sensitivity) were centered. Specifically, centring 
refers to the process of subtracting the mean from a variable so that the mean of 
the centred variable is equal to zero (Aiken & West, 1991). Importantly, this 
procedure does not alter scores in the intercorrelation matrix and hence does not 
alter the relationships between variables. When interaction terms are uncentred, 
this may introduce multicollinearity to the regression matrices, leading to 
difficulties in the estimation of regression coefficients (Aiken & West, 1991; 
Frazier et al., 2004). 
With regard to mediation analysis, hypothesised mediation models were 
tested through multiple regression using the Barron and Kenny (1986) approach. 
The first step involved in testing mediation requires that there is a significant 
relationship between the independent (IV) and dependent variable (DV). The 
second and third steps specify that there must be a relationship between the IV 
(i.e., social anxiety) and the proposed mediating variables (i.e., rash 
impulsiveness and reward sensitivity), and between the proposed mediating 
variables and the DV (i.e., substance misuse), respectively (Barron & Kenny, 
1986). The final step involves evaluating the relationship between the IV and DV, 
while controlling for the variance accounted for by the proposed mediators. If this 
equation results in a non-significant effect for the IV, the mediator is said to 
mediate the relationship between the IV and the DV (Barron & Kenny, 1996). 
Power analysis was carried out using recommendations made by Cohen, 
Cohen, West, and Aiken (2003). The results of the power analysis indicated that 
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for a medium effect size of .15 with a power of .80, a total of 70 participants were 
required for a moderation analysis using hierarchical multiple regression. 
Results 
Psychiatric and Substance Misuse Diagnoses 
Fifty-nine participants (79.7%) met DSM-IV (APA, 1994) criteria for 
SAD, with a majority of participants (77%) meeting the criteria for the 
generalised form of SAD. Hence, the remaining participants reported 
subthreshold symptoms of social anxiety. Thirty-eight participants (51.4%) met 
the criteria for alcohol dependence while five met the criteria for alcohol abuse 
(6.8%). Fifty-nine participants (79.7%) met the criteria for illicit substance 
dependence and four participants (5.4%) met the criteria for illicit substance 
abuse. Overall, 25 (34%) participants met the criteria for both alcohol and illicit 
substance abuse or dependence. Furthermore, it is important to note that the entire 
sample met the criteria for one form of dependence (i.e., either alcohol or illicit 
substance dependence). See Table 5.2 for an overview of additional psychiatric 
diagnoses, which were identified among participants using the MINI-Screen and 
MINI diagnostic interview. 
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Table 5.2  
Psychiatric Comorbidity  
Diagnosis  % of sample meeting 
diagnostic criteria  
Antisocial Personality Disorder 52.7% 
Bipolar Disorder 4.1% 
Current Major Depressive Episode 44.6% 
Generalised Anxiety Disorder 28.4% 
Obsessive-Compulsive Disorder 16.2% 
Panic Disorder 20.3% 
Past Psychotic Disorder 20.3% 
Post-Traumatic Stress Disorder 21.6% 
 
Participant Substance Misuse  
The average age that participants reported they first tried any substance 
(including alcohol) was 11.82 (SD = 3.30). The average age participants reported 
that substances began to interfere with daily activities was 20.07 (SD =7.33), 
whereas the average age participants first sought treatment was 25.25 (SD = 
8.01). Based on the TLFB, the average number of standard drinks consumed, per 
person, per day, in the 90 days preceding their assessment was 10.33 (SD = 
10.90). On the basis of the ASSIST, all participants (n = 74) in the present sample 
reported a past (i.e., lifetime) and recent history (i.e., past three months) of using 
drugs and/or alcohol. See Table 5.3 for an overview of the substance participants 
identified as most problematic in the three months preceding their assessment. 
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Table 5.3  
 
Substance Identified as Most Problematic in the Past Three Months 
Class of Drug  % of sample 
Alcohol 29.7% 
Amphetamines  18.9% 
Cannabis 13.5% 
Opiates 28.4% 
Polysubstance Use 6.8% 
Prescription Medication 2.7% 
 
Data Screening 
Preliminary data analyses were conducted on measures of social anxiety, 
substance misuse, rash impulsiveness, and reward sensitivity. Consistent with the 
assumptions of multiple regression analyses, variables were examined for out of 
range values, univariate outliers, missing values, deviations from normality and 
multivariate outliers (Tabachnick & Fidell, 2007). Table 5.4 depicts scale range, 
means, standard deviations, and minimum and maximum scores for all measured 
variables.  
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Table 5.4 
Scale Range, Mean, Standard Deviation, Minimum and Maximum Scores on 
Measures of Social Anxiety, Rash Impulsiveness, Reward Sensitivity and 
Substance Misuse 
Variable Scale 
Range 
Minimum 
Score 
Maximum 
Score 
Mean (SD) 
Social Anxiety 0-144 6 132 75.58 (25.58) 
Rash Impulsiveness 0-19 2 18 10.79 (4.12) 
Reward Sensitivity 0-17 0 16 7.99 (3.41) 
Substance Misuse 0-208 41 197 99.19 (34.06) 
 
Analyses were conducted to determine whether missing values were 
missing completely at random. Little’s MCAR statistic (χ2 [975] = 416.79, 
p = 1.00) was non-significant, indicating that data was missing completely at 
random. Examination of the missing values determined that there were 1.43% 
missing values across the dataset and less than 3% missing data on any single 
item. Subsequently, expectation maximisation was utilised to impute missing 
values.   
According to Tabachnick and Fidell (2007), univariate outliers are cases 
with standardised scores exceeding 3.29 (p <.001). Utilising this criteria there 
were no univariate outliers present in the dataset. Low absolute values for 
skewness (ranging from -.45 to .62) and kurtosis (ranging from -.58 to .22) 
indicated that these statistics did not violate the assumption of normality. Further, 
the normal probability plot of standardized residuals and the scatterplot were 
  
124 
examined to check normality, linearity and homoscedasticity. No major 
deviations from normality were identified on visual examination of both plots.  
Examination of Mahalanobis distance with four independent variables and 
a critical value of 18.47 (p < .001) revealed that there were no multivariate 
outliers present in the dataset. To verify this finding, Cook’s values were 
examined. According to Tabachnick and Fidell (2007), cases with values larger 
than 1 are a potential problem. In the present sample the maximum value for 
Cook’s distance was .38 suggesting no major problems with influence.  
Correlations among variables were less than r = .9, which is indicative of 
no major problems with multicollinearity (Tabachnick & Fidell, 2007). Further, 
tolerance values (ranging from .69 to .94) and Variance Inflation Factor (VIF) 
values (ranging from 1.06 to 1.46) for each variable were above the cut off of .10 
and below the cut off of 10, respectively. Singularity was not deemed a problem 
as individual scales were used in all analyses.  
Bivariate Correlations between Independent and Dependent Variables 
Correlations were examined to provide an indication of the relationships 
between the independent and dependent variables. As can be seen in Table 5.52, 
the relationship between rash impulsiveness and reward sensitivity (r = .35, p < 
.01), and between rash impulsiveness and social anxiety (r = .43, p < .01) were 
statistically significant. No other correlations were statistically significant.  
 
 
 
                                                 
2 Table 5.5 shows that there is a non-significant relationship between social anxiety and 
substance misuse. Hence, the underlying assumption of a relationship between the independent 
and dependent variable, which is necessary for mediation, is not met (Barron & Kenny, 1986). 
Therefore, a mediation analysis was not carried out.  
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Table 5.5 
Correlations Between Social Anxiety, Rash Impulsiveness, Reward Sensitivity and 
Substance Misuse 
Variable Social 
Anxiety 
Rash 
Impulsiveness 
Reward 
Sensitivity 
Substance 
Misuse 
Social Anxiety 1.0    
Rash Impulsiveness .43** 1.0   
Reward Sensitivity -.02 .35** 1.0  
Substance Misuse .16 .20 .13  1.0 
Note. ** = p <.01. 
 
Moderation Analysis 
To examine the first two hypotheses, a hierarchical regression analysis 
was performed. Consistent with recommendations, the predictor and moderator 
variables were centered to reduce multicollinearity (Aiken & West, 1991; Frazier 
et al., 2004; Tabachnick & Fidell, 2007). The dependent variable in the 
moderation analysis was substance misuse and the independent variables were 
social anxiety, rash impulsiveness, reward sensitivity, and the interactions of 
Social Anxiety x Rash Impulsiveness and Social Anxiety x Reward Sensitivity. 
Consistent with recommendations, the variables were entered in two stages 
(Frazier et al., 2004). In stage one the main effects of each interaction term were 
entered, and in stage two each of the interaction terms were entered. As can be 
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seen in Table 5.6, there were no significant main effects or moderator effects3. 
Therefore, no post-hoc analyses were carried out to examine the nature of 
moderator effects.  
 
Table 5.6  
Hierarchical Multiple Regression Analysis with Centred Variables to Test 
Whether Rash Impulsiveness and Reward Sensitivity Moderate the Relationship 
Between Social Anxiety and Substance Misuse 
Independent Variables Substance Misuse 
 
 adj.  R2 R2 change Beta 
 
B 
STEP 1 
 
.01 .05   
Social Anxiety 
 
  .12 .16 
Rash Impulsiveness 
 
  .12 .97 
Reward Sensitivity  
 
  .10 .97 
STEP 2 
 
-.00 .01   
Social Anxiety 
 
  .14 .94 
Rash Impulsiveness 
 
  .11 .18 
Reward Sensitivity  
 
  .10 1.05 
Interactions 
 
    
Social Anxiety x Rash Impulsiveness 
 
  -.01 -.00 
Social Anxiety x Reward Sensitivity  
 
  .12 .05 
Note. All effects were non-significant, p = >.05. 
 
 
                                                 
3 Exploratory analyses were conducted to examine whether the non-significant moderator effects 
were a result of including participants who did not meet the LSAS cut off score for SAD (i.e., 
scores <30; Mennin et al., 2002). Excluding those with LSAS scores of <30 did not change the 
nature of the results (i.e., moderator effects remained non-significant). Therefore, specific results 
will not be reported here. 
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Post-hoc Analyses 
Separating alcohol and drug misuse. 
To examine whether the non-significant moderator effects were a result of 
combining participants who misuse drugs and alcohol concomitantly, where 
studies typically examine alcohol misuse in isolation (e.g., Booth & Hasking, 
2009; see Morris et al., 2005 for a review), it was decided to conduct post-hoc 
analyses using separate drug and alcohol misuse scores. Specifically, a separate 
alcohol and illicit drug risk score was derived from the ASSIST for those who 
reported either alcohol or illicit drugs as their primary substance of misuse (refer 
to Table 5.2). Subsequently, equivalent analyses (i.e., correlation and moderation 
analyses) were conducted which yielded findings equivalent to those reported 
above. That is, there were no significant moderator effects and equivalence was 
observed regarding statistically significant correlations. Therefore, specific results 
will not be presented here.  
Discussion 
The primary aim of this study was to examine whether rash impulsiveness 
and reward sensitivity moderated the relationship between social anxiety and 
substance misuse in a clinical sample. Specifically, the first two hypotheses 
expected that the relationship between social anxiety and substance misuse would 
be strongest when rash impulsiveness and reward sensitivity were elevated. The 
data did not support these hypotheses. Furthermore, an exploratory approach was 
taken to examine whether rash impulsiveness and reward sensitivity mediated the 
relationship between social anxiety and substance misuse. The data did not 
support this tentative hypothesis. A secondary aim of this study was to describe 
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the demographic and clinical characteristics of the sample. These characteristics 
will be discussed with reference to other studies in the clinical literature.   
Rash Impulsiveness and Reward Sensitivity as Moderators 
The findings of this study are inconsistent with the contention that social 
anxiety interacts with rash impulsiveness and reward sensitivity to predict 
substance misuse. This contention was based on the findings of a series of studies 
(i.e., Booth & Hasking, 2009; Kachin et al., 2001; Kashdan et al., 2006; Kashdan 
et al., 2008; Kashdan & Hofmann, 2008; Kashdan et al., 2009), including the first 
study reported in this thesis. In particular, the findings of this study are 
inconsistent with those of Booth and Hasking (2009), who found that reward 
sensitivity, in conjunction with alcohol expectancies, moderated the relationship 
between social anxiety and alcohol consumption. Whilst the present findings were 
unexpected, it is possible that sample differences account for these inconsistent 
findings.   
Specifically, Booth and Hasking (2009) carried out their study in a 
community sample, which included a large number of undergraduate university 
students. Conversely, the present study attempted to generalise these findings to a 
clinical sample suffering from co-occurring social anxiety and substance misuse. 
Hence, it is likely that there are significant differences between these samples in 
terms of psychiatric and substance use symptomatology. For example, Booth and 
Hasking (2009) utilised a measure of alcohol consumption, which was reported as 
annual intake of alcohol in millilitres. Importantly, community samples tend to 
include participants who report substance use ranging from abstinence through to 
clinical levels of alcohol use, as was demonstrated in Booth and Hasking’s study 
and study one of this thesis. In contrast, this study utilised a sample presenting for 
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treatment of substance misuse, which may have resulted in restriction in range. 
Indeed, the standard deviation in proportion to the mean (M = 4346.11, SD = 
5842.20), which was reported for the measurement of alcohol consumption in 
Booth and Hasking’s study, was larger than the standard deviation in proportion 
to the mean reported in the present study (M = 99.19, SD = 34.06). Therefore, 
although scores on the ASSIST were normally distributed in this study, there was 
greater variability in range observed in Booth and Hasking’s study. 
Secondly, Booth and Hasking (2009) focused specifically on alcohol 
consumption, whereas this study administered a measure of global substance 
misuse. Whilst separate effects of alcohol and drug misuse were examined in 
post-hoc analyses, it is possible that the sample size of those who reported that 
alcohol was their primary substance of abuse (29.7% of the sample) was too small 
to detect a significant effect. 
Alternatively, it is possible that studies utilising community samples, and 
clinical samples of individuals presenting for treatment with a single substance 
use diagnosis (e.g., alcohol misuse in isolation), are examining a more 
homogenous population. Indeed, individuals within community samples are likely 
to have lower levels of comorbidity than individuals in clinical populations (Gum 
& Cheavens, 2008; Wagner, Cole, & Schwartzman, 1996). Furthermore, those in 
clinical samples who are dependent on more than one substance are known to 
have more psychosocial problems, physical health problems, and comorbid 
psychiatric diagnoses than those who are dependent on either illicit drugs or 
alcohol in isolation (Colpaert, Vanderplasschen, De Maeyer, Broekaert, & De 
Fruyt, 2012; Colpaert, Vanderplasschen, Van Hal, Broekaert,  & Schuyten, 2008; 
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Ford et al., 2009; Michael, John, & Duncan, 2002; Salgado, Quinlan, & Zlotnick, 
2007; Stinson et al., 2006).  
Indeed it has been noted that relatively little is known about individuals 
who are diagnosed with a concomitant drug and alcohol use disorder (Colpaert et 
al., 2012). This type of comorbidity, where an individual is diagnosed with two 
disorders within the same diagnostic class, has been termed “homotypic 
comorbidity” (Angold, Costello, & Erkanli, 1999, p. 58). Within the present 
sample, 34% of participants were characterised by homotypic comorbidity. 
Therefore, this may have impeded the capacity to examine the specific 
mechanisms underlying the co-occurrence of social anxiety and substance misuse.  
Unfortunately, it was not possible to conduct post-hoc comparisons 
between those suffering from distinct comorbidity profiles due to sample size 
restrictions. Hence, it would be advantageous for future research to examine the 
co-occurrence of social anxiety and substance misuse within specific classes of 
substance abuse or dependence, rather than individuals presenting with homotypic 
comorbidity, due to the additional complexities associated with their presentation. 
Furthermore, it is important to note that Booth and Hasking (2009) found 
evidence for three way relationships between social anxiety, reward sensitivity, 
and alcohol expectancies, in the prediction of alcohol consumption. Whilst it was 
beyond the scope of this thesis to examine the moderating role of alcohol or drug 
use expectancies, it would be advantageous to replicate the findings of Booth and 
Hasking in a clinical sample in future research.   
Lastly, it is important to acknowledge that social anxiety and impulsivity 
may not interact to predict substance misuse. Although this was the primary 
contention of this study, these relationships have not previously been examined in 
  
131 
a clinical sample. In fact, prior to the present study, only one clinical sample had 
examined impulsivity in SAD (i.e., Kashdan & Hofmann, 2008). Specifically, 
Kashdan and Hofmann (2008) examined impulsivity among a subset of SAD 
sufferers using cluster analysis, as opposed to examining relationships between 
variables. Hence, consistent with the findings of the first study, it is possible that 
elevated levels of rash impulsiveness and reward sensitivity characterise those 
with social anxiety and substance misuse comorbidity but do not interact with 
social anxiety to predict substance misuse.  
To examine some of the questions that have been raised in the above 
discussion it was decided to conduct a post-hoc moderation analysis utilising the 
community sample reported in study one of this thesis. In particular, it is possible 
that moderating role of rash impulsiveness and reward sensitivity can be 
identified in a community sample. These analyses and a summary of findings will 
be reported in the following chapter to enhance interpretability of the findings of 
this study and inform the general discussion.  
Rash Impulsiveness and Reward Sensitivity as Mediators 
The findings of this study indicated that there was a non-significant 
relationship between social anxiety and substance misuse. Hence, consistent with 
the assumptions of mediation (Barron & Kenny, 1986), a mediation analysis was 
not carried out. Further, there was a non-significant relationship between the 
proposed mediators (i.e., rash impulsiveness and reward sensitivity) and 
substance misuse. Therefore, there was no evidence for a mediating role of rash 
impulsiveness and reward sensitivity in this study. Whilst several non-significant 
relationships were observed between variables, which impeded the capacity to 
conduct a mediation analysis, significant relationships were observed between 
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social anxiety and rash impulsiveness and between both facets of impulsivity. 
Considering the dearth of clinical literature examining the relationships between 
social anxiety, impulsivity and substance misuse, the relationships observed 
between these variables will be discussed below.  
Although social anxiety and substance misuse have been inconsistently 
related in community samples (e.g., Buckner, Eggleston, & Schmidt, 2006; 
Gilles, Turk, & Fresco, 2006; Stewart, Morris, Mellings, & Komar, 2006), it is 
surprising that these variables were not related in the present study considering 
the use of a clinical sample (Strahan, Panayiotou, Clements, & Scott, 2011). 
Indeed, studies using clinical samples of individuals with substance use disorders 
have consistently found that SAD is a significant predictor of polysubstance 
dependence (Bakken et al., 2005), alcohol use disorders (Schneier et al., 2010), 
and cannabis dependence (Buckner et al., 2012). Notably, however, all of the 
abovementioned studies failed to examine correlations between variables. In fact, 
no clinical studies could be identified within the literature that had reported 
correlations between measures of social anxiety severity and substance misuse.  
That is, whilst evidence suggests that SAD and substance use disorders 
frequently co-occur (i.e., Bakken et al., 2005; Buckner et al., 2012; Schneier et 
al., 2010), these findings do not necessarily indicate that within a clinical sample, 
severity of social anxiety symptomatology is associated with severity of substance 
misuse. If this finding is confirmed in future clinical research, this would provide 
further evidence to suggest that rash impulsiveness and reward sensitivity do not 
mediate the relationship between social anxiety and substance misuse due to the 
requirement of a significant relationship between the IV and the DV (Barron & 
Kenny, 1986). Alternatively, it is possible that this relationship is explained by a 
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moderating variable, such as rash impulsiveness. Indeed, rash impulsiveness was 
significantly correlated with social anxiety in this study; however, as previously 
discussed, the restricted range with regard to the measurement of substance 
misuse may have inhibited the capacity to examine this hypothesis in this study. 
Whilst this is a plausible explanation of the findings, it is important to 
acknowledge that these correlational relationships would need to be examined in 
longitudinal research in order to make substantive conclusions about causality. 
Surprisingly, the present study also found that both facets of impulsivity 
did not significantly correlate with substance misuse. Although this finding was 
unexpected, similar findings have been reported in the clinical literature (e.g., 
Brotchie, Finch, Marsden, & Waller, 2003; Gullo, Dawe, et al. 2010). For 
example, Brotchie et al. (2003) found that contrary to their hypotheses, a measure 
of rash impulsiveness was not significantly related to drug or alcohol dependence 
in a clinical sample of substance using offenders. Brotchie et al. (2003) postulated 
that once patients reached clinical levels of substance misuse, impulsivity may 
play a central role in the prevalence of co-occurring axis one and two 
symptomatology, rather than the substance misuse itself. It is possible that this 
hypothesis explains the present findings. 
Similarly, Gullo, Dawe, et al. (2010) found a non-significant relationship 
between both facets of impulsivity and a measure of alcohol misuse (i.e., the 
AUDIT) within a sample of individuals seeking treatment for their alcohol use 
disorder. As a point of comparison, Gullo, Dawe, et al. examined equivalent 
relationships within a community sample. In contrast to the findings reported 
within the clinical sample, the relationships between both facets of impulsivity 
and alcohol misuse were statistically significant in the community sample. Whilst 
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Gullo, Dawe, et al. did not comment on why the relationship between impulsivity 
and substance misuse was non-significant in their clinical sample there are a 
series of potential reasons. 
Firstly, it is possible that the significant relationship commonly observed 
between impulsivity and substance misuse does not hold in clinical samples. This 
may be due to the high rate of impulsivity that already exists among individuals 
presenting for treatment of their substance use disorder. Thus, restriction in range 
may explain this finding in clinical samples. Alternatively, consistent with the 
above discussion (e.g., Brotchie et al., 2003), the non-significant findings may be 
related to the complexities associated with the presentation of patients in clinical 
samples. That is, impulsivity may underlie substance use initiation and 
subsequent exacerbation of substance misuse problems, but not explain the 
relationship once the diagnosis has reached the diagnostic threshold. At this point 
other variables (e.g., symptom severity, psychosocial problems, comorbidity) may 
inhibit the capacity to find significant effects.  
Moreover, these findings may also be explained by reviewing the three 
lines of evidence that are typically used to indicate that impulsivity and substance 
misuse are related (Moeller & Dougherty, 2002). Firstly, evidence commonly 
demonstrates that children and adolescents with higher impulsivity are at greater 
risk of developing a prospective substance use diagnosis (e.g., Fergusson et al., 
2008). Secondly, it has been repeatedly shown that individuals with a substance 
use diagnosis report higher levels of impulsivity than controls (e.g., Coffey et al., 
2003; Kjome et al., 2010). Lastly, a plethora of cross-sectional studies carried out 
in community samples have related impulsivity to a series of substance use 
variables (e.g., Franken & Muris, 2006a; Voigt et al., 2009).  
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Hence, whilst impulsivity has been shown to characterise substance-using 
populations, and to play a role in the onset of substance misuse, there is little 
evidence to suggest that these variables are significantly correlated in clinical 
samples. In fact, only one study could be identified that had reported a positive 
relationship between impulsivity and substance misuse in a clinical sample of 
substance dependent patients. Specifically, Moeller et al. (2001b) found that rash 
impulsiveness was significantly correlated with average daily cocaine use and 
severity in a sample of cocaine dependent individuals (n = 50). Importantly, 
Moeller et al. (2001b) excluded individuals with a past or current history of 
another axis one diagnosis. This adds further credence to the contention that 
psychiatric and homotypic comorbidity may hinder the capacity to examine 
significant effects in clinical samples. Future research should examine these 
questions in clinical samples with and without additional comorbidity to test the 
veracity of this contention. 
Demographic and Clinical Characteristics  
A secondary aim of this study was to describe the clinical characteristics 
of the sample. This is particularly important, as few previous studies have 
examined the co-occurrence of social anxiety and substance misuse in a clinical 
sample of individuals seeking treatment for their substance use disorder. Based on 
the findings of the present study, the clinical and demographic characteristics of 
the sample largely converged with other clinical studies in the literature. 
Specifically, it has consistently been found that a majority of patients 
presenting for treatment of their substance use disorder are male and unemployed 
(Colpaert et al., 2012; Fabricius, Langa, & Wilson, 2008; Torrens, Gilchrist, & 
Domingo-Salvany, 2011). Notably, the rate of unemployment within the present 
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sample was higher than that of comparable samples, with unemployment rates 
typically reported between 40 and 50% (Colpaert et al., 2012; Henkel, 2011). 
Whilst welfare rates were consistent with unemployment rates, treatment in a 
residential rehabilitation facility typically involves stays of nine to twelve months 
(Enos, 2011). Hence, patients seeking treatment in this type of facility are likely 
to be overrepresented with regard to unemployment statistics.  
In terms of concomitant psychiatric diagnoses, the findings of this study 
were largely consistent with international studies (i.e., Colpaert et al., 2012; 
Fabricus et al., 2008; Torrens et al., 2011). Specifically, it was found that more 
than half the sample met the criteria for another axis one diagnosis. In particular, 
mood and anxiety disorders were the most common concomitant diagnoses that 
were reported, which is consistent within the literature (Fabricus et al., 2008).  
With regard to axis two diagnoses, Colpaert et al. (2012) similarly found 
that over half of their sample seeking treatment for substance misuse met the 
criteria for antisocial personality disorder. This finding is in keeping with rates 
reported in other substance misusing samples (Messina, Wish, & Nemes, 1999; 
Verheul, 2001). Whilst this is a high proportion, this finding is not surprising, 
considering a diagnosis of antisocial personality disorder is based on a series of 
behavioural criteria, which overlap with behaviours that are commonly reported 
among individuals who are substance dependent. In fact, it has been argued that 
there are overlapping diagnostic criteria and features with regard to substance 
misuse and antisocial personality disorder diagnoses (Verheul, van den Bosch, & 
Ball, 2005).  
Considering the abovementioned findings it is unsurprising that 
Emmelkamp and Vedel (2006, p.12) stated that “comorbidity is the rule, rather 
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than the exception” among those seeking treatment for substance misuse. Despite 
the frequency of psychiatric comorbidity in clinical samples, it is important to 
acknowledge that this may serve as a confounding variable in being able to 
delineate the specific mechanisms underlying the co-occurrence of social anxiety 
and substance misuse. However, this is the challenge facing all clinical samples, 
in particular those researching social anxiety or substance misuse diagnoses, as 
both of these diagnoses are known to co-occur with other diagnoses at a high rate 
(Ruscio et al., 2008; Torrens et al., 2011). 
Future Directions 
Although there is strong evidence to suggest that SAD precedes the onset 
of substance misuse in a majority of cases (Buckner et al., 2012; Magee et al., 
1996 Schneier et al., 2010), it seems that social anxiety symptomatology is 
secondary to substance misuse in a proportion of cases (i.e., substance induced; 
Torrens et al., 2011). Indeed, research suggests that substance misuse precedes 
SAD in approximately 18 to 40% of cases (Bakken et al., 2005; Buckner et al., 
2012; Ross et al., 1988; Schneier et al., 2010). It is possible that order of onset is 
related to specific substances of abuse, or where the individual seeks treatment. 
Arguably, those seeking treatment for substance misuse may not recognise social 
anxiety symptoms as their primary concern. Hence, it is possible that treatment 
seeking is related to the primary diagnosis. Therefore, it would be advantageous 
for future research to examine the present research question in a sample of 
individuals seeking treatment for social anxiety who report co-occurring 
substance use problems. Furthermore, future research should endeavour to 
distinguish between those with substance induced SAD, and those with an 
independent SAD diagnosis. 
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Moreover, future research should consider an examination of gender 
differences with regard to social anxiety and substance misuse comorbidity. This 
is an important avenue for future research considering some studies have found 
gender differences with regard to the relationship between social anxiety 
symptoms and substance use (e.g., Buckner, Heimberg, & Schmidt, 2011; 
Buckner & Turner, 2009; Buckner & Vinci, 2013; Norberg, Norton, & Olivier, 
2009). Unfortunately, this was not possible in the present sample due to the 
uneven proportion of males and females. Further, the correlational research 
design limits conclusions regarding causality. For this reason, future research 
should consider longitudinal methodology to enhance knowledge regarding the 
temporal precedence of social anxiety and substance misuse diagnoses, alongside 
personality traits, such as rash impulsiveness and reward sensitivity. 
Lastly, considering that a large proportion of the present sample met 
diagnostic criteria for comorbid psychiatric diagnoses, such as major depressive 
disorder (44.6% of the sample), it would be advantageous for future research to 
include measures to ascertain the severity of comorbid symptoms. For example, 
future studies could include measures of depressive symptoms in order to 
statistically control for the possible confounding influence of depression on the 
hypothesised effects. 
Limitations 
The findings of the current study need to be considered in light of several 
limitations. Firstly, the data was collected from a convenience sample of 
participants seeking treatment for substance misuse in a residential rehabilitation 
facility. Consequently, the results are only generalisable to those with similar 
circumstances. Nonetheless, this limitation should be considered in light of the 
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difficulties associated with recruiting clinical populations, such as those suffering 
from social anxiety and substance misuse comorbidity, for research (Torrens et 
al., 2011). 
An additional limitation of the present study is the reliance on self-report 
measures of impulsivity. Whilst the scales that were used are known to be reliable 
and consistent with behavioural measures, this study may have been limited by 
participant insight (Bornovalova, Lejuez, Daughters, Zachary Rosenthal, & 
Lynch, 2005b; Moeller, Barratt, Dougherty, Schmitz, & Swann, 2001a). Hence, it 
would be beneficial to consider behavioural measures of impulsivity in future 
studies. 
Furthermore, it should be noted that although a power analysis was 
conducted to obtain an estimate for the required sample size, it is possible that the 
sample size in this study was not large enough to detect significant effects. Future 
research in this area should take this limitation into account.  
Conclusion 
The findings of this study shed doubt on the contention that social anxiety 
interacts with rash impulsiveness and reward sensitivity to predict substance 
misuse in a clinical sample of individuals seeking treatment for their substance 
use disorder. It is possible that sample differences or qualitative differences 
between clinical and community samples explain these unexpected findings. It is 
important that future studies consider the limitations of this study when 
developing future research designs.  
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CHAPTER SIX 
Post-hoc Moderation Analysis 
The previous chapter presented the findings of study two, which indicated 
that rash impulsiveness and reward sensitivity did not moderate the relationship 
between social anxiety and substance misuse in a clinical sample. A series of 
potential explanations for the findings were discussed and it was decided to 
conduct post-hoc analyses to test whether (a) rash impulsiveness and (b) reward 
sensitivity moderate the relationship between social anxiety and substance 
misuse, utilising the community sample reported in study one of this thesis.  
Specifically, it was argued that sample differences (e.g., range restriction) 
or qualitative differences (e.g., multiple comorbidities) between clinical and 
community samples may explain why these relationships do not hold in clinical 
samples. Hence, it was postulated that these relationships may be identified in 
community samples. This chapter will replicate the analyses conducted in chapter 
two to examine whether the relationship between social anxiety and substance 
misuse is strongest when rash impulsiveness and reward sensitivity are elevated. 
As there was no evidence to suggest that rash impulsiveness and reward 
sensitivity mediated the relationship between social anxiety and substance misuse 
in study two (i.e., the underlying assumption of a relationship between the 
independent and dependent variable, which is necessary for mediation was not 
met; Barron & Kenny, 1986), an exploratory mediation analysis will not be 
conducted. In the following section the results will be presented, followed by a 
brief summary of the findings. This will inform the general discussion presented 
in the following chapter.  
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Data Analysis 
For details regarding the data analytic strategy see chapter five (p. 118). 
Method 
In this study the total score on the DAST-10 will be utilised as a measure 
of drug misuse and the total score on the AUDIT will be utilised as a measure of 
alcohol misuse. For further details regarding the method see chapter four (p. 82). 
Results 
Data Cleaning  
Following on from preliminary analyses conducted in study one (see p. 
91), additional data cleaning strategies were carried out to meet the assumptions 
of moderation analysis using hierarchical multiple regression. As previously 
reported, there were nineteen univariate outliers in the dataset (i.e., cases with 
standardised scores exceeding 3.29, p <.001; Tabachnick & Fidell, 2007). 
Specifically, six outliers were from the AUDIT, eight were from the DAST-10, 
three were from the drug frequency measure, and two were from the LSAS. To 
reduce the influence of the outliers, each of the outlying cases were rescaled to 
one unit larger than the next most extreme score in the distribution (Tabachnick & 
Fidell, 2007).  
Low absolute values for skewness (ranging from .55 to 1.22) and kurtosis 
(-.39 to 1.40) indicated that these statistics did not violate the assumption of 
normality. Further, the normal probability plot of standardized residuals and the 
scatterplot were examined to check normality, linearity and homoscedasticity. No 
major deviations from normality were identified on visual examination of both 
plots. 
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Examination of Mahalanobis distance with four independent variables and 
a critical value of 18.47 (p < .001) revealed that there was one multivariate outlier 
present in the dataset. This case was deleted leaving a further 349 cases for 
analysis. Subsequently, Cook’s values were examined to identify the presence of 
influential cases in the dataset. According to Tabachnick and Fidell (2007), cases 
with values larger than 1 are a potential problem. In the present sample the 
maximum value for Cook’s distance was .23 suggesting no major problems with 
influence.  
Correlations among variables were less than r = .9, which is indicative of 
no major problems with multicollinearity (Tabachnick & Fidell, 2007). Further, 
tolerance values (ranging from .54 to .89) and VIF values (ranging from 1.12 to 
1.87) for each variable were above the cut off of .10 and below the cut off of 10, 
respectively. Singularity was not deemed a problem as individual scales were 
used in all analyses.  
Bivariate Correlations Between Independent and Dependent Variables 
Correlations were examined to provide an indication of the relationships 
between the independent and dependent variables. As can be seen in Table 6.1, 
the relationship between social anxiety and reward sensitivity was not statistically 
significant (r = .03, p >.05). The relationship between all other variables were 
statistically significant. 
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Table 6.1 
Correlations Between Social Anxiety, Rash Impulsiveness, Reward Sensitivity, 
Alcohol Misuse and Drug Misuse Variables  
Variable Social 
Anxiety 
Rash 
Impulsiveness 
Reward 
Sensitivity 
Alcohol  
Misuse 
Drug 
Misuse 
Drug 
Frequency 
Social Anxiety 1.0      
Rash 
Impulsiveness 
.29** 1.0     
Reward 
Sensitivity 
.03 .49** 1.0    
Alcohol 
Misuse 
.13* .51** .45**  1.0   
Drug Misuse .19** .38** .26** .52** 1.0  
Drug 
Frequency  
 
.20** 
 
.41** 
 
.22** 
 
.57** 
 
.70** 
 
1.0 
Note. * = p<.05, ** = p <.01. 
 
Moderation Analysis 
To replicate the analyses carried out in the previous chapter a hierarchical 
regression analysis was performed using centred predictor and moderator 
variables (Aiken & West, 1991; Frazier et al., 2004; Tabachnick & Fidell, 2007). 
The dependent variable in the moderation analysis was alcohol misuse4 and the 
independent variables were social anxiety, rash impulsiveness, reward sensitivity, 
and the interactions of Social Anxiety x Rash Impulsiveness and Social Anxiety x 
Reward Sensitivity. Consistent with recommendations, the variables were entered 
                                                 
4 Equivalent analyses were conducted using both the AUDIT and the DAST-10 as the 
dependent variable, as these are both validated measures of substance misuse. Statistically 
significant effects (including the form of the interaction and probing of the significant interaction) 
were equivalent in both models. Due to the conceptually similar nature of the findings only the 
results for the AUDIT will be reported here.   
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in two stages (Frazier et al., 2004). In stage one the main effects of each 
interaction term were entered and in stage two each of the interaction terms were 
entered.  
After the main effects were entered in stage one the adjusted R2 = .31 was 
statistically significant, F(3, 345) = 52.17, p < .001. After the interaction terms 
were entered in stage two these added to the prediction of alcohol misuse, 
adjusted R2 = .34, F(5,343) = 36.28, p < .001. The addition of the interaction 
terms in stage two added a substantial and significant increase in R2, Fchange = 
8.87, p < .001. As can be seen in Table 6.2 only one interaction term was 
statistically significant.  
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Table 6.2 
Hierarchical Multiple Regression Analysis with Centred Variables to Test 
Whether Rash Impulsiveness and Reward Sensitivity Moderate the Relationship 
Between Social Anxiety and Alcohol Misuse 
Independent Variables Alcohol Misuse 
 
 adj.  R2 R2 change Beta 
 
B 
STEP 1 
 
.31** .31**   
Social Anxiety 
 
  .02 .01 
Rash Impulsiveness 
 
  .37 .54** 
Reward Sensitivity  
 
  .27 .47** 
STEP 2 
 
.34** .03**   
Social Anxiety 
 
  -.02 -.00 
Rash Impulsiveness 
 
  .44 .30** 
Reward Sensitivity  
 
  .51 .29** 
Interactions 
 
    
Social Anxiety x Rash Impulsiveness 
 
  .01 .22** 
Social Anxiety x Reward Sensitivity  
 
  -.00 -.06 
Note. * = p <.05, ** = p <.01. 
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Post-hoc probing of significant interaction between social anxiety and 
rash impulsiveness in the prediction of alcohol misuse. 
To examine the nature of the Social Anxiety x Rash Impulsiveness 
interaction in the prediction of alcohol misuse, Aiken and West’s (1991) 
recommendations were followed. Predicted values were estimated using the 
mean, one standard deviation above the mean, and one standard deviation below 
the mean of the variables in the interaction term (i.e., social anxiety and rash 
impulsiveness). The slopes of the regression lines were then probed in order to 
examine which of the slopes were statistically significant. Probing of effects 
indicated that there was a significant effect for LSAS when rash impulsiveness 
scores were in the low range, b = -.05, t(343) = -2.72, p = <.05 and in the high 
range b = .04, t(343) = 2.27, p = <.05. There was no evidence of a statistically 
significant effect when rash impulsiveness scores were in the average range b = -
.00, t (343) = -0.33, p = >.05. A plot of the Social Anxiety x Rash Impulsiveness 
interaction at different levels of the mean is visually depicted in Figure 6.1.  
Figure 6.1. Plot of the Social Anxiety x Rash Impulsiveness interaction in the 
prediction of alcohol misuse. RI = Rash Impulsiveness. Note. * = p <.05. 
  
147 
Summary of Findings  
The primary aims of the additional analyses were to examine whether (a) 
rash impulsiveness and (b) reward sensitivity moderated the relationship between 
social anxiety and substance misuse in a community sample. The data supported 
the hypothesis that expected rash impulsiveness to moderate the relationship 
between social anxiety and substance misuse. In particular, post-hoc probing 
suggested that social anxiety was positively associated with substance misuse for 
those characterised by elevated rash impulsiveness, whereas social anxiety was 
negatively associated with substance misuse for those characterised by low levels 
of rash impulsiveness. This finding exemplifies the importance of research 
examining moderators; as such research sheds light on equivocal findings within 
the clinical literature, such as the inconsistent relationship between social anxiety 
symptoms and substance use variables (e.g., Buckner et al., 2006; Gilles et al., 
2006; Stewart et al., 2006). Furthermore, rash impulsiveness was significantly 
correlated with social anxiety in this study, which is consistent with the findings 
of study two. In contrast, there was no evidence to suggest that reward sensitivity 
was correlated with social anxiety, or that this trait moderated the relationship 
between social anxiety and substance misuse. 
A secondary finding indicated that rash impulsiveness and reward 
sensitivity were significantly correlated with all substance misuse variables. The 
findings and overall implications of the post-hoc analyses carried out in this 
chapter will be discussed in detail in the general discussion.  
Conclusion  
The analyses reported in the present chapter provide evidence to suggest 
that rash impulsiveness moderates the relationship between social anxiety and 
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substance misuse in a community sample. The overall findings, implications, 
limitations, and future research directions will be discussed in detail in the general 
discussion. 
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CHAPTER SEVEN 
General Discussion 
The primary aim of this thesis was to investigate the utility of a two-facet 
conceptualisation of impulsivity in understanding the relationship between social 
anxiety and substance misuse. It was argued that these two facets of impulsivity 
may underlie the co-occurrence of social anxiety and substance misuse for two 
primary reasons. Firstly, a small series of studies have found that impulsive-like 
traits characterise a subset of socially anxious individuals (i.e., Kachin et al., 
2001; Kashdan et al., 2008; Kashdan & Hofmann, 2008; Kashdan et al., 2009), 
and secondly, a personality profile characterised by elevated impulsivity is 
involved in the onset and maintenance of substance misuse (Anokhin et al., 2011; 
Dawe & Loxton, 2004; Fergusson et al., 2008; Moeller & Dougherty, 2002). 
Hence, it was argued that the impulsive-like traits found to characterise a subset 
of socially anxious individuals may provide an etiological explanation as to why 
some individuals with SAD develop co-occurring substance use disorders while 
others do not. 
Drawing on previous research (e.g., Franken, & Muris, 2006b; Quilty & 
Oakman, 2004), a two-facet approach to the measurement of impulsivity was 
employed to overcome the limitations of previous studies (e.g., Booth & Hasking; 
Kashdan & Hofmann, 2008), which had used a unidimensional approach in the 
measurement of impulsivity. It was argued that employing the two-facet 
conceptualisation of impulsivity enhances consistency in research and expands 
current knowledge regarding how these distinct facets of impulsivity may convey 
risk for specific behaviours and diagnoses. Hence, a major contribution of this 
thesis was to examine the involvement of rash impulsiveness and reward 
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sensitivity in the co-occurrence of social anxiety and substance misuse within 
both a community and clinical sample.  
The following section will summarise the results of the two studies 
reported in this thesis, in addition to the findings of post-hoc analyses. This 
includes a discussion of the aims, hypotheses and primary findings from each 
study, followed by an integrated discussion of the overall findings of this thesis. 
The clinical and research implications will be discussed, followed by a discussion 
of the limitations and directions for future research.   
Summary of Results 
Study One: When Social Anxiety Co-occurs with Impulsivity and Risk-
taking: Does Substance Misuse Characterise this Subset of Socially Anxious 
People?  
Study one was designed to expand on a series of studies (i.e., Kachin et 
al., 2001; Kashdan et al., 2006; Kashdan et al., 2008; Kashdan & Hofmann, 2008; 
Kashdan et al., 2009) by utilising a two-facet conceptualisation of impulsivity to 
investigate heterogeneity among socially anxious individuals in the community. It 
was argued that this research may help identify a specific personality profile that 
characterises a subset of socially anxious individuals with co-occurring substance 
use problems. Specifically, it was expected that individuals with symptoms of 
social anxiety could be meaningfully separated into two distinct subgroups based 
on characteristics typically associated with SAD, including social anxiety 
symptom severity and behavioural inhibition, and those posited to characterise the 
atypical social anxiety subgroup; including rash impulsiveness, reward sensitivity 
and risk-taking. The data supported this hypothesis. The second hypothesis 
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expected that the two social anxiety classes would report significantly different 
levels of substance misuse. The data supported this hypothesis.  
Whilst one previous study (i.e., Kashdan & Hofmann, 2008) had identified 
elevated rash impulsiveness among a subset of SAD sufferers, this was the first 
study to demonstrate that reward sensitivity may similarly characterise this 
atypical social anxiety subgroup. Furthermore, this was the first study to examine 
the severity of substance misuse among atypical social anxiety sufferers using 
validated measures. 
Study Two: Co-occurring Social Anxiety and Substance Misuse: Evaluating 
the Moderating Effects of Rash Impulsiveness and Reward Sensitivity 
Study two was designed to examine the specific mechanisms through 
which social anxiety conveys risk for substance misuse within a clinical sample. 
The sample comprised of individuals seeking treatment for their substance use 
disorder who reported co-occurring social anxiety symptomatology. Specifically, 
it was predicted that rash impulsiveness and reward sensitivity would moderate 
the relationship between social anxiety and substance misuse. The data did not 
support these hypotheses. Furthermore, an exploratory approach was taken to 
examine whether rash impulsiveness and reward sensitivity mediated the 
relationship between social anxiety and substance misuse. Surprisingly, the 
findings of these analyses indicated that there was a non-significant relationship 
between social anxiety and substance misuse. Hence, consistent with the 
assumptions of mediation (Barron & Kenny, 1986), a mediation analysis was not 
carried out. Moreover, there was a non-significant relationship between the 
proposed mediators (i.e., rash impulsiveness and reward sensitivity) and 
substance misuse. Despite the non-significant relationships observed between 
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several variables, which inhibited the capacity to conduct a mediation analysis, a 
significant relationship was observed between social anxiety and rash 
impulsiveness and between both facets of impulsivity.  
 A secondary aim of study two was to contrast the clinical characteristics 
of the sample with other studies in the clinical literature. The findings 
demonstrated that the clinical and demographic characteristics converged with 
other samples of individuals seeking treatment for their substance use disorder. 
Notably, the clinical sample reported high levels of unemployment, homotypic 
comorbidity and additional psychiatric comorbidity.  
With regard to the non-significant moderator effects, several explanations 
for the findings were proposed, which informed subsequent post-hoc analyses. 
Specifically, it was argued that range restriction within the clinical sample may 
have limited the capacity to find significant moderator effects. Alternatively, it 
was proposed that the presence of multiple comorbidities and the severity of 
substance use symptomatology may have limited the capacity to examine the 
specific mechanisms underlying the co-occurrence of social anxiety and 
substance misuse. Hence, it was postulated that the hypothesised moderator 
effects may be identified in a community sample where there are lower levels of 
psychiatric comorbidity and greater variability in range with regard to substance 
misuse. 
Post-Hoc Analyses 
Post-hoc analyses were carried out to examine the moderating role of rash 
impulsiveness and reward sensitivity in the community sample reported in study 
one of this thesis. It was found that rash impulsiveness moderated the relationship 
between social anxiety and substance misuse. Specifically, social anxiety was 
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positively associated with substance misuse for those characterised by elevated 
rash impulsiveness, whereas social anxiety was negatively associated with 
substance misuse for those characterised by low levels of rash impulsiveness. 
Further, rash impulsiveness was significantly correlated with social anxiety, 
which was consistent with the significant relationship observed between these 
constructs in the clinical sample. In contrast, there was no evidence for a 
moderating role of reward sensitivity, nor was there a significant relationship 
between social anxiety and reward sensitivity. A secondary finding indicated that 
in contrast to the clinical sample, social anxiety, reward sensitivity and rash 
impulsiveness were all significantly correlated with substance misuse. The overall 
findings of this thesis will be discussed in detail in the following section.  
Discussion of Integrated Findings 
The two studies reported in this thesis, alongside additional post-hoc 
analyses, contribute to an expanding body of knowledge regarding an atypical 
presentation of social anxiety. Although these findings are in contrast to 
prototypical descriptions of SAD (e.g., APA, 2000; Lorian & Grisham, 2010; 
Stein & Stein, 2008), the findings both converge with and expand on a small 
series of empirical studies examining heterogeneity among socially anxious 
individuals (i.e., Kachin et al., 2001; Kashdan et al., 2006; Kashdan et al., 2008; 
Kashdan & Hofmann, 2008; Kashdan et al., 2009). Taken together, the overall 
findings of this thesis are threefold. Firstly, the findings suggest that reward 
sensitivity and rash impulsiveness play important but differential roles in the co-
occurrence of social anxiety and substance misuse. Secondly, the shared clinical 
characteristics observed between participants in the clinical and community 
sample, who were suffering from social anxiety and substance misuse 
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comorbidity, confirm the presence of the atypical social anxiety subgroup, which 
was identified in study one. Thirdly, the overall findings raised important 
questions about the capacity to examine the specific mechanisms through which 
social anxiety conveys risk for substance misuse in a clinical sample of 
individuals seeking treatment for their substance use disorder. These three central 
findings will be discussed in detail in the following sections. 
The role of rash impulsiveness and reward sensitivity in social anxiety 
and substance misuse comorbidity. 
Taken together, the findings of this thesis suggest that rash impulsiveness 
may play a central role in the co-occurrence of social anxiety and substance 
misuse. Specifically, social anxiety was significantly correlated with rash 
impulsiveness in both the clinical and community sample, suggesting that despite 
the complexities prevalent within the clinical sample, including co-occurring 
psychiatric symptomatology, the relationship between social anxiety and rash 
impulsiveness could still be identified. Importantly, it was found that rash 
impulsiveness moderated the relationship between social anxiety and substance 
misuse in post-hoc analyses, which were conducted in a broad community 
sample. However, this finding did not hold in the clinical sample and will be 
discussed in detail in a later section.  
Surprisingly, reward sensitivity was not significantly correlated with 
social anxiety, nor did this variable moderate the relationship between social 
anxiety and substance misuse in the community or clinical sample. These findings 
were in contrast to hypotheses and were also inconsistent with the findings of 
study one, which found that elevated levels of reward sensitivity characterised the 
atypical social anxiety subgroup. Whilst these findings may initially appear 
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contradictory, Dawe and Loxton’s (2004) theory regarding the role of rash 
impulsiveness and reward sensitivity in substance misuse may shed light on these 
findings.  
According to Dawe and Loxton (2004), reward sensitivity conveys risk for 
substance use initiation. Specifically, individuals with elevated reward sensitivity 
are more likely to approach novel stimuli (Dawe & Loxton, 2004). Hence, it is 
possible that socially anxious individuals characterised by elevated levels of 
reward sensitivity are more likely to use approach strategies in response to their 
social anxiety symptoms, as opposed to prototypical social anxiety sufferers with 
minimal levels of reward sensitivity. Therefore, the atypical social anxiety 
sufferers may be more likely to seek out rewarding environments (e.g., a party) 
where they may be exposed to novel stimuli, such as alcohol and drugs. 
Worryingly, evidence suggests that reward sensitive individuals may be more 
susceptible to peer pressure (Knyazev, Slobodskaya, Kharchenko, & Wilson, 
2004), which may be particularly problematic for reward sensitive social anxiety 
sufferers who feel pressured to use substances in social contexts. Furthermore, 
elevated reward sensitivity is posited to increase the reinforcing effects of 
substances (Dawe et al., 2004), and in conjunction with social anxiety 
symptomatology, may reinforce substance misuse.  
 In contrast, rash impulsiveness is posited to relate to an inability to stop 
engaging in approach behaviour despite the presence of negative consequences 
(Dawe & Loxton, 2004). Hence, once substance use has commenced, elevated 
rash impulsiveness is involved in the exacerbation and maintenance of substance 
misuse. Therefore, it is possible that once an individual starts misusing substances 
on a regular basis, social anxiety and reward sensitivity no longer interact to 
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predict substance misuse. Conversely, the ongoing interaction between social 
anxiety and rash impulsiveness may relate to the subsequent increase in rash 
impulsiveness following the onset of substance misuse. Indeed, the findings of 
several studies indicate that the misuse of substances leads to neurobiological 
changes that influence the functioning of the orbitofrontal cortex (see Goldstein & 
Volkow, 2002; Schoenbaum & Shaham, 2008), which is a region of the brain that 
is posited to underlie rash impulsiveness (Dawe et al., 2004). In particular, these 
changes within the orbitofrontal cortex are believed to play a role in loss of 
control over drug use (Schoenbaum & Shaham, 2008). In contrast, the 
mesolimbic dopaminergic pathway, which is involved in reward sensitivity 
(Dawe et al., 2004), does not influence several of the key processes involved in 
addiction, including the transition from controlled to compulsive substance use 
(Schoenbaum & Shaham, 2008). 
Thus, although reward sensitivity may specify risk for the onset of 
substance misuse among a subset of socially anxious individuals, this trait may 
become less important in predicting substance misuse once an individual starts 
abusing substances on a regular basis. Consistent with this contention, in the first 
study of this thesis, the atypical social anxiety sufferers reported elevated levels 
of rash impulsiveness, reward sensitivity, and substance misuse in comparison to 
typical social anxiety sufferers, yet only rash impulsiveness interacted with social 
anxiety to predict substance misuse in post-hoc analyses. 
Furthermore, Dawe and Loxton’s (2004) theory regarding substance use 
initiation and maintenance may explain the discrepancy between the findings 
reported in this thesis and those of Booth and Hasking (2009). Specifically, Booth 
and Hasking found that reward sensitivity, in conjunction with alcohol 
  
157 
expectancies, moderated the relationship between social anxiety and alcohol 
misuse, whereas the findings of this thesis found no evidence to suggest that 
reward sensitivity moderated the relationship between social anxiety and 
substance misuse. Notably, the participants in Booth and Hasking’s study 
comprised of 50% undergraduate university students with a mean age of 21.4 (SD 
= 6.3). In contrast, the participants in the community sample reported in this 
thesis had a mean age of 34.17 (SD = 12.94). Hence, the moderating role of 
reward sensitivity in Booth and Hasking’s study may relate to the age of the 
sample, with substance misuse onset peaking in early adulthood (McGorry et al., 
2011). Consistent with this contention, the clinical sample in the present thesis 
reported that substances began to interfere with daily activities at the age of 20.07 
(SD = 7.33), which converges with the findings of other Australian studies (Mo, 
Deane, Lyons, & Kelly, in press). Alternatively, an examination of other potential 
moderators in future research (e.g., alcohol expectancies; Booth & Hasking, 
2009) may illuminate three-way moderator relationships that underlie the 
relationship between reward sensitivity, social anxiety and substance misuse.  
In summary, it is possible that elevated reward sensitivity is involved in 
the onset of substance misuse, whereas rash impulsiveness may play a more 
prominent role in the exacerbation and maintenance of substance misuse. Hence, 
elevated levels of both of these traits may be used to delineate a risk profile for 
social anxiety and substance misuse comorbidity. Whilst this is a plausible 
explanation for the findings of this thesis, it is important to acknowledge that 
these findings are based on cross-sectional research, therefore these contentions 
would need to be confirmed using longitudinal methodology. 
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Shared clinical characteristics between the community and clinical 
sample. 
Whilst the findings reported in the first study of this thesis converged with 
a series of studies examining heterogeneity among socially anxious individuals 
(i.e., Kachin et al., 2001; Kashdan et al., 2006; Kashdan et al., 2008; Kashdan & 
Hofmann, 2008; Kashdan et al., 2009), these findings are strengthened by the 
similar clinical characteristics observed between the participants in the clinical 
sample and participants in the atypical social anxiety subgroup, which was 
identified in the community sample. Specifically, both the clinical sample and the 
atypical social anxiety subgroup reported scores of over 60 on the LSAS, which 
has been shown to be indicative of generalised SAD (Mennin et al., 2002). 
Furthermore, where the clinical sample comprised of individuals suffering from 
substance use disorders, the atypical social anxiety subgroup reported a mean of 
more than three on the DAST-10, which is indicative of probable drug abuse or 
dependence (French et al., 2001; Maisto et al., 2000; Skinner, 1982). Similarly, 
the atypical social anxiety sufferers reported a mean score on the AUDIT that was 
well above the cut-off score of eight, which has been used as an indicator of 
significant alcohol-related harm (Conigrave et al., 1995). Moreover, scores on 
measures of rash impulsiveness and reward sensitivity were comparable across 
the atypical social anxiety subgroup and clinical sample, with both samples 
reporting means on these measures that differed by less than one. Arguably, these 
consistencies confirm the presence of the atypical social anxiety subgroup, which 
was identified in the LCA conducted in the first study of this thesis.  
Although there were several similarities observed across samples, it is 
equally important to highlight some of the clinical differences. Firstly, 
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participants in the clinical sample were seeking treatment for substance misuse, 
whereas a majority of individuals in the community sample had not sought 
treatment. For those that had sought treatment in the community sample, a 
majority had sought treatment for SAD (26%), with a smaller number seeking 
treatment for substance misuse (3.7% for drug misuse and 5.1% for alcohol 
misuse). It is possible that these differences influenced the findings of this thesis. 
For example, considering that individuals tend to seek treatment several years 
after the onset of substance misuse, and severity of symptoms are related to 
treatment seeking (Kessler et al., 2001), it is likely that the clinical sample 
suffered from increased symptom severity across a range of domains. This was 
observed with regard to psychiatric comorbidity. Unfortunately psychiatric 
comorbidity was not measured in the community sample, however, consistent 
with the literature, those who participate in community studies typically suffer 
from lower levels of comorbidity (Gum & Cheavens, 2008; Wagner et al., 1996). 
Furthermore, considering participants in the clinical sample were seeking 
treatment for substance misuse, this sample may have included more individuals 
with substance induced social anxiety symptomatology, which may have impeded 
the capacity to examine the hypothesis that the interaction between social anxiety 
and both facets of impulsivity predict substance misuse.  
Overall, the similarities observed between the clinical sample and atypical 
social anxiety subgroup strengthen the findings of study one. However, there 
were also some important clinical differences between these samples, which may 
have contributed to the limited capacity to examine relationships between 
variables and moderating effects in the clinical sample. Potential explanations for 
the differential findings observed across the two samples will be discussed in 
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greater detail in the following section.  
Examining the co-occurrence of social anxiety and substance misuse 
in clinical and community samples.    
One of the central findings of this thesis was the limited capacity to 
examine moderating effects and relationships between variables in a clinical 
sample seeking treatment for substance misuse. Although it was postulated that 
the moderator effects and relationships between variables may not exist as 
hypothesised, post-hoc analyses carried out in the community sample provided 
evidence to suggest that sample or qualitative differences may underlie these non-
significant findings. Specifically, within the clinical sample there was no evidence 
to suggest that rash impulsiveness or reward sensitivity moderated the 
relationship between social anxiety and substance misuse. Moreover, rash 
impulsiveness and reward sensitivity were not significantly correlated with 
substance misuse, despite the well-established relationship between impulsivity 
and substance misuse within the clinical literature (Gullo et al., 2011; Moeller & 
Dougherty, 2002). In contrast, post-hoc analyses carried out in the community 
sample found evidence for the moderating role of rash impulsiveness in social 
anxiety and substance misuse comorbidity, and demonstrated a significant 
relationship between both facets of impulsivity and substance misuse. 
One explanation for these inconsistent findings is that these relationships 
do not hold in clinical samples (e.g., Brotchie et al., 2003; Gullo, Dawe, et al., 
2010). That is, once substance misuse has reached a level of severity where the 
diagnosis meets criteria for substance abuse or dependence, the interaction effect 
and relationships between variables cannot be identified. There are a series of 
potential explanations for this. Firstly, those who present for treatment, and are 
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often included in clinical research studies, are generally characterised by more 
severe symptoms than those who do not seek treatment (Angold et al., 1999; 
Angold et al., 1998; Compton, Thomas, Stinson, & Grant, 2007; Ray, Primack, 
Chelminski, Young, & Zimmerman, 2011). Indeed, it has been postulated that 
individuals who present for treatment may not be representative of a majority of 
individuals who meet diagnostic criteria for diagnoses but are not seeking 
treatment (Sher & Trull, 1996). This was demonstrated in the clinical sample 
reported in this thesis, where one third of participants were characterised by 
homotypic comorbidity, in addition to several other axis one and two psychiatric 
diagnoses. In contrast, those in community samples are typically characterised by 
lower levels of psychiatric comorbidity (Gum & Cheavens, 2008; Wagner et al., 
1996) and may be more representative of the intended population of study (i.e., 
those suffering from co-occurring social anxiety and substance misuse to the 
exclusion of other psychiatric diagnoses). 
Hence, in a clinical sample suffering from multiple comorbidities, it may 
be difficult to examine the mechanisms specifically underlying the co-occurrence 
of social anxiety and substance misuse. That is, the influence of other 
comorbidities cannot be separated from the target disorders being studied (Sher & 
Trull, 1996). Considering the severity of symptomatology in clinical samples 
seeking treatment, it is also possible that the characteristics identified may be 
indicative of the long-term consequences of psychiatric disturbance, which may 
inhibit the delineation of the etiological mechanisms underlying the disorders of 
interest (Sher & Trull, 1996). It is possible that this explains the findings of the 
present thesis and those of others (e.g., Brotchie et al., 2003; Gullo, Dawe, et al., 
2010) who failed to find significant relationships between impulsivity and 
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substance misuse in clinical samples of substance users characterised by complex 
clinical profiles.  
Alternatively, the high rate of substance misuse already prevalent in a 
clinical sample seeking treatment for substance misuse may explain the non-
significant effects demonstrated in the clinical sample. That is, the inclusion of 
individuals who had a substance use diagnosis may have restricted the range of 
scores on these measures. Although analyses indicated there was variability in 
range, this differs from individuals in community samples where scores tend to 
vary significantly (i.e., ranging from abstinence through to diagnostic levels of 
substance misuse). Therefore, the absence of a moderating effect may not mean 
that these relationships do not exist, but rather that these relationships may not be 
statistically observable in clinical samples of individuals with substance use 
disorders. Salyers and Mueser (2001) raised similar concerns regarding their non-
significant findings in a sample of individuals with co-occurring schizophrenia 
and substance misuse. Specifically, participants were required to have a minimum 
level of substance misuse, therefore excluding those with schizophrenia who were 
abstinent from substance use. 
The abovementioned explanations for the findings of this thesis raise 
important questions regarding the generalisation of findings from community to 
clinical samples. This is particularly important because the findings of 
community-based studies are prevailing in psychology and are frequently used to 
inform treatment strategies. Therefore, if the development of treatment 
interventions are based on the findings of community samples, which have not 
been replicated in clinical samples, it is important to investigate whether 
mechanisms, such as rash impulsiveness and reward sensitivity, are still important 
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to address in treatment. Such questions will need to be examined in future 
research.  
In summary, the overall findings of this thesis highlight the utility of 
examining the involvement of rash impulsiveness and reward sensitivity in the 
co-occurrence of social anxiety and substance misuse. Specifically, these findings 
emphasise the differential roles that these traits may play in this complex 
comorbidity. These findings have several clinical and research implications, 
which will be discussed in detail in the following two sections.  
Implications of This Thesis  
Clinical implications. 
The findings of this thesis suggest that it is important to consider 
screening for impulsive traits to enhance assessment, preventative and treatment 
efforts among those with social anxiety symptomatology. Although it is not 
common practice to screen for personality traits in clinical practice, it has 
previously been postulated that such screening may have a positive impact on 
therapeutic alliance and treatment selection, which may ultimately enhance 
outcomes (Costa, & McCrae, 1992; Krueger & Eaton, 2010; Widiger & Smith, 
2008).  
Firstly, enhancing knowledge among clinicians regarding the atypical 
presentation of social anxiety may be particularly important in terms of improving 
assessment and prevention. In terms of assessment, clinician education may 
prevent misdiagnosis, which may occur due to the paradoxical symptom profile 
that individuals with SAD may present with. This is particularly important for 
clinicians in substance misuse treatment settings considering the high rate of co-
occurring SAD among those seeking treatment for their substance use problem 
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(e.g., Bakken et al., 2005; Thomas et al., 1999; Tomasson, & Vaglum, 1995; 
Staiger et al., 2008). Worryingly, failure to identify those with co-occurring social 
anxiety symptomatology in substance misuse treatment settings may lead to 
treatment dropout due to the focus on group-based treatment (Book et al., 2009).  
In terms of prevention, increased knowledge regarding the mechanisms 
underlying social anxiety and substance misuse comorbidity will enhance 
opportunities to prevent the development of co-occurring substance misuse 
among those who are at risk. For clinicians working with adolescents and young 
adults who present with subthreshold social anxiety symptomatology, part of the 
preliminary assessment could involve administering self-report measures of 
reward sensitivity, rash impulsiveness, and risk-taking.  
By identifying the atypical presentation of social anxiety early in 
treatment, this would provide an opportunity to employ specific strategies to 
reduce the behavioural expression of impulsivity with regard to substance misuse. 
One preventative treatment intervention, which has been proposed to prevent the 
onset of substance misuse, encourages individuals to seek out alternative novel 
activities, such as extreme sports (D'Silva, Harrington, Palmgreen, Donohew, & 
Lorch, 2001). This may influence the expression of reward sensitivity; given 
reward sensitive individuals are more likely to approach novel stimuli (Dawe & 
Loxton, 2004).  
However, it is important to acknowledge that such interventions have been 
proposed for the prevention of substance misuse, rather than the prevention of 
substance misuse among socially anxious individuals. Indeed, the findings of this 
thesis suggest that it may be useful to develop treatments that are known to 
address psychiatric or substance use symptomatology in the context of an 
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individual’s personality profile. This approach is consistent with the theory of 
pathoplasticity (Klein et al., 1993; Widiger & Smith, 2008), and may enhance 
outcomes for individuals who do not conform to prototypical descriptions of 
SAD.  
To illuminate this point, the findings of Randall et al. (2001) will be 
briefly discussed, as this research team examined the effectiveness of a treatment 
targeting co-occurring SAD and alcohol misuse. Specifically, Randall and 
colleagues conducted a randomised controlled trial, which assigned individuals 
with co-occurring SAD and alcohol misuse to one of two treatment conditions; 
either a treatment addressing alcohol misuse only, or a treatment addressing both 
SAD and alcohol misuse. Both treatments were delivered as an individual 
treatment and were based on principles of cognitive behavioural therapy. 
Following the intervention, both treatment groups reported modest 
improvements in symptomatology for both disorders (Randall et al., 2001). 
However, participants in the alcohol-only treatment condition reported 
significantly greater improvement with regard to frequency and quantity of 
alcohol consumed during the 3-month follow-up period (Randall et al., 2001). 
That is, those receiving treatment for SAD and alcohol misuse concurrently 
reported poorer outcomes with regard to their alcohol use. It is possible that these 
findings are related to Randall et al.’s decision to segregate the treatment of the 
two disorders because “alcoholism and social phobia are more “distinct” 
disorders” (p. 211) thereby failing to address mechanisms, such as elevated 
impulsivity, underlying the co-occurrence of these diagnoses. 
Notably, cognitive behavioural therapy for SAD, which was used in 
Randall et al.’s (2001) study, is known as the “gold standard” psychological 
  
166 
intervention for SAD sufferers (Doehrmann et al., 2013, p. 87). However, this 
intervention has been developed for the prototypical, behaviourally inhibited SAD 
sufferer. Hence, for those with an atypical presentation of SAD, engaging in 
exposure tasks, which are a primary component of treatment, are likely to involve 
attending social engagements (e.g., attending a party or social gathering to 
address SAD symptoms). Such exposure to feared social situations may be 
counterproductive for those with co-occurring SAD and substance misuse who 
have an impulsive disposition, as this may lead to exposure to alcohol and drugs. 
Hence, the traditional cognitive behavioural treatment model used in Randell et 
al.’s (2001) study may have contributed to the poorer treatment outcome among 
those receiving simultaneous treatment targeting SAD and alcohol misuse.  
In light of the abovementioned findings, it is possible that a treatment 
addressing the co-occurrence of SAD and substance misuse, in the context of an 
impulsive personality profile, may enhance both preventative and treatment 
efforts for this comorbidity. This argument converges with that of other 
researchers who contend that interventions should be matched to personality traits 
to enhance outcomes (e.g., Staiger et al., 2007; Watt et al., 2008). For example, it 
is possible that a mindfulness-based interventions may be of particular benefit in 
the treatment of co-occurring SAD and substance misuse, as this therapeutic 
modality has been shown to reduce impulsivity (Margolin et al., 2007) and 
address symptoms of social anxiety (Kocovski, Fleming, & Rector, 2009).  
Specifically, mindfulness training enhances the capacity of individuals to 
think before acting by becoming aware of the present moment (Kabat-Zinn, 
1994). Hence, such training increases the capacity for self-regulation of arousal, 
affect and behaviour, thus decreasing impulsivity (Segall, 2005; Stratton, 2006). 
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Importantly, the utility of this therapeutic modality in reducing impulsivity, and 
the behavioural expression of this trait, has recently been demonstrated in clinical 
research (e.g., Margolin et al., 2007). 
For example, Margolin et al. (2007) examined the utility of a mindfulness-
based intervention in reducing impulsivity, substance misuse, and other related 
behaviours, in a sample of substance dependent patients (n = 38). In contrast to 
the levels of rash impulsiveness reported prior to the 12-week intervention, which 
were initially consistent with the levels reported by other substance dependent 
populations, scores decreased to levels that are typically found in non-clinical 
samples by the end of the intervention (Margolin et al., 2007). Further, relative to 
a standard care control group, participants who completed the mindfulness-based 
intervention reported greater decreases in substance misuse. With regard to long-
term outcomes, it has been proposed that mindfulness-based therapies may 
influence neurobiological circuits involved in impulsivity, which may minimise 
the potential for relapse among substance users (see Witkiewitz, Lustyk, & 
Bowen, 2012). 
There is also preliminary evidence to suggest that mindfulness-based 
interventions are effective in treating social anxiety symptomatology (Kocovski et 
al., 2009). Specifically, Kocovski et al. (2009) reported that following a 12-week 
mindfulness-based intervention, participants with SAD who completed treatment 
(n = 29) reported significant reductions in social anxiety symptom severity, co-
occurring depressive symptoms, and rumination. Considering that research 
suggests mindfulness-based interventions are effective in addressing SAD 
symptoms, impulsivity and the behavioural expression of this trait, it is possible 
that this intervention could be used in both preventative and treatment efforts. 
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Specifically, it would be advantageous for future research to examine the 
utility of a mindfulness-based intervention in the treatment of individuals 
suffering from co-occurring SAD and substance misuse. Furthermore, it is 
important for future research to examine the utility of mindfulness in addressing 
reward sensitivity; as to date there is only evidence to suggest that this 
intervention reduces rash impulsiveness (i.e., Margolin et al., 2007). Such 
research could inform the development of preventative efforts for those with 
symptoms of social anxiety who are at risk of developing comorbid substance 
misuse.  
Research implications. 
In addition to clinical implications, there are a series of research 
implications stemming from the findings of this thesis. Firstly, it is important to 
highlight that the findings of this thesis differ from several previous studies 
examining the two-facet conceptualisation of impulsivity in comorbidity (i.e., 
Alloy et al., 2009; Hopley & Brunelle, 2012; Kane et al., 2004). Specifically, 
previous studies have largely examined whether impulsivity underlies the 
relationship between two disorders that share biological substrates (Moeller et al., 
2001a). That is, previous studies have examined the relationship between two 
disorders that are posited to co-occur in the context of shared-vulnerability, 
whereby the association between disorders is partly due to shared impulsive 
symptomatology. Such diagnoses include comorbidity of substance misuse with 
bulimia nervosa (Kane et al., 2004), bipolar disorder (Alloy et al., 2009) and 
psychopathy (Hopley & Brunelle, 2012). 
 In contrast, the findings of this thesis indicate that shared vulnerability 
may not be the only circumstance where impulsivity plays a role in the etiology of 
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comorbidity. Specifically, this thesis provides evidence to suggest that it is 
possible for impulsivity to co-occur with anxiety, emphasising the dimensional 
nature of these traits (Corr, 2004). Whilst these findings suggest that researchers 
should continue examining the involvement of impulsivity in social anxiety, as 
this is a relatively new line of research, the findings of this thesis also suggest that 
researchers should consider examining heterogeneity within other psychiatric 
conditions. For example, it may be valuable for researchers to examine 
subpopulations within diagnostic categories, which may enhance outcomes for 
those who do not receive benefit from traditional treatment models. The use of 
personality inventories to examine heterogeneity within psychiatric diagnoses 
may enhance the capacity to observe subpopulations of individuals presenting 
with atypical characteristics.  
Furthermore, as demonstrated in this thesis, the multiple comorbidities 
that were identified in the clinical sample may have inhibited the capacity to 
examine the mechanisms specifically underlying the co-occurrence of social 
anxiety and substance misuse. Psychiatric comorbidity is not unique to SAD and 
substance misuse, but is a commonality in clinical research. Therefore, it is 
important for researchers to ensure that they screen for psychiatric comorbidity 
and are transparent in reporting this in their research so that findings can easily be 
compared across studies.  
Finally, consistent with several lines of research, this thesis demonstrates 
the utility of employing a two-facet conceptualisation of impulsivity in research 
examining this trait. As reiterated throughout this thesis, previous researchers 
have demonstrated that these two facets of impulsivity are distinct (e.g., Quilty & 
Oakman, 2004; Zelenski & Larsen, 1999), and it has been argued that these 
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should be included in research to capture the multifaceted nature of this construct. 
Consistent with these contentions, it was found that rash impulsiveness was 
significantly correlated with social anxiety in both the clinical and community 
samples reported in this thesis. Furthermore, rash impulsiveness moderated the 
relationship between social anxiety and substance misuse in the community 
sample. In contrast, reward sensitivity was not correlated with social anxiety in 
either sample, nor did this variable moderate the relationship between social 
anxiety and substance misuse. In spite of these differential relationships, rash 
impulsiveness and reward sensitivity were significantly correlated with each other 
in both the community and clinical samples. The abovementioned findings 
regarding rash impulsiveness and reward sensitivity are consistent with the 
contention that these facets are distinct but related aspects of impulsivity (Franken 
& Muris, 2006b; Quilty & Oakman, 2004). 
Arguably, if a unidimensional measure of impulsivity was utilised in the 
studies reported in this thesis, knowledge would not have been enhanced 
regarding how the different facets of impulsivity may convey risk for co-
occurring social anxiety and substance misuse. Hence, the findings of this thesis 
provide further credence to the contention that researchers investigating 
impulsivity should no longer rely on a unidimensional conceptualisation of 
impulsivity (Dick et al., 2010).  
Whilst several future research directions have been discussed throughout 
this chapter, the following section will briefly review some of the methodological 
limitations of both studies reported in this thesis, which point towards additional 
future research directions.  
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Limitations and Future Research Directions 
The results of the studies reported in this thesis must be considered in 
conjunction with their limitations, which have implications for future research. As 
the limitations and future research directions pertaining to each study have 
already been discussed in previous chapters, those that were evident across both 
studies will be discussed here.  
Firstly, due to the cross-sectional nature of the research designs it was not 
possible to examine the temporal presence of diagnoses or personality traits. To 
address this limitation, future research should consider including personality 
characteristics, such as rash impulsiveness and reward sensitivity, in longitudinal 
research examining the co-occurrence of SAD and substance misuse. In 
particular, it has been noted that substance misuse can exacerbate the presentation 
of impulsivity (de Wit, 2009; Verdejo-García et al., 2008). Hence, it is possible 
that substance misuse among SAD sufferers influences the expression of 
impulsivity. Through such research it will be possible to determine whether there 
are different pathways through which SAD and substance misuse comorbidity 
develop. For example, current evidence suggests that SAD precedes substance 
misuse in approximately 60 to 82% of cases (Bakken et al., 2005; Buckner et al., 
2012; Ross et al., 1988; Schneier et al., 2010), suggesting that substance misuse 
precedes SAD in 18 to 40% of cases. For this reason, it is important to examine 
the circumstances in which this occurs, as these individuals may respond to 
different treatments due to distinct etiological pathways underlying the co-
occurrence of diagnoses. 
One of the primary limitations of the two studies presented in this thesis is 
the reliance on self-report measures. Whilst the first study enabled participants to 
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complete their questionnaire online, which has been recommended to ensure 
confidentiality for participants reporting substance misuse (Miller & Sønderlund, 
2010), this was not possible in the clinical sample, which was only open to those 
presenting for treatment of their substance use disorder. Despite the differences in 
questionnaire administration, both studies did not control for social desirability 
beyond providing assurances that responses were confidential, which has the 
potential to mask the relationships between variables (Podsakoff, MacKenzie, 
Lee, & Podsakoff, 2003).  
Furthermore, self-report measures depend on participant insight into their 
own personality style and symptoms (Moeller et al., 2001a). This may be 
particularly problematic among substance dependent participants who, due to the 
effects of long-term substance misuse, may lack the insight or cognitive capacity 
to provide an accurate report of their own behaviour (Bornovalova et al., 2005b). 
One way to address this limitation in future research is to consider utilising 
behavioural measures of rash impulsiveness (e.g., delayed discounting) and 
reward sensitivity (e.g., the CARROT), in conjunction with self-report measures. 
Whilst the studies reported in this thesis specifically included individuals 
with subthreshold symptoms of social anxiety, it would be interesting for future 
research to examine differences between those who meet the diagnostic criteria 
for SAD and those who report subthreshold symptoms. It is possible that 
relationships between SAD, rash impulsiveness, reward sensitivity and substance 
misuse may differ if subthreshold symptoms of social anxiety pose a greater risk 
for the development of co-occurring substance misuse (Crum & Pratt, 2001; 
Merikangas et al., 2002; Robinson et al., 2011).  
Lastly, the participants in the samples used in the present thesis were 
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ethnically homogeneous. Specifically, a majority of individuals were born in, and 
reside in Australia. Thus, results may not generalise to other ethnic groups. Future 
research should examine the cross-cultural validity of the current findings.  
 Conclusion 
This thesis utilised a two-facet conceptualisation of impulsivity to 
examine etiological mechanisms that may underlie the co-occurrence of social 
anxiety and substance misuse. Expanding on the findings of previous research, 
there was evidence to suggest that elevated levels of rash impulsiveness, reward 
sensitivity, and risk-taking characterise a subset of socially anxious individuals 
with comorbid substance use problems. Novel findings suggested that elevated 
levels of rash impulsiveness and reward sensitivity may play important but 
differential roles in the co-occurrence of social anxiety and substance misuse. 
These findings add to an expanding body of literature that suggests impulsivity is 
a multidimensional construct comprised of two distinct but related facets.   
Furthermore, the overall findings raised important questions about the 
capacity to examine the specific mechanisms through which social anxiety 
conveys risk for substance misuse in a clinical sample of individuals seeking 
treatment for their substance use disorder. This finding has implications for future 
research, with regard to assessing and reporting psychiatric comorbidity, and 
generalising research findings from community to clinical samples. The clinical 
implications of this thesis point towards enhanced knowledge for clinicians 
regarding an atypical presentation of social anxiety, and suggest that mindfulness-
based approaches may be effective in the prevention and treatment of co-
occurring social anxiety and substance misuse. 
Although the findings of this thesis converge with and expand on previous 
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research, it is important to acknowledge that research examining the involvement 
of impulsive traits in the co-occurrence of social anxiety and substance misuse is 
in its infancy. Hence, further research needs to be conducted before substantive 
conclusions can be made regarding the specific roles that rash impulsiveness and 
reward sensitivity play in this comorbidity. Despite this, it is hoped that the 
findings of this thesis are incorporated into future research designs, which may 
ultimately enhance outcomes for those suffering from SAD and substance misuse 
comorbidity. 
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Appendix A 
Method and Results of Systematic Review Concerning Two-facet 
Conceptualisation of Impulsivity in Substance Misuse 
The primary aim of the systematic review was to review all studies that have 
measured the two-facet conceptualisation of impulsivity in substance misuse. 
PsycARTICLES, PsychINFO, Academic Search Complete, Psychology and 
Behavioral Sciences Collection, MEDLINE Complete and Science Direct (Social 
Sciences and Humanities Collection) databases were reviewed using the search 
terms presented in Table A1. It was beyond the scope of the present review to 
have a second reviewer examine the literature as per the Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA; Liberati et al., 
2009) guidelines. Inclusion criteria included community samples of substance 
users, individuals who met a formal diagnosis of substance abuse or dependence, 
peer-reviewed journal articles, and articles written in the English language. 
Exclusion criteria included animal studies and studies investigating one-facet of 
impulsivity.   
Initial searches identified 200 articles. After duplicates were removed 142 
abstracts were screened and 24 potentially relevant articles were identified. After 
examination of full-text articles, studies where only one facet of impulsivity was 
measured (n = 3), studies where neither rash impulsiveness nor reward sensitivity 
measures were administered (n = 2), and studies that did not report outcomes 
related to impulsivity or substance use (n = 3) were excluded, leaving a total of 16 
articles to be included in the qualitative synthesis (see Figure A1 for the flow of 
information through different phases of the review). Refer to Table A2 for 
characteristics of included studies. 
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 Figure A1. Flowchart of systematic review concerning two-facet 
conceptualisation of impulsivity in substance misuse.  
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Table A1 
 
Search Terms used in Database Searches Pertaining to the Two-Facet Conceptualisation of Impulsivity in Substance Misuse 
 
 Search Terms 
Substance Misuse Substance* OR Substance use OR Substance Misuse OR Substance Dependen* OR Substance Abuse OR Alcohol use OR Alcohol 
Misuse OR Alcohol Dependence OR Alcohol Abuse OR Drug use OR Drug Misuse OR Drug Depend* OR Drug Abuse OR cocaine OR 
crack OR opi* OR heroin OR amphetamine OR methamphetamine OR MDMA OR ecstasy OR methylenedioxymethamphetamine OR 
cannabis OR marijuana OR psychedelic OR mushroom OR glue OR inhalant OR poly* 
 
Rash Impulsiveness  Rash Impulsiv* OR Sensation Seeking OR Fun-seeking OR Novelty Seek* OR Barratt Impulsiveness Scale OR Impulsiveness Scale OR 
Impuls* 
 
Reward Sensitivity  Reward Drive OR Reward Sensitivity OR Sensitivity to Reward OR Reward Responsiv* OR BAS Drive  
 
 
 
 
Table A2 
 
Characteristics of the Included Studies Utilising the Two-Facet Conceptualisation of Impulsivity in Substance Misuse Research, Ordered by Year of Publication 
 
Reference Design Participants  Substance Use 
Measure  
Rash 
Impulsiveness  
(RI) Measure 
Reward 
Sensitivity (RS) 
Measure 
Outcomes Risk of Bias  
Brunelle et al., 
2004  
Cross-
sectional  
19 male high 
heart-rate 
responders and 18 
male low heart-
rate responders 
from Canada (total 
n = 37) 
Measured heart 
rate response to 
alcohol 
intoxication (1ml 
of 95% alcohol 
USP per kilogram 
of body weight) 
Impulsivity and 
Sensation Seeking 
subscale of the 
Substance Use 
Risk Profile Scale 
(Woicik et al., 
2009) 
SR subscale of the 
SPSRQ (Torrubia 
et al., 2001) 
High heart rate responders 
reported significantly higher RS 
and Sensation Seeking scores 
than low heart-rate responders. 
Scores on the Impulsivity 
subscale trended towards 
significance (p = .08). 
Small sample  
 
Limited 
generalisability 
(all male sample) 
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Franken and 
Muris, 2006a 
Cross-
sectional 
276 undergraduate 
psychology 
students from the 
Netherlands  
Quantity-
Frequency- 
Variability Index 
of Alcohol Use 
(Lemmens, Tan, 
& Knibbe, 1992) 
 
Dichotomous drug 
use measure 
(developed for 
study purposes) 
BAS Fun Seeking 
subscale (Carver & 
White, 1994) 
 
BAS Drive and 
BAS Reward 
Responsiveness 
subscales (Carver 
& White, 1994) 
 
BAS Drive was significantly 
correlated with number of illegal 
substances used and BAS Fun 
Seeking was significantly 
correlated with drinking 
quantity, binge drinking and 
number of illegal substances 
used.  
Limited 
generalisability 
(student sample) 
 
Franken et al., 
2006 
Cross-
sectional 
39 alcohol misuse 
inpatients, 71 drug 
misuse inpatients 
and 96 controls 
from the 
Netherlands (total 
n = 206) 
Inpatient status 
used as measure 
of substance use.  
BAS Fun Seeking 
subscale (Carver & 
White, 1994) 
 
BAS Drive and 
BAS Reward 
Responsiveness 
subscales (Carver 
& White, 1994) 
 
Significant differences between 
groups on BAS total, BAS Fun 
Seeking and BAS Drive. Post-
hoc tests with Bonferroni 
correction showed that the group 
effects were the result of 
differences between the control 
group and drug misuse 
inpatients.   
Selection bias 
Loxton, Wan, et 
al., 2008 
Cross-
sectional 
360 club-drug 
users and 303 non-
drug users from 
Hong Kong 
Developed for 
study purposes; 
frequency 
measure of 
substance use and 
polydrug use  
Chinese version of 
Zuckerman’s 
Sensation Seeking 
Scale (SSS; 
Zuckerman, 1994)  
 
BAS Fun Seeking 
subscale (Carver & 
White, 1994) 
 
BAS Drive and 
BAS Reward 
Responsiveness 
subscales (Carver 
& White, 1994) 
 
Club-drug users scored 
significantly higher than non-
drug users on the SSS, BAS Fun 
Seeking and BAS Drive 
subscales. There was no 
significant effect of personality 
on drug preference.  
Measurement 
bias (substance 
use measure)   
Meda et al., 2009 Cross-
sectional 
36 individuals with 
a family history of 
alcohol abuse, 20 
former and 31 
current cocaine 
Structured 
Clinical Interview 
for DSM-IV 
(First, Spitzer, 
Gibbon, & 
Sensation Seeking 
Scale (Zuckerman, 
1994) 
 
Barratt 
SR subscale of the 
SPSRQ (Torrubia 
et al., 2001) 
 
BAS Drive and 
At risk and substance addicted 
participants scored significantly 
higher than controls on the 
Barratt Impulsiveness Scale and 
the SR subscale.  
Self-selection 
bias 
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users and 89 
controls (total n = 
176)  
Williams, 2002). 
 
Detailed 
substance use 
histories 
Impulsiveness 
Scale (Patton et al., 
1995) 
 
BAS Fun Seeking 
subscale (Carver & 
White, 1994) 
 
BAS Reward 
Responsiveness 
subscales (Carver 
& White, 1994) 
 
Voigt et al., 2009 Cross-
sectional 
1014 college 
undergraduate 
students  
Developed for 
study purposes; 
risky health 
behaviours 
questionnaire, 
including tobacco 
use, drug and 
alcohol use 
BAS Fun Seeking 
subscale (Carver & 
White, 1994) 
 
BAS Drive and 
BAS Reward 
Responsiveness 
subscales (Carver 
& White, 1994) 
 
BAS Fun Seeking was 
significantly associated with 
alcohol, tobacco and drug use. 
BAS Drive was non-
significantly associated with 
alcohol, tobacco and drug use 
and BAS Reward 
Responsiveness was 
significantly negatively 
associated with alcohol, tobacco 
and drug use. 
Limited 
generalisability 
(student sample) 
 
Measurement 
bias (substance 
use measure)   
Egan et al., 2010 Cross-
sectional 
A community 
sample of 102 
ecstasy users and 
105 non-ecstasy 
users (total n = 
207)  
Developed for 
study purposes; 
Frequency, 
quantity, and total 
consumption of 
ecstasy use 
Impulsiveness 
subscale of the I7  
(Eysenck et al., 
1985) 
 
SR subscale of the 
SPSRQ (Torrubia 
et al., 2001) 
Significant differences between 
groups on measures of RI and 
RS.  
Measurement 
bias (substance 
use measure)   
Gullo, Jackson & 
Dawe, 2010. 
Cross-
sectional 
165 university 
students 
AUDIT (Saunders 
et al., 1993) 
Impulsiveness 
subscale of the I7  
(Eysenck et al., 
1985) 
 
SR subscale of the 
SPSRQ (Torrubia 
et al., 2001) 
In a hierarchical regression 
examining the direct relationship 
between personality and 
hazardous drinking RS and RI 
accounted for 4% and 5% 
unique variance, respectively. 
Scores on RS and RI were 
significantly related to AUDIT 
scores.  
Limited 
generalisability 
(student sample) 
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Gullo, Dawe, et 
al., 2010 
Cross-
sectional 
Study 1: 342 
young adults 
 
Study 2: 121 
treatment seeking 
substance abusers 
AUDIT (Saunders 
et al., 1993) 
 
ASSIST (WHO 
ASSIST Working 
Group, 2002) 
 
Alcohol section of 
the Addiction 
Severity Index 
(McLellan, 
Cacciola, & 
Zanis, 1997) 
 
 
 
 
 
Impulsiveness 
subscale of the I7  
(Eysenck et al., 
1985) 
 
SR subscale of the 
SPSRQ (Torrubia 
et al., 2001) 
 
BAS Drive 
subscale (Carver 
& White, 1994 
Study 1: RI and RS were directly 
associated with separate 
cognitive mechanisms (drinking 
refusal self-efficacy and positive 
alcohol expectancy, 
respectively) and related to 
hazardous alcohol use.  
Study 2: RI and RS were directly 
associated with separate 
cognitive mechanisms (drinking 
refusal self-efficacy and positive 
alcohol expectancy, 
respectively) and related to 
hazardous alcohol use. 
 
 
Self-selection 
bias 
 
 
 
 
 
 
 
 
 
 
 
 
Ibáñez et al., 2010 Cross-
sectional  
539 Spanish 
undergraduate 
students  
Alcohol 
Consumption 
Scale (Grau & 
Ortet, 1999) 
Spanish version of 
the Novelty 
Seeking subscale 
of the 
Temperament and 
Character 
Inventory 
(Gutierrez-Zotzes 
et al., 2004) 
Sensitivity to 
Reward subscale 
of the SPSRQ 
(Torrubia et al.,  
2001) 
A hierarchical linear regression 
was carried out on personality 
factors, which included a series 
of personality variables. The 
findings suggested that two 
personality factors predicted 
alcohol use. One factor was 
termed disagreeable 
disinhibition and included the 
RS scale. The second factor was 
termed unconscious disinhibition 
and included the RI subscale.   
Limited 
generalisability  
(student sample) 
Willem et al., 
2010 
Cross-
sectional 
284 high school 
students from 
Belgium  
Teen Addiction 
Severity Index 
(Kaminer, 
Bukstein, & 
Tarter, 1991) 
BAS Fun Seeking 
subscale (Carver & 
White, 1994) 
 
BAS Drive and 
BAS Reward 
Responsiveness 
subscales (Carver 
& White, 1994) 
Age of first use and quantity of 
alcohol use were significantly 
related to BAS Drive and BAS 
Fun Seeking.  In a hierarchical 
linear regression BAS Fun 
Limited 
generalisability 
(student sample) 
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 Seeking uniquely predicted age 
of first use and quantity of 
alcohol use.  
Gullo et al., 2011 Cross- 
Sectional  
183 British and 
271 Australian 
young adults 
AUDIT (Saunders 
et al., 1993) 
 
ASSIST (WHO 
ASSIST Working 
Group, 2002) 
 
Impulsiveness 
subscale of the I7  
(Eysenck et al., 
1985) 
 
BAS Fun Seeking 
subscale (Carver & 
White, 1994) 
 
Novelty seeking 
subscale of the 
TPQ (Cloninger, 
1987) 
BAS Drive and 
BAS Reward 
Responsiveness 
subscales (Carver 
& White, 1994) 
 
Structural equation modelling 
demonstrated that a two-facet 
conceptualisation of impulsivity 
explains more variance in the 
prediction of substance misuse 
than a more parsimonious one-
facet model. 
Limited 
generalisability 
to substance 
dependent 
individuals  
Lyvers et al., 2011 Cross-
sectional 
132 adults  AUDIT (Saunders 
et al., 1993) 
 
Barratt 
Impulsiveness 
Scale (Patton et al., 
1995) 
 
SR subscale of the 
SPSRQ (Torrubia 
et al., 2001) 
The relationship between 
disinhibition and drinking 
behaviour was partially 
mediated by RS. Conversely, RI 
scores contributed little to the 
prediction of AUDIT scores and 
did not mediate the extent to 
which disinhibition influenced 
AUDIT scores.  
Limited 
generalisability 
to substance 
dependent 
individuals  
 
 
 
 
 
Hamilton et al., 
2012 
Cross-
sectional  
446 adults  AUDIT (Saunders 
et al., 1993) 
Barratt 
Impulsiveness 
Scale (Patton et al., 
1995) 
 
BAS Fun Seeking 
subscale (Carver & 
White, 1994) 
 
BAS Drive and 
BAS Reward 
Responsiveness 
subscales (Carver 
& White, 1994) 
 
Hazardous drinkers significantly 
differed from non-hazardous 
drinkers on both measures of RI 
and BAS reward responsiveness. 
There were no significant 
differences on BAS Drive.  
Self-selection 
bias 
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Lyvers et al., 2012 Cross-
sectional 
124 university 
students who 
reported using 
alcohol at least 
occasionally  
AUDIT (Saunders 
et al., 1993) 
Barratt 
Impulsiveness 
Scale (Patton et al., 
1995) 
SR subscale of the 
SPSRQ (Torrubia 
et al., 2001) 
AUDIT defined harmful 
drinkers reported earlier age of 
onset of weekly drinking and 
scored higher on RI and RS 
measures than lower risk groups. 
Differences remained significant 
after controlling for duration of 
alcohol exposure.  
Limited 
generalisability 
(student sample) 
Kabbani and 
Kambouropoulos, 
2013 
Cross-
sectional 
132 adults  AUDIT (Saunders 
et al., 1993) 
Impulsiveness 
subscale of the I7  
(Eysenck et al., 
1985) 
 
SR subscale of the 
SPSRQ (Torrubia 
et al., 2001) 
RS positively predicted drinking 
expectancies, which in turn 
positively predicted alcohol use. 
There was a significant direct 
effect of RS on alcohol use. RI 
positively predicted perceived 
impaired control, which in turn 
positively predicted alcohol use. 
There was not a significant 
direct effect of RI on alcohol 
use.  
Gender 
generalisability 
(mainly female 
participants) 
 
Self-selection 
bias 
 
Small sample 
size 
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Appendix B 
Method and Results of Systematic Review Concerning Two-Facet 
Conceptualisation of Impulsivity in Comorbidity 
The primary aim of the systematic review was to review studies that have 
measured the two-facet conceptualisation of impulsivity in comorbidity. 
PsycARTICLES, PsychINFO, Academic Search Complete, Psychology and 
Behavioral Sciences Collection, MEDLINE Complete and Science Direct (Social 
Sciences and Humanities Collection) databases were reviewed using the search 
terms presented in table B1. It was beyond the scope of the present review to have 
a second reviewer examine the literature as per the PRISMA guidelines (Liberati 
et al., 2009). Inclusion criteria included peer-reviewed journal articles and articles 
written in the English language. Exclusion criteria included animal studies and 
studies investigating one-facet of impulsivity.  
Initial searches identified 42 articles. After duplicates were removed 30 
abstracts were screened and four potentially relevant articles were identified. 
After examination of full-text articles one study that examined impulsivity in 
psychopathy alone was excluded, leaving a total of three articles to be included in 
the qualitative synthesis (see Figure B1 for the flow of information through 
different phases of the review). Refer to Table B2 for characteristics of included 
studies. 
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Figure B1. Flowchart of systematic review concerning two-facet 
conceptualisation of impulsivity in comorbidity research.
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Table B1 
 
Search Terms used in Database Searches Pertaining to the Two-Facet Conceptualisation of Impulsivity in Comorbidity 
 
 Search Terms 
Rash Impulsiveness  Rash Impulsiv* OR Sensation Seeking OR Fun-seeking OR Novelty Seek* OR Barratt Impulsiveness Scale OR Impulsiveness Scale OR Impuls* 
 
Reward Sensitivity  
 
Reward Drive OR Reward Sensitivity OR Sensitivity to Reward OR Reward Responsiv* OR BAS Drive  
 
Comorbidity  Comorb* OR Co-occur* OR Dual Diagnosis OR Co-morb* 
 
 
 
Table B2 
 
Characteristics of the Included Studies Utilising the Two-Facet Conceptualisation of Impulsivity in Comorbidity Research, Ordered by Year of Publication 
 
Reference Design Participants  Substance Use 
Measure  
Rash 
Impulsiveness 
Measure 
Reward 
Sensitivity 
Measure 
Outcomes Risk of Bias  
Kane et al., 
(2004) 
Cross-
sectional 
23 women with co-
occurring bulimia 
nervosa and alcohol 
abuse or 
dependence, 22 
women with bulimia 
nervosa and 21 
women who did not 
meet the criteria for 
either disorder (total 
n = 66) 
AUDIT 
(Saunders et al., 
1993) 
Impulsiveness 
subscale of the I7  
(Eysenck et al., 
1985) 
 
BAS Fun Seeking 
subscale (Carver 
& White, 1994) 
 
 
 
BAS Drive and 
BAS Reward 
Responsiveness 
subscales (Carver 
& White, 1994) 
 
CARROT (Powell 
et al., 1996) 
 
The comorbid and bulimic group 
scored significantly higher than 
controls on the CARROT, 
Impulsiveness subscale of the I7 
and BAS Reward Responsiveness 
subscale. Further, comorbid 
women scored significantly 
higher than bulimic women on 
the Impulsiveness subscale of the 
I7 and non-significantly higher on 
the CARROT.  
Small sample 
 
Gender 
generalisability  
 
Alloy et al., 
(2009) 
Longitudinal  132 participants with 
a bipolar spectrum 
disorder (98 Bipolar 
The Michigan 
Alcoholism 
Screening Test 
BAS Fun Seeking 
subscale (Carver 
& White, 1994) 
BAS Drive and 
BAS Reward 
Responsiveness 
BAS Total score, BAS Fun 
Seeking subscale and scores on 
the IN subscale prospectively 
Limited 
generalisability 
(high functioning 
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II patients, 34 
Cyclothymic) and 
153 controls (total n 
= 285)  
(Selzer, 1971) 
 
DAST (Skinner, 
1992) 
 
Impulsive 
Nonconformity 
Scale (IN; 
Chapman et al., 
1984) 
subscales (Carver 
& White, 1994) 
 
predicted substance use 
problems. BAS total, BAS Fun 
Seeking and IN mediated the 
association between bipolar 
spectrum status and substance use 
problems.  
sample of bipolar 
patients as all 
university 
students)  
Hopley & 
Brunelle 
(2012)  
Cross-
sectional 
92 male offenders 
serving custodial 
sentences 
Two step 
process; 1) 
Checklist of 
substances used 
problematically, 
2) checklist of 
criteria for 
substance 
dependence 
based on DSM-
IV-TR 
diagnostic 
criteria (APA, 
2000) 
Impulsivity (IMP) 
and Sensation 
Seeking (SS) 
subscale of the 
Substance Use 
Risk Profile Scale 
(Woicik et al., 
2009) 
SR scale of the 
SPSRQ (Torrubia 
et al., 2001) 
 
Psychopathy scores were strongly 
related to IMP, SS and RS. The 
IMP subscale mediated the 
relationship between psychopathy 
and stimulant dependence, 
hallucinogen dependence and 
alcohol dependence.  
Gender 
generalisability  
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Appendix C 
Online Questionnaire 
 
(Displayed on Webpage) 
Demographic Information 
 
1:  What is your age?  ____ years 
 
2: Gender RMale   R Female 
 
3: Which country were you born in?_________ 
 
4: Which country do you currently live in?______________ 
 
5: What is the highest level of education you have completed? 
 
RPrimary School 
R Some High School 
R Completed High School (i.e., VCE/HSC or equivalent) 
R Tafe Diploma/Certificate/Trade Qualification 
R University Qualification 
 
6: Have you ever received treatment for social anxiety (e.g., counselling, medication, support 
groups)?   
 
R Yes  
RNo  
 
IF YES 
 
6a) What type of treatment did you receive? ______________________ 
 
6b) How long ago did you receive treatment?  
 
RI am currently receiving treatment  
R Less than 6 months ago  
R Between 6 and 12 months ago  
R More than 12 months ago; please specify length of time________  
 
6c) How long did you receive treatment for?  
 
Please specify in months________ 
 
6d) At what age did you first notice symptoms of social anxiety?________ 
 
7: Have you ever received treatment for alcohol problems (e.g., counselling, detox, residential 
rehabilitation, Alcoholics Anonymous, medication)?  
 
RYes  
RNo  
 
IF YES 
7a) What type of treatment did you receive? ________  
 
7b) How long ago did you receive treatment?  
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RI am currently receiving treatment  
RLess than 6 months ago  
R Between 6 and 12 months ago  
R More than 12 months ago; please specify length of time________  
 
7c) How long did you receive treatment for?  
Please specify in months________  
 
7d. At what age did you first start drinking alcohol on a regular basis?______ 
 
8: Have you ever received treatment for drug problems (e.g., counselling, detox, residential 
rehabilitation, Narcotics Anonymous, medication)?  
 
RYes  
RNo  
 
8a) What type of treatment did you receive? _______  
 
8b) How long ago did you receive treatment?  
 
RI am currently receiving treatment  
RLess than 6 months ago  
RBetween 6 and 12 months ago  
RMore than 12 months ago; please specify length of time________  
 
8c) How long did you receive treatment for?  
 
Please specify in months_______  
 
 
8d) At what age did you first start using drugs on a regular basis?__________ 
 
 
 
AUDIT 
 
Instructions: Please select the response that best describes your answer to each question. 
 
 
1. How often do you have a drink containing alcohol? 
 
RNever 
RMonthly or less 
R2-4 times a month 
R2-3 times a week 
R4 or more times a week 
 
2. How many drinks containing alcohol do you have on a typical day when you are drinking? 
 
R1 or 2 
R3 or 4  
R5 or 6  
R7 to 9  
R10 or more 
 
 
3. How often do you have six or more drinks on one occasion? 
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RNever 
RLess than monthly 
RMonthly 
RWeekly 
RDaily or almost daily    
4. How often during the last year have you found that you were not able to stop drinking once you 
had started? 
 
RNever 
RLess than monthly 
RMonthly 
RWeekly 
RDaily or almost daily    
 
  
5. How often during the last year have you failed to do what is normally expected of you because 
of your drinking? 
 
RNever 
RLess than monthly 
RMonthly 
RWeekly 
RDaily or almost daily    
 
6. How often during the last year have you needed a first drink in the morning to get yourself 
going after a heavy drinking session? 
 
RNever 
RLess than monthly 
RMonthly 
RWeekly 
RDaily or almost daily    
 
7. How often during the last year have you had a feeling of guilt or remorse after drinking? 
 
RNever 
RLess than monthly 
RMonthly 
RWeekly 
RDaily or almost daily    
 
8. How often during the last year have you been unable to remember what happened the night 
before because of your drinking? 
 
RNever 
RLess than monthly 
RMonthly 
RWeekly 
RDaily or almost daily    
 
9. Have you or someone else been injured because of your drinking? 
 
RNo 
R Yes, but not in the last year 
RYes, during the past year 
 
10. Has a relative or friend or a doctor or other health worker, been concerned about your drinking 
or suggested you cut down? 
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RNo 
R Yes, but not in the last year 
RYes, during the past year 
 
 
DAST-10 
 
The following questions concern information about your potential involvement with drugs, 
excluding alcohol and tobacco, during the past 12 months. 
  
When the words “drug abuse” are used, they mean the use of prescribed or over-the-counter 
medications used in excess of the directions and any non-medical use of drugs. The various 
classes of drugs may include: cannabis (e.g., marijuana, hash), solvents, tranquilizers (e.g., 
Valium), barbiturates, cocaine, stimulants (e.g., speed), hallucinogens (e.g., LSD) or narcotics 
(e.g., heroin). Remember that the questions do not include alcohol or tobacco. 
 
If you have difficulty with a statement, then choose the response that is mostly right.  
 
These questions refer to the past 12 months only  
 
1. Have you used drugs other than those required for medical reasons? 
 
RYes RNo 
 
2. Do you abuse more than one drug at a time? 
 
RYes RNo 
 
3. Are you always able to stop using drugs when you want to? 
 
RYes RNo 
 
4. Have you had “blackouts” or “flashbacks” as a result of drug use? 
 
RYes RNo 
 
5. Do you ever feel bad or guilty about your drug use? 
 
RYes RNo 
 
6. Does your spouse (or parent) ever complain about your involvement with drugs? 
 
RYes RNo 
 
7. Have you neglected your family because of your use of drugs? 
 
RYes RNo 
 
8. Have you engaged in illegal activities in order to obtain drugs? 
 
RYes RNo 
 
9. Have you ever experienced withdrawal symptoms (felt sick) when you stopped taking drugs? 
 
RYes RNo 
 
10. Have you had medical problems as a result of your drug use (e.g., memory loss, hepatitis, 
convulsions, bleeding, etc.)? 
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RYes RNo 
 
 
 
 
Drug Use Frequency  
 
Instructions: Please indicate if you have ever used any of the following substances 
 
1. Tobacco: Cigarettes, Chewing, Cigars 
RYes RNo 
 
2. Cannabis: Marijuana, Pot, Hash, Grass 
RYes RNo 
 
3. Cocaine: Coke, Crack 
RYes RNo 
 
4. Amphetamine type stimulants: Speed, Meth, Ice, Ecstasy  
RYes RNo 
 
5. Sedatives: Valium, Serepax, Rohypnol  
RYes RNo 
 
6. Opioids: Heroin, Morphine, Methadone, Codeine  
RYes RNo 
 
7. Other:  ___________ 
RYes RNo 
 
 
Instructions: Please indicate how often you have used the following substances over the past 12 
months.  
 
1. Tobacco: Cigarettes, Chewing, Cigars 
RNot at all 
RMonthly or less 
R2-4 times a month 
R2-3 times a week 
R4 or more times a week 
 
2. Cannabis: Marijuana, Pot, Hash, Grass 
RNot at all 
RMonthly or less 
R2-4 times a month 
R2-3 times a week 
R4 or more times a week 
 
3. Cocaine: Coke, Crack 
RNot at all 
RMonthly or less 
R2-4 times a month 
R2-3 times a week 
R4 or more times a week 
 
4. Amphetamine type stimulants: Speed, Meth, Ice, Ecstasy  
RNot at all 
RMonthly or less 
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R2-4 times a month 
R2-3 times a week 
R4 or more times a week 
 
5. Sedatives: Valium, Serepax, Rohypnol  
RNot at all 
RMonthly or less 
R2-4 times a month 
R2-3 times a week 
R4 or more times a week 
 
6. Opioids: Heroin, Morphine, Methadone, Codeine  
RNot at all 
RMonthly or less 
R2-4 times a month 
R2-3 times a week 
R4 or more times a week 
 
7. Other:  ___________ 
RNot at all 
RMonthly or less 
R2-4 times a month 
R2-3 times a week 
R4 or more times a week 
 
 
 
Impulsiveness Subscale of the I7 
 
Instructions: Please answer each question by selecting the “Yes” or the “No” box. Work quickly 
and do not think too long about the exact meaning of each question. Please remember to answer 
each question.  
 
Items: 
1. Do you often buy things on impulse? 
RYes RNo 
 
2. Do you generally do and say things without stopping to think? 
RYes RNo 
 
3. Do you often get into a jam because you do things without thinking? 
RYes RNo 
 
4. Are you an impulsive person?   
RYes RNo 
 
5. Do you usually think carefully before doing anything? 
RYes RNo 
 
6. Do you often do things on the spur of the moment? 
RYes RNo 
  
7. Do you mostly speak before thinking things out? 
RYes RNo 
 
8. Do you often get involved in things you later wish you could get out of? 
RYes RNo 
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9. Do you get so ‘carried away’ by new and exciting ideas that you never think of possible snags?  
  
RYes RNo 
 
10. Do you need to use a lot of self-control to keep out of trouble? 
RYes RNo 
 
11. Would you agree that almost everything enjoyable is illegal or immoral? 
RYes RNo 
 
12. Are you often surprised at people’s reactions to what you do or say? 
RYes RNo 
 
13. Do you think an evening out is more successful if it is unplanned or arranged at the last 
moment? 
RYes RNo 
 
14. Do you usually work quickly, without bothering to check? 
RYes RNo 
 
15. Do you often change your interests? 
RYes RNo 
 
16. Before making up your mind, do you consider all the advantages and disadvantages? 
RYes RNo 
 
17. Do you prefer to ‘sleep on it’ before making decisions? 
RYes RNo 
 
18. When people shout at you, do you shout back?  
RYes RNo 
 
19. Do you usually make up your mind quickly?   
RYes RNo 
 
SRSRQ 
 
Instructions: Please respond to each question by selecting the “Yes” or the “No” box.  
 
1. Does the prospect of obtaining money motivate you strongly to do some things? 
RYes RNo 
 
2. Do you prefer not to ask for something when you are not sure you will obtain it? 
RYes RNo 
 
3. Are you often afraid of new or unexpected situations?  
RYes RNo 
 
4. Is it difficult for you to telephone someone you do not know?  
RYes RNo 
 
5. Do you often do things to be praised? 
RYes RNo 
 
6. Do you like being the centre of attention at a party of a social meeting?  
RYes RNo 
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7. In tasks that you are not prepared for, do you attach great importance to the possibility of 
failure?  
RYes RNo 
 
8. Do you spend a lot of time on obtaining a good image?  
RYes RNo 
 
9. Are you easily discouraged in difficult situations?  
RYes RNo 
 
10. Are you a shy person?  
RYes RNo 
 
11. When you are in a group, do you try to make your opinions the most intelligent or funniest?  
RYes RNo 
 
12. Whenever possible, do you avoid demonstrating your skills for fear of being embarrassed? 
RYes RNo 
 
13. Do you often take the opportunity to pick up people you find attractive?  
RYes RNo 
 
14. When you are with a group, do you have difficulties selecting a good topic to talk about?  
RYes RNo 
 
15. As a child, did you do a lot of things to get people’s approval?  
RYes RNo 
 
16. Does the possibility of social advancement move you to action, even if this involves not 
playing fair?  
RYes RNo 
 
17. Do you think a lot before complaining in a restaurant if your meal is not well prepared? 
RYes RNo 
 
18. Do you generally give preference to those activities that imply an immediate gain?  
RYes RNo 
 
19. Do you often have trouble resisting the temptation of doing forbidden things?  
RYes RNo 
 
20. Whenever you can, do you avoid going to unknown places?  
RYes RNo 
 
21. Do you like to compete and do everything you can to win? 
RYes RNo 
 
22. Are you often worried by things that you said or did? 
RYes RNo 
 
23. Would it be difficult for you to ask your boss for a raise (salary increase)? 
RYes RNo 
 
24. Do you generally try to avoid speaking in public? 
RYes RNo 
 
25. Do you, on a regular basis, think that you could do more things if it was not for your insecurity 
or fear? 
RYes RNo 
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26. Do you sometimes do things for quick gains? 
RYes RNo 
 
27. Comparing yourself to people you know, are you afraid of many things? 
RYes RNo 
 
28. Does your attention easily stray from your work in the presence of an attractive stranger? 
RYes RNo 
 
29. Do you often find yourself worrying about things to the extent that performance in intellectual 
abilities is impaired? 
RYes RNo 
 
30. Are you interested in money to the point of being able to do risky jobs? 
RYes RNo 
 
31. Do you often refrain from doing something you like in order not to be rejected or disapproved 
by others? 
RYes RNo 
 
32. Do you like to be competitive in all of your activities? 
RYes RNo 
 
33. Would you like to be a socially powerful person? 
RYes RNo 
 
34. Do you often refrain from doing something because of your fear of being embarrassed? 
RYes RNo 
 
35. Do you like displaying your physical abilities even though this may involve danger? 
RYes RNo 
 
 
 
LSAS 
 
Instructions: Please answer two questions for each situation listed below. The first question asks 
how anxious or fearful you feel in the situation. The second question asks how often you avoid the 
situation. If you come across a situation that you ordinarily do not experience, imagine "what if 
you were faced with that situation" and then, rate the degree to which you would fear this 
hypothetical situation and how often you would tend to avoid it. Make the fear or anxiety rating in 
the first column and the avoidance rating in the second column. Please base your ratings on the 
way that situations have affected you in the last week. 
 
 
 Avoidance Rating 
 
Fear or Anxiety Rating 
 
1. 
Telephoning 
in public.  
RNever avoid this situation 
ROccasionally avoid this situation (up 
to 33% of the time) 
ROften avoid this situation (33 to 
67% of the time) 
RUsually avoid this situation (67 to 
100% of the time) 
 
RNo fear or anxiety in this situation 
RMild fear or anxiety in this situation 
RModerate fear or anxiety in this 
situation 
RSevere fear or anxiety in this situation 
 
2. 
Participating 
in small 
RNever avoid this situation 
ROccasionally avoid this situation (up 
to 33% of the time) 
RNo fear or anxiety in this situation 
RMild fear or anxiety in this situation 
RModerate fear or anxiety in this 
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groups.  ROften avoid this situation (33 to 
67% of the time) 
RUsually avoid this situation (67 to 
100% of the time) 
 
situation 
RSevere fear or anxiety in this situation 
 
3. Eating in 
public places.  
RNever avoid this situation 
ROccasionally avoid this situation (up 
to 33% of the time) 
ROften avoid this situation (33 to 
67% of the time) 
RUsually avoid this situation (67 to 
100% of the time) 
 
RNo fear or anxiety in this situation 
RMild fear or anxiety in this situation 
RModerate fear or anxiety in this 
situation 
RSevere fear or anxiety in this situation 
 
4. Drinking 
with others in 
public places.  
RNever avoid this situation 
ROccasionally avoid this situation (up 
to 33% of the time) 
ROften avoid this situation (33 to 
67% of the time) 
RUsually avoid this situation (67 to 
100% of the time) 
 
RNo fear or anxiety in this situation 
RMild fear or anxiety in this situation 
RModerate fear or anxiety in this 
situation 
RSevere fear or anxiety in this situation 
 
5. Talking to 
people in 
authority.  
RNever avoid this situation 
ROccasionally avoid this situation (up 
to 33% of the time) 
ROften avoid this situation (33 to 
67% of the time) 
RUsually avoid this situation (67 to 
100% of the time) 
 
RNo fear or anxiety in this situation 
RMild fear or anxiety in this situation 
RModerate fear or anxiety in this 
situation 
RSevere fear or anxiety in this situation 
 
6. Acting, 
performing or 
giving a talk 
in front of an 
audience. 
RNever avoid this situation 
ROccasionally avoid this situation (up 
to 33% of the time) 
ROften avoid this situation (33 to 
67% of the time) 
RUsually avoid this situation (67 to 
100% of the time) 
 
RNo fear or anxiety in this situation 
RMild fear or anxiety in this situation 
RModerate fear or anxiety in this 
situation 
RSevere fear or anxiety in this situation 
 
7. Going to a 
party.  
RNever avoid this situation 
ROccasionally avoid this situation (up 
to 33% of the time) 
ROften avoid this situation (33 to 
67% of the time) 
RUsually avoid this situation (67 to 
100% of the time) 
 
RNo fear or anxiety in this situation 
RMild fear or anxiety in this situation 
RModerate fear or anxiety in this 
situation 
RSevere fear or anxiety in this situation 
 
8. Working 
while being 
observed.  
RNever avoid this situation 
ROccasionally avoid this situation (up 
to 33% of the time) 
ROften avoid this situation (33 to 
67% of the time) 
RUsually avoid this situation (67 to 
100% of the time) 
 
RNo fear or anxiety in this situation 
RMild fear or anxiety in this situation 
RModerate fear or anxiety in this 
situation 
RSevere fear or anxiety in this situation 
 
9. Writing 
while being 
observed.  
RNever avoid this situation 
ROccasionally avoid this situation (up 
to 33% of the time) 
ROften avoid this situation (33 to 
67% of the time) 
RNo fear or anxiety in this situation 
RMild fear or anxiety in this situation 
RModerate fear or anxiety in this 
situation 
RSevere fear or anxiety in this situation 
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RUsually avoid this situation (67 to 
100% of the time) 
 
 
10. Calling 
someone you 
don’t know 
very well.  
RNever avoid this situation 
ROccasionally avoid this situation (up 
to 33% of the time) 
ROften avoid this situation (33 to 
67% of the time) 
RUsually avoid this situation (67 to 
100% of the time) 
 
RNo fear or anxiety in this situation 
RMild fear or anxiety in this situation 
RModerate fear or anxiety in this 
situation 
RSevere fear or anxiety in this situation 
 
11. Talking 
with people 
you don’t 
know very 
well. 
RNever avoid this situation 
ROccasionally avoid this situation (up 
to 33% of the time) 
ROften avoid this situation (33 to 
67% of the time) 
RUsually avoid this situation (67 to 
100% of the time) 
 
RNo fear or anxiety in this situation 
RMild fear or anxiety in this situation 
RModerate fear or anxiety in this 
situation 
RSevere fear or anxiety in this situation 
 
12. Meeting 
strangers.  
RNever avoid this situation 
ROccasionally avoid this situation (up 
to 33% of the time) 
ROften avoid this situation (33 to 
67% of the time) 
RUsually avoid this situation (67 to 
100% of the time) 
 
RNo fear or anxiety in this situation 
RMild fear or anxiety in this situation 
RModerate fear or anxiety in this 
situation 
RSevere fear or anxiety in this situation 
 
13. Urinating 
in a public 
bathroom.  
RNever avoid this situation 
ROccasionally avoid this situation (up 
to 33% of the time) 
ROften avoid this situation (33 to 
67% of the time) 
RUsually avoid this situation (67 to 
100% of the time) 
 
RNo fear or anxiety in this situation 
RMild fear or anxiety in this situation 
RModerate fear or anxiety in this 
situation 
RSevere fear or anxiety in this situation 
RNo fear or anxiety in this situation 
RMild fear or anxiety in this situation 
RModerate fear or anxiety in this 
situation 
RSevere fear or anxiety in this situation 
 
14. Entering a 
room when 
others are 
already 
seated.  
RNever avoid this situation 
ROccasionally avoid this situation (up 
to 33% of the time) 
ROften avoid this situation (33 to 
67% of the time) 
RUsually avoid this situation (67 to 
100% of the time) 
 
RNo fear or anxiety in this situation 
RMild fear or anxiety in this situation 
RModerate fear or anxiety in this 
situation 
RSevere fear or anxiety in this situation 
 
15. Being the 
centre of 
attention.  
RNever avoid this situation 
ROccasionally avoid this situation (up 
to 33% of the time) 
ROften avoid this situation (33 to 
67% of the time) 
RUsually avoid this situation (67 to 
100% of the time) 
 
RNo fear or anxiety in this situation 
RMild fear or anxiety in this situation 
RModerate fear or anxiety in this 
situation 
RSevere fear or anxiety in this situation 
 
16. Speaking 
up at a 
meeting.  
RNever avoid this situation 
ROccasionally avoid this situation (up 
to 33% of the time) 
ROften avoid this situation (33 to 
RNo fear or anxiety in this situation 
RMild fear or anxiety in this situation 
RModerate fear or anxiety in this 
situation 
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67% of the time) 
RUsually avoid this situation (67 to 
100% of the time) 
 
RSevere fear or anxiety in this situation 
 
17. Taking a 
test.  
RNever avoid this situation 
ROccasionally avoid this situation (up 
to 33% of the time) 
ROften avoid this situation (33 to 
67% of the time) 
RUsually avoid this situation (67 to 
100% of the time) 
 
RNo fear or anxiety in this situation 
RMild fear or anxiety in this situation 
RModerate fear or anxiety in this 
situation 
RSevere fear or anxiety in this situation 
 
18. 
Expressing a 
disagreement 
or disapproval 
to people you 
don’t know 
very well. 
RNever avoid this situation 
ROccasionally avoid this situation (up 
to 33% of the time) 
ROften avoid this situation (33 to 
67% of the time) 
RUsually avoid this situation (67 to 
100% of the time) 
 
RNo fear or anxiety in this situation 
RMild fear or anxiety in this situation 
RModerate fear or anxiety in this 
situation 
RSevere fear or anxiety in this situation 
 
19.  Looking 
at people you 
don’t know 
very well in 
the eyes.  
RNever avoid this situation 
ROccasionally avoid this situation (up 
to 33% of the time) 
ROften avoid this situation (33 to 
67% of the time) 
RUsually avoid this situation (67 to 
100% of the time) 
 
RNo fear or anxiety in this situation 
RMild fear or anxiety in this situation 
RModerate fear or anxiety in this 
situation 
RSevere fear or anxiety in this situation 
 
20. Giving a 
report to a 
group.  
RNever avoid this situation 
ROccasionally avoid this situation (up 
to 33% of the time) 
ROften avoid this situation (33 to 
67% of the time) 
RUsually avoid this situation (67 to 
100% of the time) 
 
RNo fear or anxiety in this situation 
RMild fear or anxiety in this situation 
RModerate fear or anxiety in this 
situation 
RSevere fear or anxiety in this situation 
 
21. Trying to 
pick up 
someone.  
RNever avoid this situation 
ROccasionally avoid this situation (up 
to 33% of the time) 
ROften avoid this situation (33 to 
67% of the time) 
RUsually avoid this situation (67 to 
100% of the time) 
 
RNo fear or anxiety in this situation 
RMild fear or anxiety in this situation 
RModerate fear or anxiety in this 
situation 
RSevere fear or anxiety in this situation 
 
22. Returning 
goods to a 
store.  
RNever avoid this situation 
ROccasionally avoid this situation (up 
to 33% of the time) 
ROften avoid this situation (33 to 
67% of the time) 
RUsually avoid this situation (67 to 
100% of the time) 
 
RNo fear or anxiety in this situation 
RMild fear or anxiety in this situation 
RModerate fear or anxiety in this 
situation 
RSevere fear or anxiety in this situation 
 
23. Giving a 
party.  
RNever avoid this situation 
ROccasionally avoid this situation (up 
to 33% of the time) 
ROften avoid this situation (33 to 
67% of the time) 
RUsually avoid this situation (67 to 
RNo fear or anxiety in this situation 
RMild fear or anxiety in this situation 
RModerate fear or anxiety in this 
situation 
RSevere fear or anxiety in this situation 
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100% of the time) 
 
24. Resisting 
a high 
pressure 
salesperson. 
RNever avoid this situation 
ROccasionally avoid this situation (up 
to 33% of the time) 
ROften avoid this situation (33 to 
67% of the time) 
RUsually avoid this situation (67 to 
100% of the time) 
 
RNo fear or anxiety in this situation 
RMild fear or anxiety in this situation 
RModerate fear or anxiety in this 
situation 
RSevere fear or anxiety in this situation 
 
 
 
 
 
 
 
The Reckless Behaviour Questionnaire 
 
Instructions: Please indicate how many times you have participated in the following types of 
behaviour during the past year.  
 
1. Driven while under the influence of alcohol.  
RNever 
ROnce 
R2-5 times 
R6-10 times 
RMore than 10 times 
 
2. Had sex without using contraceptives (withdrawal and having sex at a “safe” time of the 
menstrual cycle doesn’t count as contraception). NB: Respond N/A to this question if it is not 
applicable to you (e.g., if you are trying to fall pregnant or if you are in a long-term 
relationship and have reached menopause).   
RNever 
ROnce 
R2-5 times 
R6-10 times 
RMore than 10 times 
RN/A 
 
3. Damaged or destroyed public or private property. 
RNever 
ROnce 
R2-5 times 
R6-10 times 
RMore than 10 times 
 
4. Used marijuana. 
RNever 
ROnce 
R2-5 times 
R6-10 times 
RMore than 10 times 
 
5. Shoplifted. 
RNever 
ROnce 
R2-5 times 
R6-10 times 
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RMore than 10 times 
 
6. Driven a car at over 130 kilometres per hour. 
RNever 
ROnce 
R2-5 times 
R6-10 times 
RMore than 10 times 
 
7. Had sex with someone you didn't know well. 
RNever 
ROnce 
R2-5 times 
R6-10 times 
RMore than 10 times 
 
8. Used cocaine. 
RNever 
ROnce 
R2-5 times 
R6-10 times 
RMore than 10 times 
 
9. Driven more than 30 kilometres per hour over the speed limit 
RNever 
ROnce 
R2-5 times 
R6-10 times 
RMore than 10 times 
 
10. Used illegal drugs other than marijuana or cocaine. 
RNever 
ROnce 
R2-5 times 
R6-10 times 
RMore than 10 times 
 
 
Please enter your email address if you wish to enter the draw to win one of six $50 Coles-
Myer gift cards 
_____________________ 
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Appendix D 
Plain Language Statement 
 
DEAKIN UNIVERSITY 
PLAIN LANGUAGE STATEMENT AND CONSENT FORM 
 
TO:  Participant 
 
 
Plain Language Statement  
Date:                                      17th of November 2011 
 
Full Project Title:                Co-occurring social anxiety and substance use  
                                              Problems: The role of rash impulsivity and  
                                              reward drive. 
Principal Researchers:       Dr Nicolas Kambouropoulos 
                                              Associate Professor Petra Staiger 
 
Student Researcher:           Julia Nicholls 
 
1. Your Consent 
Men and women who are aged 18 and above are invited to take part in this research 
project.  
 
This Plain Language Statement contains detailed information about the research project. 
Its purpose is to explain to you as openly and clearly as possible all the procedures 
involved in this project before you decide whether or not to take part in it.  
 
Please read this Plain Language Statement carefully. Feel free to ask questions about 
any information in the document. You may also wish to discuss the project with a relative 
or friend or your local health worker. Feel free to do this.  
 
Once you understand what the project is about and if you agree to take part in it, you will 
be asked to complete the following online questionnaire. Your consent will be indicated 
by electronically submitting your responses, following completion of the questionnaire, to 
the researchers’ anonymous database. 
 
You can print a copy of the Plain Language Statement to keep as a record. 
2. Purpose and Background 
We are interested in learning more about the relationship between social anxiety and 
substance use. We believe that this is important because research suggests that a large 
proportion of individuals seeking treatment for their drug and alcohol problems also report 
social anxiety issues.  
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In particular, we are interested in examining the role that impulsivity, a personality 
characteristic, plays in this relationship. By investigating the personality characteristics 
associated with social anxiety and substance use it is hoped that researchers may be 
able to develop a targeted treatment intervention in the years to come. 
 
This project is being conducted by a postgraduate student as part of the Doctor of 
Clinical Psychology degree at Deakin University, Burwood. It is hoped a total of 500 men 
and women will participate in this project. The results of this research may be used to 
help researcher Julia Nicholls to obtain a postgraduate degree. 
3. Funding 
This research is funded by Deakin University. 
4. Procedures 
Once you have understood and consented to participate in the research you will be 
asked to fill out an online questionnaire, which will take approximately twenty minutes to 
complete. You will be asked questions about drug and alcohol use, impulsivity, risk-
taking and symptoms of social anxiety.  
 
The following are examples of statements and questions which you will be asked to 
respond to: 
x I am afraid that people will find fault with me 
x Is it difficult for you to telephone someone you do not know?  
x Do you often get involved in things you later wish you could get out of? 
x Do you generally do and say things without stopping to think? 
x How often do you have six or more drinks on one occasion? 
 
Once you have completed the questionnaire you can submit your responses 
electronically. Your responses will be sent to the researchers’ anonymous database. You 
are reminded not to include any personal information that could identify you in your 
questionnaire responses. 
5. Possible Benefits 
The findings from this study might assist in the future development of treatment programs 
for individuals with substance use problems and social anxiety difficulties. We cannot 
guarantee or promise that you personally will receive any benefits from this project. 
6. Possible Risks 
No physical or psychological harms are expected as a result of participating in this study. 
However, it is possible that answering questions related to anxiety or your use of alcohol 
and/or illicit drugs may raise concerns. If you have any concerns about your health we 
suggest you contact your general practitioner, Beyond Blue (1300 22 4636 or 
www.beyondblue.org.au)  or DirectLine (1800 888 236). 
 
7. Privacy, Confidentiality and Disclosure of Information 
Any information obtained in connection with this project is anonymous, and therefore 
cannot be used to identify you. Only the researchers will have access to the anonymous 
information obtained in the questionnaires, which will remain strictly confidential. To 
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maintain confidentiality, please ensure that you do not attach your name or any other 
information that could identify you when you complete your questionnaire. While the 
researchers cannot guarantee the complete security of information transmitted through 
the internet, individual participants will not be identifiable from completion of the 
anonymous questionnaire.  
 
Your anonymous responses from this questionnaire will be stored within a locked file 
within the School of Psychology at Deakin University for a minimum or six years, after 
which all files will be destroyed. Again, only the researchers will have access to this data.  
 
We plan to use the results from this study as part of the thesis requirements for a 
Doctoral degree. A report of the study may also be submitted for publication, however in 
any publication, information will be provided in such a way that individual participants 
cannot be identified as only aggregated data will be reported. 
 
8. Results of Project 
If you wish to find out the results of this study, please contact the researchers Dr Nicolas 
Kambouropoulos (nicolas.kambouropoulos@deakin.edu.au), Associate Professor Petra 
Staiger (petra.staiger@deakin.edu.au) or Julia Nicholls (jn@deakin.edu.au) and the 
details will be forwarded to you at the completion of the study.  Please be advised that it 
will not be possible for us to provide you with individual feedback on your responses as 
your data is anonymous. 
 
9. Participation is Voluntary 
Participation in any research project is voluntary. If you do not wish to take part you are 
not obliged to. If you decide to take part and later change your mind, do not submit your 
responses to the questionnaire.  
 
Your decision whether to take part or not to take part, will not affect your relationship with 
Deakin University. 
 
Before you make your decision, a member of the research team will be available to 
answer any questions you have about the research project. You can ask for any 
information you want. Complete the questionnaire only after you have had a chance to 
ask your questions and have received satisfactory answers. 
          
10. Ethical Guidelines 
This project will be carried out according to the National Statement on Ethical Conduct in 
Human Research (2007) produced by the National Health and Medical Research Council 
of Australia. This statement has been developed to protect the interests of people who 
agree to participate in human research studies. 
 
The ethics aspects of this research project have been approved by the Human Research 
Ethics Committee of Deakin University. 
          
11.Complaints 
If you have any complaints about any aspect of the project, the way it is being conducted 
or any questions about your rights as a research participant, then you may contact: The 
Manager, Office of Research Integrity, Deakin University, 221 Burwood Highway, 
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Burwood Victoria 3125, Telephone: 9251 7129, Facsimile: 9244 6581; research-
ethics@deakin.edu.au  
Please quote project number HEAG-H 106/2011  
 
12. Reimbursement for your costs 
You will have the opportunity to be entered into a draw to win one of six $50 Coles-Myer 
vouchers to thank you for your time and participation in our project. This will involve 
completing an entry form after you have completed the questionnaire in order to keep 
your responses anonymous. Winners will be randomly drawn and contacted via email. 
    
13. Further Information, Queries or Any Problems 
If you require further information or if you have any problems concerning this project (for 
example, any side effects), you can contact the principal researchers Dr Nicolas 
Kambouropoulos (nicolas.kambouropoulos@deakin.edu.au) or Associate Professor 
Petra Staiger (petra.staiger@deakin.edu.au). Alternatively you can contact the student 
researcher, Julia Nicholls (jn@deakin.edu.au). 
 
If you wish to take part in this research please click the following button to indicate that 
you have read and understood the terms of the plain language statement and agree to 
participate. Pressing the Submit button at the conclusion of the questionnaire will indicate 
your consent. To maintain anonymity, please ensure that you do not attach your name or 
any other information that could identify you when you submit your completed 
questionnaire.  
 
(I AGREE) 
 
If you do not wish to take part, thank you for your time. 
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Appendix E 
Clinician-Administered Questionnaires 
The following section asks you some general questions about yourself. 
1. Age in years:      
2. Gender:         Male      Female 
3. Where were you born? 
 Australia   New Zealand/Oceania  South America/Caribbean 
 Africa   Middle East   North America 
 Asia   Europe   Other (please specify)________ 
4. Which ethnic/cultural group do you most identify with? (e.g. Australian) _________ 
5. Are you Aboriginal/Torres Strait Islander?       Yes        No 
6. What is your current relationship status? 
 Never married   Married/Living with Partner   Separated/Divorced  
 Steady relationship (not living together)    Widowed 
7. What is the highest level of education you have completed? 
 Primary School     TAFE Diploma/Certificate/Trade Qualification 
 Some High School                  University qualification 
 Completed VCE/HSC    
8. What is your usual occupation? ____________________________________ 
9. What is your current employment status? 
 Unemployed  Employed – part-time/casual  Employed – full-time 
 Student  Retired                 Other (please specify) ____________ 
10. Do you receive any Centrelink benefits?  Yes      No  
11. Who are your main social supports? (Tick all that apply) 
 Parents  Other family  Organisational support (e.g. Odyssey staff) 
 Partner  Friends  Other (please specify) _____________ 
12. Where do you usually live? 
 Rented house       Public housing     Parents’ or other family        
                                                                                                       members’ house 
 House you owned       Homeless/No fixed address   Other (please specify)  
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13. Which suburb do you live in? ____________________________________ 
 
This section asks questions about your alcohol and drug use and treatment history. 
14. At what age did you first try any drugs (including cigarettes or alcohol)?__________________ 
15 At what age did alcohol or drugs begin to interfere with your daily 
activities?_______________  
16. Which drug has caused you the most problems or hassles in the past 3 months? 
(please nominate the most problematic)_______________________________ 
17.What age did you first seek treatment for your drug/alcohol 
problem?______________________ 
18. Please list the number of times that you have attended or used any of the following treatments: 
 Residential rehabilitation:  _______  Pharmacotherapy: _______ 
 Drug/Alchol counselling : _______  NA/AA:  _______ 
 Detoxification:     _______  Home based withdrawal_____ 
19. Have you had problems with anxiety, depression or other mental health issues in the past? 
 Yes        No 
If yes, which mental health issue(s) have you had problems with? 
 
Y/N 
How old were 
you when you 
first had 
problems with 
[mental health 
issue]? 
Did you 
receive 
any 
treatment 
(Y/N)?  
 
How many 
separate 
episodes of 
treatment did 
you receive? 
Are you currently 
taking any 
prescribed 
medication for 
[mental health 
issue] on a regular 
basis? (Y/N) 
What is it? (please 
list) 
Anxiety      
Depression      
Psychosis      
Other (specify): 
_____________ 
     
Other (specify): 
_____________ 
     
 
20. Are you aware of any family members who have been diagnosed with:  
  Anxiety    Depression   Alcohol/Drug problem 
If so, who?          
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20. Do you suffer from a chronic health condition?     Yes        No 
If yes, what do you suffer from?      If yes, are you 
taking any medication for this condition?     Yes        No 
If yes, what is it called?        
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Timeline Followback (only the first page of the ninety day calendar is presented here) 
To help us evaluate your alcohol and drug use, we need to get an idea of what substance use was 
like in the past 90 days. To do this, we would like to fill out a timeline calendar.    
 
 
 
 
 
 
 
Note: Record on the calendar which drugs were used, and when they were taken. Also record how 
many standard drinks were consumed on any drinking day (refer to standard drinks chart). 
 
Period:___________________________ 
 
Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
 
 
 
 
      
 
 
 
 
 
 
 
      
 
 
 
      
 
 
 
      
 
 
 
 
      
 
 
 
 
Complete the following information: 
Number of days to gather information: 90 days 
Start date (day 1): _________________ 
End date (yesterday): _______________ 
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Q1 In your life 
which of 
the 
following 
substances 
have you 
ever used? 
Circle Yes 
or No 
YES 
NO 
YES 
NO 
YES 
NO 
YES 
NO 
YES 
NO 
YES 
NO 
YES 
NO 
YES 
NO 
YES 
NO 
YES 
NO 
                                          Complete Q2 to Q8 for all substances answered “Yes” 
Q2 In the past 
3 months, 
how often 
have you 
used ….. ? 
0 – Never 
2 – Once/ 
twice 
3 – 
Monthly 
4 – Weekly 
6 – Daily/ 
Almost 
Daily 
          
Q3 During the 
past 3 
months, 
how long 
have you 
had strong 
desires or 
urges to 
use…….? 
0 – Never 
3 – Once/ 
twice 
4 – 
Monthly 
5 – Weekly 
6 – Daily/ 
Almost 
Daily 
          
Q4 During the 
past 3 
months, 
how often 
has you 
use of 
…….. led to 
health, 
social, 
legal or 
financial 
problems? 
0 – Never 
4 – Once/ 
twice 
5 – 
Monthly 
6 – Weekly 
7 – Daily/ 
Almost 
Daily 
          
Q5 During the 
past 3 
months 
how often 
have you 
failed to do 
what is 
normally 
expected 
of you 
0 – Never 
5 – Once/ 
twice 
6 – 
Monthly 
7 – Weekly 
8 – Daily/ 
Almost 
Daily 
          
If “Never” go to Q6 for that substance 
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because of 
your use 
of…? 
Q6 Has a 
friend, 
relative or 
any one 
else ever 
expressed 
concern at 
your use 
of……? 
0 - Never 
6 - Yes in 
past 3 
months 
3 - Yes not 
in past 3 
months 
          
Q7 Have you 
ever tried 
and failed 
to control, 
cut down 
or stop 
using…….? 
0 - Never 
6 - Yes in 
past 3 
months 
3 - Yes not 
in past 3 
months 
          
Q8 Have you 
ever used 
any drug 
by 
injection 
(non 
medical)  
0 - Never 
2 - Yes in 
past 3 
months 
1 - Yes not 
in past 3 
months 
          
Scores           
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Appendix F 
Plain Language Statement and Consent Form 
 
 
DEAKIN UNIVERSITY 
PLAIN LANGUAGE STATEMENT AND CONSENT FORM 
 
TO:  Participant 
 
 
Plain Language Statement  
Date:                   12 August 2010 
Full Project Title:  Improving the retention rate for residential treatment 
of substance abuse by sequential intervention for 
social anxiety 
Principal Researchers:           Associate Professor Petra Staiger,  
                                                  Professor Mike Kyrios,  
Dr Nicolas Kambouropoulos 
 
Associate Researchers:         Dr Stefan Gruenert, Ms Caroline Long  
Student Researchers:             Julia Nicholls, Annette Raber  
 
This Plain Language Statement and Consent Form is 7 pages long. Please make sure 
you have all the pages.  
1. Your Consent 
You are invited to take part in this research project.  
This Plain Language Statement contains detailed information about the research project. 
Its purpose is to explain to you as openly and clearly as possible all the procedures 
involved in this project before you decide whether or not to take part in it.  
Please read this Plain Language Statement carefully. Feel free to ask questions about 
any information in the document.  You may also wish to discuss the project with a relative 
or friend or your local health worker. Feel free to do this. 
Once you understand what the project is about and if you agree to take part in it, you will 
be asked to sign the Consent Form. By signing the Consent Form, you indicate that you 
understand the information and that you give your consent to participate in the research 
project. 
You will be given a copy of the Plain Language Statement and Consent Form to keep as 
a record. 
2. Purpose and Background 
The purpose of this project is examine whether addressing a person’s social anxiety 
issues prior to entering residential drug and alcohol treatment means that it is more likely 
that the person will enter and remain in treatment.  
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Not completing residential drug and alcohol treatment is a common problem and it is 
possible that significant anxiety issues may contribute to this problem. We believe that 
addressing social anxiety symptoms before and/or at the early stages of residential 
treatment may help people stay in treatment, and therefore help them get the most from 
the residential treatment. 
In order to see if helping people manage their social anxiety prior to entry into Odyssey 
House will help them stay in the program, we will be offering a widely used psychological 
treatment to randomly selected individuals and comparing their progress with people who 
have not had the social anxiety treatment.  
A total of 90 people will participate in this project. As we want to see if including social 
anxiety treatment before entering the residential treatment is helpful, we need to have 
half the people go through the normal Odyssey House waitlist procedure and half the 
people receive the social anxiety treatment in addition to the normal Odyssey House 
waitlist procedures. You will not be able to choose which group you are in. 
Forty-five individuals will receive the two individual and two small group sessions of 
social anxiety treatment while on the waitlist to enter the usual Odyssey House 
residential treatment program and a combination of therapeutic letters and telephone 
booster sessions in the first two weeks of entering Odyssey house. The other participants 
will follow the usual waitlist procedure (i.e. you will receive standard treatment preparing 
you for entry into Odyssey House – this may involve you attending one or two group 
preparation sessions). All participants will receive standard treatment once they have 
entered Odyssey House. 
You are invited to participate in this research project because you are a client of Odyssey 
House Victoria and have reported experiencing issues with social anxiety.  
3. Funding 
This research is totally funded by the Australian Research Council Linkage Project Grant.  
4. Procedures 
The first component of this project will involve completing an initial assessment. At this 
time you will be asked to complete a written questionnaire and take part in a clinical 
interview. This will take approximately 90 minutes to complete. These questions will 
address social anxiety issues, general anxiety and depression, drug and alcohol use and 
overall well-being. All participants will be asked to complete further assessment sessions 
approximately 6 weeks later, then 3 and 12 months after TC entry. 
At the end of this first assessment appointment you will be randomly assigned to one of 
two groups. One group will receive two individual and two small group therapy sessions 
targeting social anxiety issues, whilst they are on the normal waiting period for to enter 
Odyssey House residential treatment. Participants in this group will be asked to attend 
each session, which will be held at Odyssey House, 660 Bridge Road, Richmond. The 
sessions will be run by experienced senior therapists and there will be 2- to 4 participants 
in each group.  Each session of the social anxiety intervention will be audio taped, in 
order to ensure quality of training and provide feedback and assistance to the therapists 
providing the training.  The recordings will not be utilised for any data analysis and 
audiotapes will be destroyed at the completion of the project.  Once they have entered 
the Therapeutic Community (TC), members of this group will also receive a combination 
of therapeutic letters or telephone booster sessions from the senior therapist reminding 
them of the skill and information received during the social anxiety program. 
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The therapy follows a widely used approach to treating social anxiety symptoms, 
including: thought challenging, shifting from critical internal focus to the social situation 
and facing feared situations in a gradual way. Those randomly assigned to the other 
group will commence at Odyssey House at the end of the normal waiting period. All 
participants will receive the usual treatment for their drug and alcohol use once they enter 
Odyssey House. 
By consenting to take part in this project you are also giving us permission to access 
relevant clinical information from your first appointment (i.e. the intake interview) with 
Odyssey House. This information will involve any mental health information and previous 
treatment information. We are requesting access to this information so that we do not 
need to ask you again during the assessment interview conducted as part of this 
research.   
You will be asked to complete several questionnaires at four separate points in time*: 
1. Initial baseline assessment interview 
2. At the end of the final group therapy session  
3. Three months after entering the TC. 
4. Twelve months after entering the TC 
Please note that if you do not enter the TC or if you are randomly assigned to the other 
group, you are still eligible to be included in the study and we will follow up with you at 
similar time points. 
The questionnaires will take approximately 60 - 90 minutes to complete on each occasion 
and a random sample of 20% of participants will also be asked to provide a urine sample 
at the third interview (3 months after entering TC).  The purpose of the urine sample is to 
confirm any self-reported alcohol and/or drug use.  You are free to refuse to provide a 
sample. 
Examples of questions asked at each point in time are:  
Your background; for example “What was your employment status prior to treatment?” 
and “Do you receive any Centrelink benefits?” 
Your anxiety symptoms; for example “Rate your levels of Fear or Anxiety in when 1. 
Telephoning in public  2. Eating in public places”) 
Your alcohol and drug use; for example “In your life which of the following substances 
have you ever used?” 
5. Possible Benefits 
If you are randomly assigned to receive the social anxiety intervention it is possible that 
you will notice improvement in your social anxiety concerns. All participants will receive 
the regular treatment for substance abuse that is provided by Odyssey House Victoria.  
The findings from this study might assist in future modification of substance abuse 
programs aimed to increase the effectiveness of these programs, and in particular, for 
people with social anxiety issues. 
We cannot guarantee or promise that you personally will receive any benefits from this 
project. 
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6. Possible Risks 
It is possible that some people may find answering questions about any anxiety they are 
experiencing upsetting. If you experience any immediate distress as a result of your 
participation please speak with your Odyssey House Victoria clinician. 
During treatment you will be asked to face potentially anxiety-provoking situations, as this 
has been found to be effective in overcoming anxiety. You will be able to choose these 
situations together with your clinician such that you experience only a manageable level 
of anxiety. 
If you would like to speak with someone at a later stage you can contact beyondblue who 
will be able to assist you with any concerns and with finding appropriate support. Their 
phone number is 1300 22 4636. 
You can suspend or end your participation in the project if distress occurs.  
7. Privacy, Confidentiality and Disclosure of Information 
All information gathered from participants will be kept confidential and secure in 
accordance with Deakin University guidelines, and will not be used for any other purpose 
than that of this research. Information will not be released to any third party without full 
and informed consent of the participants, except as required by law. No identifiable 
details will be kept with the information that is stored. All information on clients collected 
during this research will be destroyed after 6 years.  
It is possible that the results of this study will be published in a scientific journal however 
individual responses will not be identifiable as only group data will be submitted.  
In accordance with the Freedom of Information Act 1982 (Vic), you have the right to 
access and to request correction of information held about you by Deakin University. 
8. Results of Project 
At the completion of the study a summary of the project’s findings will be made available 
upon request. A summary of the result will be available in late 2013 by contacting 
Associate Professor Petra Staiger (pstaiger@deakin.edu.au or 03 9244 6876).  
9. Further Information or Any Problems 
If you require further information or if you have any problems concerning this project (for 
example, feelings of distress), you can contact the A/Prof Petra Staiger or Dr Stefan 
Gruenert.  
Associate Professor Petra Staiger 
School of Psychology 
Faculty of Health, Medicine, Nursing  
and Behavioural Sciences 
Deakin University 
221 Burwood Highway 
Burwood, 3125 
03 9244 6876 
pstaiger@deakin.edu.au 
Dr Stefan Gruenert 
CEO 
Odyssey House Victoria 
660 Bridge Road 
Richmond 3121 
03 9420 7600 
 
10. Complaints 
If you have any complaints about any aspect of the project, the way it is being conducted 
or any questions about your rights as a research participant, then you may contact:   
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The Manager, Office of Research Integrity, Deakin University, 221 Burwood Highway, 
Burwood Victoria 3125, Telephone: 9251 7129, Facsimile: 9244 6581; research-
ethics@deakin.edu.au. 
Please quote project number EC 2010-007. 
11. Participation is Voluntary 
Participation in any research project is voluntary. If you do not wish to take part you are 
not obliged to. If you decide to take part and later change your mind, you are free to 
withdraw from the project at any stage.  
Your decision whether to take part or not to take part, or to take part and then withdraw, 
will not affect your routine treatment, your relationship with those treating you or your 
relationship with the researchers, Odyssey House Victoria, Deakin University or 
Swinburne University of Technology. 
Before you make your decision, a member of the research team will be available so that 
you can ask any questions you have about the research project. You can ask for any 
information you want. Sign the Consent Form only after you have had a chance to ask 
your questions and have received satisfactory answers. 
If you decide to withdraw from the project your participation will immediately cease and 
you may ask for any information obtained from you will not be used.  
12. Reimbursement for your costs 
You will not be paid for your participation in this trial. However, you will be reimbursed 
with Coles Group/MYER gift vouchers to compensate you for your time, for the interviews 
completed when not in residence at the TC.  Due to the extra effort and time involved, 
participants who travel to Odyssey House head office in Richmond for their interview will 
receive a greater level of reimbursement.   An initial reimbursement of $25 will be paid to 
all participants upon completion of the first (baseline) interview schedule in person, whilst 
participants who complete them over the phone will receive $15; following the same 
policy, subsequent interviews will be reimbursed either $20 or $10. Reimbursement will 
be made at the end of the final interview. We have not yet received funding to conduct 
the 12 month interview and we hope to include extra reimbursement for this component 
in the near future. 
If you are selected to receive the social anxiety treatment, or if you complete an interview 
in person at Odyssey House Victoria head office, additional cost for reasonable expenses 
incurred to attend the training sessions will also be reimbursed upon presentation of valid 
receipt (eg: validated METCARD or 2 hr parking ticket). 
13. Ethical Guidelines 
This project will be carried out according to the National Statement on Ethical Conduct in 
Human Research 2007 produced by the National Health and Medical Research Council 
of Australia. This statement has been developed to protect the interests of people who 
agree to participate in human research studies. 
The ethical aspects of this research project have been approved by the Human Research 
Ethics Committee of Deakin University and Swinburne University of Technology. 
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DEAKIN UNIVERSITY 
PLAIN LANGUAGE STATEMENT AND CONSENT FORM 
 
TO:  Participant 
 
Consent Form 
Date:        12 August 2010 
Project Title: Improving the retention rate for residential treatment of 
substance abuse by sequential intervention for social anxiety 
 
 
I have read and I understand the Plain Language Statement. 
I have had an opportunity to ask questions and I am satisfied with the answers I have 
received. 
I freely agree to participate in this project according to the conditions in the Plain 
Language Statement.  
I will be given a copy of the Plain Language Statement and Consent Form to keep. 
I understand that the researcher has agreed not to reveal my identity and personal 
details if information about this project is published or presented in any public form.   
 
Participant’s Name (printed) …………………………………………………….................... 
Signature        Date 
 
Name of Witness to Participant’s Signature (printed) ………………………………………   
Signature        Date 
 
 
